The Carlyle Group Inc. (CG) 10-Q4 May 232023 Q1 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2023	May 03, 2023
Entity Listings [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-35538
Entity Registrant Name	Carlyle Group Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	45-2832612
Entity Address, Address Line One	1001 Pennsylvania Avenue, NW
Entity Address, City or Town	Washington
Entity Address, State or Province	DC
Entity Address, Postal Zip Code	20004-2505
City Area Code	202
Local Phone Number	729-5626
Entity Common Stock, Shares Outstanding		362,114,917
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001527166
Current Fiscal Year End Date	--12-31
Common Stock
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock
Trading Symbol	CG
Security Exchange Name	NASDAQ
4.625% Subordinated Notes due 2061 of Carlyle Finance L.L.C.
Entity Listings [Line Items]
Title of 12(b) Security	4.625% Subordinated Notes due 2061 of Carlyle Finance L.L.C.
Trading Symbol	CGABL
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 1,010.1	$ 1,360.7
Cash and cash equivalents held at Consolidated Funds	228.8	209
Restricted cash	16.8	0.8
Corporate treasury investments	102	20
Investments, including accrued performance allocations of $7,134.0 million and $7,117.7 million as of March 31, 2023 and December 31, 2022, respectively	10,784.1	10,767.9
Investments of Consolidated Funds	7,067.3	6,894.4
Due from affiliates and other receivables, net	499.3	579.4
Due from affiliates and other receivables of Consolidated Funds, net	100.6	101.9
Fixed assets, net	141.8	139.9
Lease right-of-use assets, net	331.5	337
Deposits and other	111.1	78.4
Intangible assets, net	866.4	897.8
Deferred tax assets	14.1	15.8
Total assets	21,273.9	21,403
Liabilities and equity
Debt obligations	2,275.6	2,271.7
Loans payable of Consolidated Funds	6,085.9	5,905.2
Accounts payable, accrued expenses and other liabilities	304.8	369.2
Accrued compensation and benefits	3,894.2	4,320.9
Due to affiliates	314.1	362.5
Deferred revenue	411.7	126.4
Deferred tax liabilities	389.5	402.7
Other liabilities of Consolidated Funds	250.8	279.3
Lease liabilities	494.9	502.9
Accrued giveback obligations	40.9	40.9
Total liabilities	14,462.4	14,581.7
Commitments and contingencies
Common stock, $0.01 par value, 100,000,000,000 shares authorized (362,056,444 and 362,298,650 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively)	3.6	3.6
Additional paid-in-capital	3,195.5	3,138.5
Retained earnings	3,280.9	3,401.1
Accumulated other comprehensive loss	(305.2)	(322.2)
Non-controlling interests in consolidated entities	636.7	600.3
Total equity	6,811.5	6,821.3
Total liabilities and equity	$ 21,273.9	$ 21,403

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accrued performance allocations	$ 7,134	$ 7,117.7
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	100,000,000,000	100,000,000,000
Common stock, issued (in shares)	362,056,444	362,298,650
Common stock, outstanding (in shares)	362,056,444	362,298,650

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
Condensed Consolidated Statements of Operations - USD ($)	Mar. 31, 2023	Mar. 31, 2022
Revenues
Investment income	$ 172,500,000	$ 1,029,800,000
Interest and other income	44,000,000	25,800,000
Interest and other income of Consolidated Funds	121,900,000	61,700,000
Total revenues	859,000,000	1,581,800,000
Compensation and benefits
Cash-based compensation and benefits	260,200,000	254,300,000
Equity-based compensation	54,400,000	39,700,000
Performance allocations and incentive fee related compensation	105,700,000	370,700,000
Total compensation and benefits	420,300,000	664,700,000
General, administrative and other expenses	159,200,000	106,300,000
Interest	29,700,000	27,800,000
Interest and other expenses of Consolidated Funds	93,700,000	42,800,000
Other non-operating expenses	100,000	300,000
Total expenses	703,000,000	841,900,000
Other income
Net investment income of Consolidated Funds	3,600,000	2,800,000
Income before provision for income taxes	159,600,000	742,700,000
Provision for income taxes	34,300,000	147,900,000
Net income	125,300,000	594,800,000
Net income attributable to non-controlling interests in consolidated entities	24,600,000	23,200,000
Net income attributable to common shares	$ 100,700,000	$ 571,600,000
Net income attributable to The Carlyle Group Inc. per common share (see Note 12)
Basic (in dollars per share)	$ 0.28	$ 1.60
Diluted (in dollars per share)	$ 0.28	$ 1.57
Weighted-average common shares
Basic (in shares)	362,944,260	357,574,838
Diluted (in shares)	365,357,833	363,010,282
Fund management fees
Revenues
Fund management fees and incentive fees	$ 500,800,000	$ 450,500,000
Incentive fees
Revenues
Fund management fees and incentive fees	19,800,000	14,000,000
Performance allocations
Revenues
Investment income	160,800,000	710,200,000
Principal investment income
Revenues
Investment income	$ 11,700,000	$ 319,600,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 125.3	$ 594.8
Other comprehensive income (loss)
Foreign currency translation adjustments	19.8	(39.8)
Defined benefit plans
Unrealized gain (loss) for the period	0.3	(1.8)
Less: reclassification adjustment for gain (loss) during the period, included in cash-based compensation and benefits expense	(0.1)	0.3
Other comprehensive income (loss)	20	(41.3)
Comprehensive income	145.3	553.5
Comprehensive income attributable to non-controlling interests in consolidated entities	27.6	17.4
Comprehensive income attributable to The Carlyle Group Inc.	$ 117.7	$ 536.1

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Equity - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in-Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Non- controlling Interests in Consolidated Entities
Beginning balance (in shares) at Dec. 31, 2021		355,400,000
Beginning balance at Dec. 31, 2021	$ 5,706.2	$ 3.6	$ 2,717.6	$ 2,805.3	$ (247.5)	$ 427.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased (in shares)	(1,700,000)	(1,700,000)
Shares repurchased	$ (80.4)			(80.4)
Equity-based compensation	$ 39		39
Shares issued for equity-based awards (in shares)		3,200,000
Shares issued for performance allocations (in shares)	636,461	600,000
Shares issued for performance allocations	$ 31.3		31.3
Shares issued related to the acquisition of CBAM (in shares)		4,200,000
Shares issued related to the acquisition of CBAM	194.5		194.5
Contributions	146.8					146.8
Dividends and distributions	(236.6)			(89.5)		(147.1)
Net income	594.8			571.6		23.2
Currency translation adjustments	(39.8)				(34)	(5.8)
Defined benefit plans, net	(1.5)				(1.5)
Ending balance (in shares) at Mar. 31, 2022		361,700,000
Ending balance at Mar. 31, 2022	$ 6,354.3	$ 3.6	2,982.4	3,207	(283)	444.3
Beginning balance (in shares) at Dec. 31, 2022	362,298,650	362,300,000
Beginning balance at Dec. 31, 2022	$ 6,821.3	$ 3.6	3,138.5	3,401.1	(322.2)	600.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased (in shares)	(3,000,000)	(3,000,000)
Shares repurchased	$ (100.3)			(100.3)
Equity-based compensation	54.8		54.8
Shares issued for equity-based awards (in shares)		2,800,000
Dividend-equivalent rights on certain equity-based awards	$ 0		2.2	(2.2)
Shares issued for performance allocations (in shares)	0
Contributions	$ 18.7					18.7
Dividends and distributions	(128.3)			(118.4)		(9.9)
Net income	125.3			100.7		24.6
Currency translation adjustments	19.8				16.8	3
Defined benefit plans, net	$ 0.2				0.2
Ending balance (in shares) at Mar. 31, 2023	362,056,444	362,100,000
Ending balance at Mar. 31, 2023	$ 6,811.5	$ 3.6	$ 3,195.5	$ 3,280.9	$ (305.2)	$ 636.7

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities
Net income	$ 125.3	$ 594.8
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	44	19.4
Equity-based compensation	54.4	39.7
Non-cash performance allocations and incentive fees, net	(36.7)	(300.8)
Non-cash principal investment income	(7.7)	(315.3)
Other non-cash amounts	10.8	5.3
Consolidated Funds related:
Realized/unrealized (gain) loss on investments of Consolidated Funds	(145)	43.4
Realized/unrealized (gain) loss from loans payable of Consolidated Funds	141.4	(46.2)
Purchases of investments by Consolidated Funds	(386.6)	(1,025.9)
Proceeds from sale and settlements of investments by Consolidated Funds	332.5	1,113.7
Non-cash interest income, net	(3.7)	(2.7)
Change in cash and cash equivalents held at Consolidated Funds	(20.8)	(21.1)
Change in other receivables held at Consolidated Funds	7.1	(6)
Change in other liabilities held at Consolidated Funds	(32.8)	(34.1)
Purchases of investments	(18.5)	(307.5)
Proceeds from the sale of investments	78.6	158.3
Payments of contingent consideration	(68.6)	(5.7)
Changes in deferred taxes, net	(15.1)	110.9
Change in due from affiliates and other receivables	16.9	(9.5)
Change in deposits and other	(33.9)	(39.8)
Change in accounts payable, accrued expenses and other liabilities	(63.9)	(14.3)
Change in accrued compensation and benefits	(371.9)	(580.1)
Change in due to affiliates	(0.2)	(0.2)
Change in lease right-of-use assets and lease liabilities	(2.8)	(2.5)
Change in deferred revenue	284.7	254.5
Net cash used in operating activities	(112.5)	(371.7)
Cash flows from investing activities
Purchases of corporate treasury investments	(101.1)	0
Proceeds from corporate treasury investments	20.1	0
Purchases of fixed assets, net	(12.9)	(12.3)
Purchase of CBAM intangibles and investments, net	0	(618.4)
Net cash used in investing activities	(93.9)	(630.7)
Cash flows from financing activities
Payments on CLO borrowings	(1.1)	(8.9)
Proceeds from CLO borrowings, net of financing costs	0	40.8
Net borrowings (payments) on loans payable of Consolidated Funds	68.7	(21.8)
Dividends to common stockholders	(118.4)	(89.5)
Payment of deferred consideration for Carlyle Holdings units	(68.8)	(68.8)
Contributions from non-controlling interest holders	18.7	146.8
Distributions to non-controlling interest holders	(9.9)	(147.1)
Common shares issued for performance allocations	0	31.3
Common shares repurchased	(100.3)	(80.4)
Change in due to/from affiliates financing activities	74.6	33.1
Net cash used in financing activities	(136.5)	(164.5)
Effect of foreign exchange rate changes	8.3	(17.4)
Decrease in cash, cash equivalents and restricted cash	(334.6)	(1,184.3)
Cash, cash equivalents and restricted cash, beginning of period	1,361.5	2,475.1
Cash, cash equivalents and restricted cash, end of period	1,026.9	1,290.8
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents	1,010.1	1,290.2
Restricted cash	16.8	0.6
Total cash, cash equivalents and restricted cash, end of period	1,026.9	1,290.8
Cash and cash equivalents held at Consolidated Funds	228.8	168.9
Consolidated Operating Entities
Cash flows from operating activities
Net income	108.1	569.7
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	44	19.4
Equity-based compensation	54.4	39.7
Non-cash performance allocations and incentive fees, net	(38.2)	(300.8)
Non-cash principal investment income	(8.7)	(295.4)
Other non-cash amounts	10.8	5.3
Consolidated Funds related:
Purchases of investments	(19)	(294.1)
Proceeds from the sale of investments	78.9	169.5
Payments of contingent consideration	(68.6)	(5.7)
Changes in deferred taxes, net	(15.1)	110.9
Change in due from affiliates and other receivables	17	(8.8)
Change in deposits and other	(33.9)	(39.8)
Change in accounts payable, accrued expenses and other liabilities	(63.9)	(14.3)
Change in accrued compensation and benefits	(371.9)	(580.1)
Change in due to affiliates	(0.2)	(0.2)
Change in lease right-of-use assets and lease liabilities	(2.8)	(2.5)
Change in deferred revenue	284.7	254.5
Net cash used in operating activities	(24.4)	(372.7)
Cash flows from investing activities
Purchases of corporate treasury investments	(101.1)	0
Purchases of fixed assets, net	(12.9)	(12.3)
Purchase of CBAM intangibles and investments, net	0	(618.4)
Net cash used in investing activities	(93.9)	(630.7)
Cash flows from financing activities
Payments on CLO borrowings	(1.1)	(8.9)
Proceeds from CLO borrowings, net of financing costs	0	40.8
Dividends to common stockholders	(118.4)	(89.5)
Payment of deferred consideration for Carlyle Holdings units	(68.8)	(68.8)
Contributions from non-controlling interest holders	2	5.8
Distributions to non-controlling interest holders	(8.5)	(27.1)
Common shares issued for performance allocations	0	31.3
Common shares repurchased	(100.3)	(80.4)
Change in due to/from affiliates financing activities	73	33.1
Net cash used in financing activities	(222.1)	(163.7)
Effect of foreign exchange rate changes	5.8	(17.2)
Decrease in cash, cash equivalents and restricted cash	(334.6)	(1,184.3)
Cash, cash equivalents and restricted cash, beginning of period	1,361.5	2,475.1
Cash, cash equivalents and restricted cash, end of period	1,026.9	1,290.8
Supplemental non-cash disclosures
Issuance of common shares related to the acquisition of CBAM	0	194.5
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents	1,010.1	1,290.2
Restricted cash	16.8	0.6
Total cash, cash equivalents and restricted cash, end of period	1,026.9	1,290.8
Cash and cash equivalents held at Consolidated Funds	228.8	168.9
Consolidated Operating Entities \| MRE
Cash flows from investing activities
Proceeds from corporate treasury investments	$ 20.1	$ 0

Organization and Basis of Prese

Organization and Basis of Presentation	3 Months Ended
Organization and Basis of Presentation	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Basis of Presentation	1. Organization and Basis of Presentation Carlyle is one of the world’s largest global investment firms that deploys private capital across its business through three reportable segments: Global Private Equity, Global Credit and Global Investment Solutions (see Note 15). In the Global Private Equity segment, Carlyle advises buyout, growth, real estate, infrastructure and natural resources funds. The primary areas of focus for the Global Credit segment are liquid credit, private credit, real assets credit, and other credit such as insurance solutions, loan syndication and capital markets. The Global Investment Solutions segment provides investment opportunities and resources for investors and clients through secondary purchases and financing of existing portfolios, managed co-investment programs and primary fund investments. Carlyle typically serves as the general partner, investment manager or collateral manager, making day-to-day investment decisions concerning the assets of these products. Basis of Presentation The accompanying financial statements include the accounts of the Company and its consolidated subsidiaries. In addition, certain Carlyle-affiliated funds, related co-investment entities and certain CLOs managed by the Company (collectively, the “Consolidated Funds”) have been consolidated in the accompanying financial statements pursuant to accounting principles generally accepted in the United States (“U.S. GAAP”), as described in Note 2. The consolidation of the Consolidated Funds generally has a gross-up effect on assets, liabilities and cash flows, and generally has no effect on the net income attributable to the Company. The economic ownership interests of the other investors in the Consolidated Funds are reflected as non-controlling interests in consolidated entities in the accompanying condensed consolidated financial statements (see Note 2). The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information. These statements, including notes, have not been audited, exclude some of the disclosures required for annual financial statements, and should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the United States Securities and Exchange Commission (“SEC”). The operating results presented for interim periods are not necessarily indicative of the results that may be expected for any other interim period or for the entire year. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair presentation of the financial condition and results of operations for the interim periods presented.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
Summary of Significant Accounting Policies	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Principles of Consolidation The Company consolidates all entities that it controls either through a majority voting interest or as the primary beneficiary of variable interest entities (“VIEs”). The Company evaluates (1) whether it holds a variable interest in an entity, (2) whether the entity is a VIE, and (3) whether the Company’s involvement would make it the primary beneficiary. In evaluating whether the Company holds a variable interest, fees (including management fees, incentive fees and performance allocations) that are customary and commensurate with the level of services provided, and where the Company does not hold other economic interests in the entity that would absorb more than an insignificant amount of the expected losses or returns of the entity, are not considered variable interests. The Company considers all economic interests, including indirect interests, to determine if a fee is considered a variable interest. For those entities where the Company holds a variable interest, the Company determines whether each of these entities qualifies as a VIE and, if so, whether or not the Company is the primary beneficiary. The assessment of whether the entity is a VIE is generally performed qualitatively, which requires judgment. These judgments include: (a) determining whether the equity investment at risk is sufficient to permit the entity to finance its activities without additional subordinated financial support, (b) evaluating whether the equity holders, as a group, can make decisions that have a significant effect on the economic performance of the entity, (c) determining whether two or more parties’ equity interests should be aggregated, and (d) determining whether the equity investors have proportionate voting rights to their obligations to absorb losses or rights to receive returns from an entity. For entities that are determined to be VIEs, the Company consolidates those entities where it has concluded it is the primary beneficiary. The primary beneficiary is defined as the variable interest holder with (a) the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and (b) the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. In evaluating whether the Company is the primary beneficiary, the Company evaluates its economic interests in the entity held either directly or indirectly by the Company. As of March 31, 2023, assets and liabilities of the consolidated VIEs reflected in the unaudited condensed consolidated balance sheets were $7.4 billion and $6.3 billion, respectively. As of December 31, 2022, assets and liabilities of the consolidated VIEs reflected in the unaudited condensed consolidated balance sheets were $7.2 billion and $6.2 billion, respectively. Except to the extent of the consolidated assets of the VIEs, the holders of the consolidated VIEs’ liabilities generally do not have recourse to the Company. The Company’s Consolidated Funds are primarily CLOs, which are VIEs that issue loans payable that are backed by diversified collateral asset portfolios consisting primarily of loans or structured debt. In exchange for managing the collateral for the CLOs, the Company earns investment management fees, including in some cases subordinated management fees and contingent incentive fees. In cases where the Company consolidates the CLOs (primarily because of a retained interest that is significant to the CLO), those management fees and contingent incentive fees have been eliminated as intercompany transactions. As of March 31, 2023, the Company held $112.7 million of investments in these CLOs which represents its maximum risk of loss. The Company’s investments in these CLOs are generally subordinated to other interests in the entities and entitle the Company to receive a pro rata portion of the residual cash flows, if any, from the entities. Investors in the CLOs have no recourse against the Company for any losses sustained in the CLO structure. The Company’s Consolidated Funds also include certain investment funds in our Global Private Equity segment that are accounted for as consolidated VIEs due to the Company providing financing to bridge investment purchases. As of March 31, 2023, the Company held $376.5 million of notes receivable from these investment funds which represents its maximum risk of loss. Entities that do not qualify as VIEs are generally assessed for consolidation as voting interest entities. Under the voting interest entity model, the Company consolidates those entities it controls through a majority voting interest. All significant inter-entity transactions and balances of entities consolidated have been eliminated. Investments in Unconsolidated Variable Interest Entities The Company holds variable interests in certain VIEs that are not consolidated because the Company is not the primary beneficiary, including its investments in certain CLOs and certain AlpInvest vehicles, as well as its strategic investment in NGP Management Company, L.L.C. (“NGP Management” and, together with its affiliates, “NGP”). Refer to Note 4 for information on the strategic investment in NGP. The Company’s involvement with such entities is in the form of direct or indirect equity interests and fee arrangements. The maximum exposure to loss represents the loss of assets recognized by the Company relating to its variable interests in these unconsolidated entities. The assets recognized in the Company’s unaudited condensed consolidated balance sheets related to the Company’s variable interests in these non-consolidated VIEs were as follows: As of March 31, 2023 December 31, 2022 (Dollars in millions) Investments $ 1,084.9 $ 1,124.0 Accrued performance allocations 455.0 406.0 Management fee receivables 43.3 49.6 Total $ 1,583.2 $ 1,579.6 These amounts represent the Company’s maximum exposure to loss related to the unconsolidated VIEs as of March 31, 2023 and December 31, 2022. Basis of Accounting The accompanying financial statements are prepared in accordance with U.S. GAAP. Management has determined that the Company’s Funds are investment companies under U.S. GAAP for the purposes of financial reporting. U.S. GAAP for an investment company requires investments to be recorded at estimated fair value and the unrealized gains and/or losses in an investment’s fair value are recognized on a current basis in the statements of operations. Additionally, the Funds do not consolidate their majority-owned and controlled investments (the “Portfolio Companies”). In the preparation of these unaudited condensed consolidated financial statements, the Company has retained the specialized accounting for the Funds. All of the investments held and notes issued by the Consolidated Funds are presented at their estimated fair values in the Company’s condensed consolidated balance sheets. Interest and other income of the Consolidated Funds, interest expense and other expenses of the Consolidated Funds, and net investment income (losses) of Consolidated Funds are included in the Company’s unaudited condensed consolidated statements of operations. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management’s estimates are based on historical experiences and other factors, including expectations of future events that management believes to be reasonable under the circumstances. It also requires management to exercise judgment in the process of applying the Company’s accounting policies. Assumptions and estimates regarding the valuation of investments and their resulting impact on performance allocations and incentive fees involve a higher degree of judgment and complexity and these assumptions and estimates may be significant to the consolidated financial statements and the resulting impact on performance allocations and incentive fees. Actual results could differ from these estimates and such differences could be material. Business Combinations The Company accounts for business combinations using the acquisition method of accounting, under which the purchase price of the acquisition is allocated to the assets acquired and liabilities assumed using the fair values determined by management as of the acquisition date. Contingent consideration obligations that are elements of consideration transferred are recognized as of the acquisition date as part of the fair value transferred in exchange for the acquired business. Acquisition-related costs incurred in connection with a business combination are expensed as incurred. Revenue Recognition The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers . Revenue is recognized when the Company transfers promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those goods or services. ASC 606 includes a five-step framework that requires an entity to: (i) identify the contract(s) with a customer, which includes assessing the collectability of the consideration to which it will be entitled in exchange for the goods or services transferred to the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when the entity satisfies a performance obligation. The Company accounts for performance allocations that represent a performance-based capital allocation from fund limited partners to the Company (commonly known as “carried interest”) as earnings from financial assets within the scope of ASC 323, Investments — Equity Method and Joint Ventures , and therefore are not in the scope of ASC 606. In accordance with ASC 323, the Company records equity method income (losses) as a component of investment income based on the change in its proportionate claim on net assets of the investment fund, including performance allocations, assuming the investment fund was liquidated as of each reporting date pursuant to each fund’s governing agreements. See Note 4 for additional information on the components of investments and investment income. Performance fees that do not meet the definition of performance-based capital allocations are in the scope of ASC 606 and are included in incentive fees in the unaudited condensed consolidated statements of operations. The calculation of unrealized performance revenues utilizes investment valuations of the funds’ underlying investments, which are derived using the policies, methodologies and templates prepared by the Company’s valuation group, as described in Note 3, Fair Value Measurement. While the determination of who is the customer in a contractual arrangement will be made on a contract-by-contract basis, the customer will generally be the investment fund for the Company’s significant management and advisory contracts. The customer determination impacts the Company’s analysis of the accounting for contract costs. Fund Management Fees The Company provides management services to funds in which it holds a general partner interest or to funds or certain portfolio companies with which it has an investment advisory or investment management agreement. The Company considers the performance obligations in its contracts with its funds to be the promise to provide (or to arrange for third parties to provide) investment management services related to the management, policies and operations of the funds. As it relates to the Company’s performance obligation to provide investment management services, the Company typically satisfies this performance obligation over time as the services are rendered, since the funds simultaneously receive and consume the benefits provided as the Company performs the service. The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised services to the funds. Management fees earned from each investment management contract over the contract life represent variable consideration because the consideration the Company is entitled to varies based on fluctuations in the basis for the management fee, for example fund net asset value (“NAV”) or assets under management (“AUM”). Given that the management fee basis is susceptible to market factors outside of the Company’s influence, management fees are constrained and, therefore, estimates of future period management fees are generally not included in the transaction price. Revenue recognized for the investment management services provided is generally the amount determined at the end of the period because that is when the uncertainty for that period is resolved. For closed-end carry funds in the Global Private Equity and Global Credit segments, management fees generally range from 1.0% to 2.0% of commitments during the fund’s investment period based on limited partners’ capital commitments to the funds. Following the expiration or termination of the investment period, management fees generally are based on the lower of cost or fair value of invested capital and the rate charged may also be reduced. These terms may vary for certain separately managed accounts, longer-dated carry funds, and other closed-end funds. The Company will receive management fees during a specified period of time, which is generally ten years from the initial closing date, or, in some instances, from the final closing date, but such termination date may be earlier in certain limited circumstances or later if extended for successive one-year periods, typically up to a maximum of two years. Depending upon the contracted terms of investment advisory or investment management and related agreements, these fees are generally called semi-annually in advance and are recognized as earned over the subsequent six month period. For certain longer-dated carry funds and certain other closed-end funds, management fees are called quarterly over the life of the funds. Within the Global Credit segment, for CLOs and other structured products, management fees generally range from 0.4% to 0.5% based on the total par amount of assets or the aggregate principal amount of the notes in the CLO and are generally due quarterly in arrears based on the terms and recognized over the respective period. Management fees for the CLOs and other structured products are governed by indentures and collateral management agreements. The Company will receive management fees for the CLOs until redemption of the securities issued by the CLOs, which is generally five Under the strategic advisory services agreement with Fortitude, the Company earns a recurring management fee based on Fortitude’s general account assets, which adjusts within an agreed range based on Fortitude’s overall profitability and which is due quarterly in arrears. Management fees for the Company’s carry fund vehicles in the Global Investment Solutions segment generally range from 0.25% to 1.0% of the vehicle’s capital commitments during the commitment fee period of the relevant fund. Following the expiration of the commitment fee period, the management fees generally range from 0.25% to 1.0% on (i) the net invested capital; (ii) the lower of cost or net asset value of the capital invested, or (iii) the net asset value for unrealized investments. Management fees for the Global Investment Solutions carry fund vehicles are generally due quarterly in advance and recognized over the related quarter. As of March 31, 2023 and December 31, 2022, management fee receivables, net of allowances for credit losses, were $169.5 million and $236.9 million, respectively, and are included in due from affiliates and other receivables, net, in the unaudited condensed consolidated balance sheets. The Company also provides transaction advisory and portfolio advisory services to the portfolio companies, and where covered by separate contractual agreements, recognizes fees for these services when the performance obligation has been satisfied and collection is reasonably assured. The Company is generally required to offset its fund management fees earned by a percentage of the transaction and advisory fees earned, which is referred to as the “rebate offset,” which generally ranges from 80% to 100%. The Company also recognizes underwriting fees from the Company’s loan syndication and capital markets business, Carlyle Global Capital Markets. Fund management fees include transaction and portfolio advisory fees, as well as capital markets fees, of $13.4 million and $14.6 million for the three months ended March 31, 2023 and 2022, respectively, net of rebate offsets as defined in the respective partnership agreements. Fund management fees exclude the reimbursement of any partnership expenses paid by the Company on behalf of the Carlyle funds pursuant to the limited partnership agreements, including amounts related to the pursuit of actual, proposed, or unconsummated investments, professional fees, expenses associated with the acquisition, holding and disposition of investments, and other fund administrative expenses. For the professional fees that the Company arranges for the investment funds, the Company concluded that the nature of its promise is to arrange for the services to be provided and it does not control the services provided by third parties before they are transferred to the customer. Therefore, the Company concluded it is acting in the capacity of an agent. Accordingly, the reimbursement for these professional fees paid on behalf of the investment funds is presented on a net basis in general, administrative and other expenses in the unaudited condensed consolidated statements of operations. The Company also incurs certain costs, primarily employee travel and entertainment costs, employee compensation and systems costs, for which it receives reimbursement from the investment funds in connection with its performance obligation to provide investment and management services. For reimbursable travel, compensation and systems costs, the Company concluded it controls the services provided by its employees and the resources used to develop applicable systems before they are transferred to the customer and therefore is a principal. Accordingly, the reimbursement for these costs incurred by the Company to manage the fund limited partnerships are presented on a gross basis in interest and other income in the unaudited condensed consolidated statements of operations and the expense in general, administrative and other expenses or cash-based compensation and benefits expenses in the unaudited condensed consolidated statements of operations. Incentive Fees In connection with management contracts from certain of its Global Credit funds, the Company is also entitled to receive performance-based incentive fees when the return on assets under management exceeds certain benchmark returns or other performance targets. In such arrangements, incentive fees are recognized when the performance benchmark has been achieved. Incentive fees are variable consideration because they are contingent upon the investment vehicle achieving stipulated investment return hurdles. Investment returns are highly susceptible to market factors outside of the Company’s influence. Accordingly, incentive fees are constrained until all uncertainty is resolved. Estimates of future period incentive fees are generally not included in the transaction price because these estimates are constrained. The transaction price for incentive fees is generally the amount determined at the end of each accounting period to which they relate because that is when the uncertainty for that period is resolved, as these fees are not subject to clawback. Investment Income (Loss), including Performance Allocations Investment income (loss) represents the unrealized and realized gains and losses resulting from the Company’s equity method investments, including any associated general partner performance allocations, and other principal investments, including CLOs. General partner performance allocations consist of the allocation of profits from certain of the funds to which the Company is entitled (commonly known as carried interest). For closed-end carry funds in the Global Private Equity and Global Credit segments, the Company is generally entitled to a 20% allocation (or approximately 2% to 12.5% for most of the Global Investment Solutions segment carry fund vehicles) of the net realized income or gain as a carried interest after returning the invested capital, the allocation of preferred returns of generally 7% to 9% and return of certain fund costs (generally subject to catch-up provisions as set forth in the fund limited partnership agreement). These terms may vary on longer-dated funds, certain credit funds, and external co-investment vehicles. Carried interest is recognized upon appreciation of the funds’ investment values above certain return hurdles set forth in each respective partnership agreement. The Company recognizes revenues attributable to performance allocations based upon the amount that would be due pursuant to the fund partnership agreement at each period end as if the funds were terminated at that date. Accordingly, the amount recognized as investment income for performance allocations reflects the Company’s share of the gains and losses of the associated funds’ underlying investments measured at their then-current fair values relative to the fair values as of the end of the prior period. Because of the inherent uncertainty, these estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and it is reasonably possible that the difference could be material. Carried interest is ultimately realized when: (i) an underlying investment is profitably disposed of, (ii) certain costs borne by the limited partner investors have been reimbursed, (iii) the fund’s cumulative returns are in excess of the preferred return and (iv) the Company has decided to collect carry rather than return additional capital to limited partner investors. Realized carried interest may be required to be returned by the Company in future periods if the fund’s investment values decline below certain levels. When the fair value of a fund’s investments remains constant or falls below certain return hurdles, previously recognized performance allocations are reversed. In all cases, each fund is considered separately in this regard, and for a given fund, performance allocations can never be negative over the life of a fund. If upon a hypothetical liquidation of a fund’s investments at their then-current fair values, previously recognized and distributed carried interest would be required to be returned, a liability is established for the potential giveback obligation. As of March 31, 2023 and December 31, 2022, the Company has accrued $40.9 million and $40.9 million, respectively, for giveback obligations. Principal investment income (loss) is realized when the Company redeems all or a portion of its investment or when the Company receives or is due cash income, such as dividends or distributions. Unrealized principal investment income (loss) results from the Company’s proportionate share of the investee’s unrealized earnings, including changes in the fair value of the underlying investment, as well as the reversal of unrealized gain (loss) at the time an investment is realized. As it relates to the Company’s investments in NGP (see Note 4), principal investment income includes the related amortization of the basis difference between the Company’s carrying value of its investment and the Company’s share of underlying net assets of the investee, as well as the compensation expense associated with compensatory arrangements provided by the Company to employees of its equity method investee. Interest Income Interest income is recognized when earned. For debt securities representing non-investment grade beneficial interests in securitizations, the effective yield is determined based on the estimated cash flows of the security. Changes in the effective yield of these securities due to changes in estimated cash flows are recognized on a prospective basis as adjustments to interest income in future periods. Interest income earned by the Company is included in interest and other income in the accompanying unaudited condensed consolidated statements of operations. Interest income of the Consolidated Funds was $109.8 million and $56.5 million for the three months ended March 31, 2023 and 2022, respectively, and is included in interest and other income of Consolidated Funds in the accompanying unaudited condensed consolidated statements of operations. Credit Losses The Company measures all expected credit losses for financial assets held at the reporting date in accordance with ASC 326, Financial Instruments — Credit Losses , based on historical experience, current conditions, and reasonable and supportable forecasts. The Company assesses the collection risk characteristics of the outstanding amounts in its due from affiliates balance into the following pools of receivables: • Reimbursable fund expenses receivables, • Management fee receivables, • Incentive fee receivables, • Transaction fee receivables, • Portfolio fee receivables, and • Notes receivable. The Company generally utilizes either historical credit loss information or discounted cash flows to calculate expected credit losses for each pool. The Company’s receivables are predominantly with its investment funds, which have low risk of credit loss based on the Company’s historical experience. Historical credit loss data may be adjusted for current conditions and reasonable and supportable forecasts, including the Company’s expectation of near-term realization based on the liquidity of the affiliated investment funds. Compensation and Benefits Cash-based Compensation and Benefits – Cash-based compensation and benefits includes salaries, bonuses (discretionary awards and guaranteed amounts), performance payment arrangements and benefits paid and payable to Carlyle employees. Bonuses are accrued over the service period to which they relate. Equity-Based Compensation – Compensation expense relating to the issuance of equity-based awards is measured at fair value on the grant date. The compensation expense for awards that vest over a future service period is recognized over the relevant service period on a straight-line basis. The compensation expense for awards that do not require future service is recognized immediately. Cash settled equity-based awards are classified as liabilities and are re-measured at the end of each reporting period. The compensation expense for awards that contain performance conditions is recognized when it is probable that the performance conditions will be achieved; in certain instances, such compensation expense may be recognized prior to the grant date of the award. The compensation expense for awards that contain market conditions is based on a grant-date fair value that factors in the probability that the market conditions will be achieved and is recognized over the requisite service period on a straight-line basis. Certain equity-based awards contain dividend-equivalent rights, which are subject to the same terms and conditions, including with respect to vesting and settlement, that apply to the related award. Dividend-equivalents are accounted for as a reclassification from retained earnings to additional paid-in capital at the time dividends are declared and do not result in incremental compensation expense. Equity-based awards issued to non-employees are generally recognized as general, administrative and other expenses, except to the extent they are recognized as part of the Company’s equity method earnings because they are issued to employees of equity method investees. The Company recognizes equity-based award forfeitures in the period they occur as a reversal of previously recognized compensation expense. The reduction in compensation expense is determined based on the specific awards forfeited during that period. Furthermore, the Company recognizes all excess tax benefits and deficiencies as income tax benefit or expense in the unaudited condensed consolidated statements of operations. Performance Allocations and Incentive Fee Related Compensation – A portion of the performance allocations and incentive fees earned is due to employees and advisors of the Company. These amounts are accounted for as compensation expense in conjunction with the recognition of the related performance allocations and incentive fee revenue and, until paid, are recognized as a component of the accrued compensation and benefits liability. Accordingly, upon a reversal of performance allocations or incentive fee revenue, the related compensation expense, if any, is also reversed. As of March 31, 2023 and December 31, 2022, the Company had recorded a liability of $3.6 billion, for both periods, related to the portion of accrued performance allocations and incentive fees due to employees and advisors, respectively, which was included in accrued compensation and benefits in the accompanying unaudited condensed consolidated balance sheets. Income Taxes The Carlyle Group Inc. is a corporation for U.S. federal income tax purposes and thus is subject to U.S. federal, state and local corporate income taxes. Tax positions taken by the Company are subject to periodic audit by U.S. federal, state, local and foreign taxing authorities. The interim provision for income taxes is calculated using the discrete effective tax rate method as allowed by ASC 740, Accounting for Income Taxes . The discrete method is applied when the application of the estimated annual effective tax rate is impractical because it is not possible to reliably estimate the annual effective tax rate. In addition, the discrete method treats the year to date period as if it was the annual period and determines the income tax expense or benefit on that basis. The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement reporting and the tax basis of assets and liabilities using enacted tax rates in effect for the period in which the difference is expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period of the change in the provision for income taxes. Further, deferred tax assets are recognized for the expected realization of available net operating loss and tax credit carry forwards. A valuation allowance is recorded on the Company’s gross deferred tax assets when it is “more likely than not” that such asset will not be realized. When evaluating the realizability of the Company’s deferred tax assets, all evidence, both positive and negative, is evaluated. Items considered in this analysis include the ability to carry back losses, the reversal of temporary differences, tax planning strategies, and expectations of future earnings. The Company accounts for the valuation allowance assessment on its deferred tax assets and without regard to the Company’s potential future corporate alternative minimum tax (“CAMT”) status. Lastly, the Company accounts for the tax on global intangible low-taxed income (“GILTI”) as incurred and therefore has not recorded deferred taxes related to GILTI on its foreign subsidiaries. Under U.S. GAAP for income taxes, the amount of tax benefit to be recognized is the amount of benefit that is “more likely than not” to be sustained upon examination. The Company analyzes its tax filing positions in all of the U.S. federal, state, local and foreign tax jurisdictions where it is required to file income tax returns, as well as for all open tax years in these jurisdictions. If, based on this analysis, the Company determines that uncertainties in tax positions exist, a

Fair Value Measurement

Fair Value Measurement	3 Months Ended
Fair Value Measurement	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurement	3. Fair Value Measurement The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the above fair value hierarchy levels as of March 31, 2023: (Dollars in millions) Level I Level II Level III Total Assets Investments of Consolidated Funds (1) : Equity securities (2) $ — $ — $ 435.5 $ 435.5 Bonds — — 593.2 593.2 Loans — — 5,481.7 5,481.7 — — 6,510.4 6,510.4 Investments in CLOs and other: Investments in CLOs — — 544.8 544.8 Other investments (3) 1.5 41.9 76.1 119.5 1.5 41.9 620.9 664.3 Corporate treasury investments Commercial paper and other — 102.0 — 102.0 — 102.0 — 102.0 Foreign currency forward contracts — 2.1 — 2.1 Subtotal $ 1.5 $ 146.0 $ 7,131.3 $ 7,278.8 Investments measured at net asset value 569.6 Total $ 7,848.4 Liabilities Loans payable of Consolidated Funds (4) $ — $ — $ 5,647.9 $ 5,647.9 Foreign currency forward contracts — 1.6 — 1.6 Total (5) $ — $ 1.6 $ 5,647.9 $ 5,649.5 (1) This balance excludes $556.9 million related to investments of consolidated funds that are included in investments measured at net asset value. (2) This balance includes $382.7 million related to investments that have been bridged by the Company to investment funds and are accounted for as consolidated VIEs as of March 31, 2023. (3) The Level III balance excludes $50.3 million related to three corporate investments in equity securities which the Company has elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to ASC 321, Investments – Equity Securities . As a non-recurring fair value measurement, the fair value of these equity securities is excluded from the tabular Level III rollforward disclosures. (4) Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interest held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. (5) Total liabilities balance excludes $280.5 million of senior notes measured at amortized cost and a $157.5 million revolving credit balance, both related to loans payable of Consolidated Funds. The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the above fair value hierarchy levels as of December 31, 2022: (Dollars in millions) Level I Level II Level III Total Assets Investments of Consolidated Funds (1) : Equity securities (2) $ — $ — $ 430.6 $ 430.6 Bonds — — 594.9 594.9 Loans — — 5,352.9 5,352.9 — — 6,378.4 6,378.4 Investments in CLOs — — 526.1 526.1 Other investments (3) 1.6 41.6 79.4 122.6 Corporate treasury investments Commercial paper and other — 20.0 — 20.0 — 20.0 — 20.0 Foreign currency forward contracts — 2.2 — 2.2 Subtotal $ 1.6 $ 63.8 $ 6,983.9 $ 7,049.3 Investments measured at net asset value 528.5 Total $ 7,577.8 Liabilities Loans payable of Consolidated Funds (4) $ — $ — $ 5,491.6 $ 5,491.6 Foreign currency forward contracts — 3.2 — 3.2 Total (5) $ — $ 3.2 $ 5,491.6 $ 5,494.8 (1) This balance excludes $516.0 million related to investments of consolidated funds that are included in investments measured at net asset value. (2) This balance includes $377.4 million related to investments that have been bridged by the Company to investment funds and are accounted for as consolidated VIEs as of December 31, 2022. (3) The Level III balance excludes $58.2 million related to two corporate investments in equity securities which the Company has elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to ASC 321, Investments – Equity Securities . As a non-recurring fair value measurement, the fair value of these equity securities is excluded from the tabular Level III rollforward disclosures. (4) Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. (5) Total liabilities balance excludes $235.6 million of senior notes measured at amortized cost and a $178.0 million revolving credit balance related to loans payable of Consolidated Funds. The changes in financial instruments measured at fair value for which the Company has used Level III inputs to determine fair value are as follows (Dollars in millions): Financial Assets Three Months Ended March 31, 2023 Investments of Consolidated Funds Equity Bonds Loans Investments in CLOs Other investments Total Balance, beginning of period $ 430.6 $ 594.9 $ 5,352.9 $ 526.1 $ 79.4 $ 6,983.9 Purchases 5.4 29.8 237.3 — — 272.5 Sales and distributions — (47.0) (169.7) (7.9) (0.9) (225.5) Settlements — (4.1) (101.6) — — (105.7) Realized and unrealized gains (losses), net Included in earnings (0.5) 11.4 116.0 19.1 (2.4) 143.6 Included in other comprehensive income — 8.2 46.8 7.5 — 62.5 Balance, end of period $ 435.5 $ 593.2 $ 5,481.7 $ 544.8 $ 76.1 $ 7,131.3 Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date $ (0.4) $ 8.5 $ 107.3 $ 19.1 $ (3.3) $ 131.2 Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date $ — $ 8.7 $ 48.6 $ 7.5 $ — $ 64.8 Financial Assets Three Months Ended March 31, 2022 Investments of Consolidated Funds Equity Bonds Loans Investments in CLOs Other investments Total Balance, beginning of period $ 17.9 $ 599.5 $ 5,898.1 $ 361.1 $ 78.7 $ 6,955.3 Purchases 0.1 182.5 766.0 227.6 0.9 1,177.1 Sales and distributions (6.8) (186.9) (731.0) (14.1) (2.0) (940.8) Settlements — (0.3) (162.8) — — (163.1) Realized and unrealized gains (losses), net Included in earnings 0.4 (13.8) (53.9) (9.6) (1.6) (78.5) Included in other comprehensive income (0.3) (15.8) (103.9) (4.6) — (124.6) Balance, end of period $ 11.3 $ 565.2 $ 5,612.5 $ 560.4 $ 76.0 $ 6,825.4 Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date $ 0.3 $ (14.5) $ (59.4) $ (9.6) $ (1.6) $ (84.8) Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date $ (0.2) $ (10.8) $ (87.0) $ (4.6) $ — $ (102.6) Financial Liabilities Loans Payable of Consolidated Funds Three Months Ended March 31, 2023 2022 Balance, beginning of period $ 5,491.6 $ 5,811.0 Borrowings 0.6 1,108.4 Paydowns (2.1) (415.4) Sales (38.1) (669.5) Realized and unrealized (gains) losses, net Included in earnings 141.4 (46.2) Included in other comprehensive income 54.5 (106.2) Balance, end of period $ 5,647.9 $ 5,682.1 Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date $ 142.4 $ (49.8) Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date $ 54.5 $ (102.6) Realized and unrealized gains and losses included in earnings for Level III investments for investments in CLOs and other investments are included in investment income (loss), and such gains and losses for investments of Consolidated Funds and loans payable of the Consolidated Funds are included in net investment gains (losses) of Consolidated Funds in the unaudited condensed consolidated statements of operations. Gains and losses included in other comprehensive income for all Level III financial asset and liabilities are included in accumulated other comprehensive loss and non-controlling interests in consolidated entities. The following table summarizes quantitative information about the Company’s Level III inputs as of March 31, 2023: Fair Value at Valuation Technique(s) Unobservable Input(s) Range (Dollars in millions) March 31, 2023 Assets Investments of Consolidated Funds: Equity securities $ 2.5 Consensus Pricing Indicative Quotes ($ per share) 0.00 - 392.50 (0.08) 365.4 Discounted Cash Flow Discount Rates 10% - 10% (10%) Terminal Growth Rate 0% - 7% (5%) Comparable Multiple EBITDA Multiple 12.7x - 12.7x (12.7x) TCF Multiple 24.5x - 24.5x (24.5x) 50.0 Discounted Cash Flow Discount Rates 10% - 10% (10%) Terminal Growth Rate 0% - 7% (5%) Comparable Multiple TCF Multiple 24.5x - 24.5x (24.5x) 0.3 Comparable Multiple EBITDA Multiple 13.8x - 19.0x (17.8x) 17.3 Other (1) N/A N/A Bonds 593.2 Consensus Pricing Indicative Quotes (% of Par) 40 - 107 (89) Loans 5,121.2 Consensus Pricing Indicative Quotes (% of Par) 0 - 102 (94) 11.4 Discounted Cash Flow Discount Rates 8% - 13% (13%) 329.7 Discounted Cash Flow Discount Rates 7% - 10% (8%) 8.4 Consensus Pricing Indicative Quotes (% of Par) 98% -98% (98%) 10.5 Consensus Pricing Indicative Quotes (% of Par) 86% - 86% (86%) 0.5 Other (1) N/A N/A 6,510.4 Investments in CLOs: Senior secured notes 476.6 Consensus Pricing with Discounted Cash Flow Indicative Quotes (% of Par) 72 - 100 (95) Discount Margins (Basis Points) 170 - 1,365 (314) Default Rates 2% - 3% (2%) Recovery Rates 60% - 60% (60%) Subordinated notes and preferred shares 68.2 Consensus Pricing with Discounted Cash Flow Indicative Quotes (% of Par) 0 - 86 (55) Discount Rates 15% - 25% (20%) Default Rates 2% - 3% (2%) Recovery Rates 60% - 60% (60%) Other investments: BDC preferred shares 73.6 Market Yield Analysis Market Yields 11% - 11% (11%) Aviation subordinated notes 2.5 Discounted Cash Flow Discount Rates 21% - 21% (21%) Total $ 7,131.3 Liabilities Loans payable of Consolidated Funds: Senior secured notes $ 5,451.1 Other (1) N/A N/A Subordinated notes and preferred shares 196.8 Consensus Pricing with Discounted Cash Flow Indicative Quotes (% of Par) 21 - 99 (39) Discount Rates 15% - 25% (20%) Default Rates 2% - 3% (3%) Recovery Rates 60% - 60% (60%) Total $ 5,647.9 (1) Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. The following table summarizes quantitative information about the Company’s Level III inputs as of December 31, 2022: Fair Value at Valuation Technique(s) Unobservable Input(s) Range (Dollars in millions) December 31, 2022 Assets Investments of Consolidated Funds: Equity securities $ 3.1 Consensus Pricing Indicative Quotes ($ per share) 0.00 - 4.73 (0.18) 363.5 Discounted Cash Flow Discount Rates 10% - 10% (10%) Terminal Growth Rate 0% - 7% (5%) Comparable Multiple EBITDA Multiple 12.7x - 12.7x (12.7x) TCF Multiple 23.8x - 23.8x (23.8x) 64.0 Other (1) N/A N/A Bonds 594.9 Consensus Pricing Indicative Quotes (% of Par) 46 - 105 (88) Loans 5,043.4 Consensus Pricing Indicative Quotes (% of Par) 0 - 100 (91) 11.8 Discounted Cash Flow Discount Rates 0% - 9% (1%) 248.7 Discounted Cash Flow Discount Rates 7% - 10% (8%) 37.4 Consensus Pricing Indicative Quotes (% of Par) 97% - 98% (97%) 11.1 Consensus Pricing Indicative Quotes (% of Par) 91% - 91% (91%) 0.5 Other (1) N/A N/A 6,378.4 Investments in CLOs: Senior secured notes 462.1 Discounted Cash Flow with Consensus Pricing Indicative Quotes (% of Par) 67 - 100 (93) Discount Margins (Basis Points) 170 - 1,800 (386) Default Rates 2% - 3% (2%) Recovery Rates 50% - 70% (60%) Subordinated notes and preferred shares 64.0 Discounted Cash Flow with Consensus Pricing Indicative Quotes (% of Par) 0 - 82 (40) Discount Rate 15% - 25% (20%) Default Rates 2% - 3% (2%) Recovery Rates 50% - 70% (60%) Other investments: BDC preferred shares 76.9 Market Yield Analysis Market Yields 11% - 11% (11%) Aviation subordinated notes 2.5 Discounted Cash Flow Discount Rates 21% - 21% (21%) Total $ 6,983.9 Liabilities Loans payable of Consolidated Funds: Senior secured notes $ 5,303.3 Other (2) N/A N/A Subordinated notes and preferred shares 188.3 Discounted Cash Flow with Consensus Pricing Indicative Quotes (% of Par) 21 - 96 (38) Discount Rates 15% - 25% (20%) Default Rates 2% - 3% (3%) Recovery Rates 50% - 70% (60%) Total $ 5,491.6 (1) Fair value approximates transaction price that was in close proximity to the reporting date. (2) Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. The significant unobservable inputs used in the fair value measurement of investments of the Company’s consolidated funds are indicative quotes. Significant decreases in indicative quotes in isolation would result in a significantly lower fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s investments in CLOs and other investments include indicative quotes, discount margins, discount rates, default rates, and recovery rates. Significant decreases in indicative quotes or recovery rates in isolation would result in a significantly lower fair value measurement. Significant increases in discount margins, discount rates or default rates in isolation would result in a significantly lower fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s loans payable of Consolidated Funds are discount rates, default rates, recovery rates and indicative quotes. Significant increases in discount rates or default rates in isolation would result in a significantly lower fair value measurement. Significant decreases in recovery rates or indicative quotes in isolation would result in a significantly lower fair value measurement.

Investments

Investments	3 Months Ended
Investments	Mar. 31, 2023
Investments [Abstract]
Investments	4. Investments Investments consist of the following: As of March 31, 2023 December 31, 2022 (Dollars in millions) Accrued performance allocations $ 7,134.0 $ 7,117.7 Principal equity method investments, excluding performance allocations 2,915.6 2,922.0 Principal investments in CLOs 544.8 526.1 Other investments 189.7 202.1 Total $ 10,784.1 $ 10,767.9 Accrued Performance Allocations The components of accrued performance allocations are as follows: As of March 31, 2023 December 31, 2022 (Dollars in millions) Global Private Equity $ 5,484.4 $ 5,577.1 Global Credit 226.3 193.9 Global Investment Solutions 1,423.3 1,346.7 Total $ 7,134.0 $ 7,117.7 Approximately 22% of accrued performance allocations at March 31, 2023 are related to Carlyle Partners VI, L.P.and Carlyle Partners VII, L.P., two of the Company’s Global Private Equity funds. Approximately 13% of accrued performance allocations at December 31, 2022 are related to Carlyle Partners VI, L.P., one of the Company’s Global Private Equity funds. Accrued performance allocations are shown gross of the Company’s accrued performance allocations and incentive fee related compensation (see Note 7), and accrued giveback obligations, which are separately presented in the unaudited condensed consolidated balance sheets. The components of the accrued giveback obligations are as follows: As of March 31, 2023 December 31, 2022 (Dollars in millions) Global Private Equity $ (18.4) $ (18.4) Global Credit (22.5) (22.5) Total $ (40.9) $ (40.9) Principal Equity-Method Investments, Excluding Performance Allocations The Company’s principal equity method investments (excluding performance allocations) include its fund investments in Global Private Equity, Global Credit, and Global Investment Solutions typically as general partner interests, and its investments in Fortitude through a Carlyle-affiliated fund (included within Global Credit) and NGP (included within Global Private Equity), which are not consolidated. Principal investments are related to the following segments: As of March 31, 2023 December 31, 2022 (Dollars in millions) Global Private Equity (1) $ 1,826.3 $ 1,853.5 Global Credit (2) 987.5 974.2 Global Investment Solutions 101.8 94.3 Total $ 2,915.6 $ 2,922.0 (1) The balance includes $1,011.2 million and $1,015.7 million as of March 31, 2023 and December 31, 2022, respectively, related to the Company’s equity method investments in NGP. (2) As of March 31, 2023 and December 31, 2022, the balance includes $619.7 million and $646.0 million, respectively, related to the Company’s investments in Fortitude. Investment in Fortitude On November 13, 2018, the Company acquired a 19.9% interest in Fortitude Group Holdings, LLC (“Fortitude Holdings”), a wholly owned subsidiary of American International Group, Inc. (“AIG”) (the “Minority Transaction”), pursuant to a Membership Interest Purchase Agreement by and among the Company, AIG and Fortitude Holdings, dated as of July 31, 2018 (the “2018 MIPA”). Fortitude Holdings owns 100% of the outstanding common shares of Fortitude Reinsurance Company Ltd., a Bermuda domiciled reinsurer (“Fortitude Re,” f/k/a “DSA Re”) established to reinsure a portfolio of AIG’s legacy life, annuity and property and casualty liabilities. The Company paid $381 million in cash at closing of the Minority Transaction (the “Initial Purchase Price”) and expects to pay up to $95 million in additional deferred consideration following December 31, 2023. In May 2020, the Initial Purchase Price was adjusted upward by $99.5 million in accordance with the 2018 MIPA as Fortitude Holdings chose not to distribute a planned non-pro rata dividend to AIG prior to May 13, 2020. The Company paid $79.6 million of such adjustment in May 2020 and will pay the remaining $19.9 million following December 31, 2023. On June 2, 2020, Carlyle FRL, L.P. (“Carlyle FRL”), a Carlyle-affiliated investment fund, acquired a 51.6% ownership interest in Fortitude Holdings from AIG (the “Control Transaction”) and T&D United Capital Co., Ltd. (“T&D”), a subsidiary of T&D Holdings, Inc., purchased a 25.0% ownership interest as a strategic third-party investor pursuant to a Membership Interest Purchase Agreement by and among the Company, AIG, Carlyle FRL, and T&D, dated as of November 25, 2019 (the “2019 MIPA”). At closing, the Company contributed its existing 19.9% interest in Fortitude Holdings to Carlyle FRL, such that Carlyle FRL held a 71.5% interest in Fortitude Holdings. Taken together, Carlyle FRL and T&D had 96.5% ownership of Fortitude Holdings. On October 1, 2021, Carlyle FRL, T&D and AIG effected a restructuring of the ownership of Fortitude Holdings that interposed FGH Parent, L.P. (“FGH Parent”), as the direct parent company of Fortitude Holdings (the “Restructuring”). Each of Carlyle FRL, T&D and AIG contributed the entirety of their interest in Fortitude Holdings to FGH Parent in exchange for an equivalent ownership interest in FGH Parent. References to “Fortitude” prior to the Restructuring refer to Fortitude Holdings. For periods subsequent to the Restructuring, references to “Fortitude” refer to FGH Parent. In March 2022, the Company raised $2.0 billion in third-party equity capital from certain investors in Carlyle FRL and T&D, and committed $100 million from the Company for additional equity capital in Fortitude. In May 2022, Fortitude called $1.1 billion of the capital raise, with the remaining capital expected to be called in 2023. In connection with the capital raise and subsequent funding, the Company’s indirect ownership of Fortitude decreased from 19.9% to 13.5%. As a result of the dilution, the Company recorded a reduction in the carrying value of its equity method investment and corresponding loss of $176.9 million. At the time the remaining capital is called by Fortitude, the Company’s indirect ownership is expected to further decrease to 10.5%, and the Company expects to record an additional reduction in the carrying value of its equity method investment and corresponding loss of approximately $117 million, based on the carrying value as of March 31, 2023, subject to change based on the timing of the dilution and changes in the carrying value of the investment. As of March 31, 2023, the carrying value of the Company’s investment in Carlyle FRL, which is an investment company that accounts for its investment in Fortitude at fair value, was $619.7 million, relative to its cost of $514.7 million. The Company has an asset management relationship with Fortitude pursuant to which Fortitude committed to allocate assets in asset management strategies and vehicles of the Company and its affiliates. As of March 31, 2023, Fortitude Holdings and certain Fortitude reinsurance counterparties have committed approximately $9.6 billion of capital to-date to various Carlyle strategies. On April 1, 2022, the Company entered into a strategic advisory services agreement with certain subsidiaries of Fortitude through a newly-formed investment advisor, Carlyle Insurance Solutions Management L.L.C. (“CISM”). Under the agreement, CISM provides Fortitude with certain services, including business development and growth, transaction origination and execution, and capital management services in exchange for a recurring management fee based on Fortitude’s general account assets, which adjusts within an agreed range based on Fortitude’s overall profitability. Third party investors who participated in the March 2022 capital raise also made a minority investment in CISM, which is reflected as non-controlling interest in consolidated entities in the unaudited condensed consolidated financial statements. Investment in NGP The Company has equity interests in NGP Management Company, L.L.C. (“NGP Management”), the general partners of certain carry funds advised by NGP, and principal investments in certain NGP funds. The Company does not control NGP and accounts for its investments in NGP under the equity method of accounting, and includes these investments in the Global Private Equity segment. These interests entitle the Company to an allocation of income equal to 55.0% of the management fee related revenues of NGP Management which serves as the investment advisor to certain NGP funds as well as 47.5% of the performance allocations received by certain current and future NGP fund general partners. The Company’s investments in NGP as of March 31, 2023 and December 31, 2022 are as follows: As of March 31, 2023 December 31, 2022 (Dollars in millions) Investment in NGP Management $ 370.1 $ 369.7 Investments in NGP general partners - accrued performance allocations 566.1 564.5 Principal investments in NGP funds 75.0 81.5 Total investments in NGP $ 1,011.2 $ 1,015.7 Investment in NGP Management . The Company’s equity interests in NGP Management entitle the Company to an allocation of income equal to 55.0% of the management fee related revenues of NGP Management, which serves as the investment advisor to the NGP Energy Funds. Management fees are generally calculated as 1.0% to 2.0% of the limited partners’ commitments during the fund’s investment period, and 0.5% to 2.0% based on the lower of cost or fair market value of invested capital following the expiration or termination of the investment period. Management fee related revenues from NGP Management are primarily driven by NGP XII and NGP XI during the three months ended March 31, 2023 and 2022. The Company records investment income (loss) for its equity income allocation from NGP management fee related revenues and also records its share of any allocated expenses from NGP Management, expenses associated with the compensatory elements of the investment, and the amortization of the basis differences related to the definite-lived identifiable intangible assets of NGP Management. The net investment income (loss) recognized in the Company’s unaudited condensed consolidated statements of operations for the three months ended March 31, 2023 and 2022 were as follows: Three Months Ended March 31, 2023 2022 (Dollars in millions) Management fee related revenues from NGP Management $ 18.1 $ 17.0 Expenses related to the investment in NGP Management (3.4) (2.8) Amortization of basis differences from the investment in NGP Management — (0.3) Net investment income from NGP Management $ 14.7 $ 13.9 The difference between the Company’s remaining carrying value of its investment and its share of the underlying net assets of the investee was amortized over a period of 10 years from the initial investment date and was fully amortized as of December 31, 2022. The Company assesses the remaining carrying value of its equity method investment for impairment whenever events or circumstances indicate that the carrying value may not be recoverable, and considers factors including, but not limited to, expected cash flows from its interest in future management fees and NGP’s ability to raise new funds. Investment in the General Partners of NGP Carry Funds . The Company’s investment in the general partners of the NGP Carry Funds entitle it to 47.5% of the performance allocations received by certain current and future NGP fund general partners. The Company records its equity income allocation from NGP performance allocations in principal investment income (loss) from equity method investments rather than performance allocations in its unaudited condensed consolidated statements of operations. The Company recognized $1.7 million of net investment earnings related to these performance allocations for the three months ended March 31, 2023. The Company recognized $250.4 million of net investment earnings related to these performance allocations for the three months ended March 31, 2022. Principal Investments in NGP Funds . The Company also holds principal investments in the NGP Carry Funds. The Company recognized net investment earnings (losses) related to principal investment income in its unaudited condensed consolidated statements of operations of $(0.1) million and $18.0 million for the three months ended March 31, 2023 and 2022, respectively. Principal Investments in CLOs and Other Investments Principal investments in CLOs as of March 31, 2023 and December 31, 2022 were $544.8 million and $526.1 million, respectively, and consisted of investments in CLO senior and subordinated notes. A portion of the Company’s principal investments in CLOs is collateral to CLO term loans (see Note 6). As of March 31, 2023 and December 31, 2022, other investments include the Company’s investment in the BDC Preferred Shares at fair value of $73.6 million and $76.9 million, respectively (see Note 9). Investment Income (Loss) The components of investment income (loss) are as follows: Three Months Ended March 31, 2023 2022 (Dollars in millions) Performance allocations Realized $ 179.6 $ 266.9 Unrealized (18.8) 443.3 160.8 710.2 Principal investment income (loss) from equity method investments (excluding performance allocations) Realized 38.5 32.8 Unrealized (30.2) 295.3 8.3 328.1 Principal investment income (loss) from investments in CLOs and other investments Realized (1.1) 2.3 Unrealized (1) 4.5 (10.8) 3.4 (8.5) Total $ 172.5 $ 1,029.8 (1) The three months ended March 31, 2023 includes investment loss of $13.3 million associated with the remeasurement of a corporate investment, which was previously carried at cost, resulting from observable price changes pursuant to ASC 321, Investments - Equity Securities . The performance allocations included in revenues are derived from the following segments: Three Months Ended March 31, 2023 2022 (Dollars in millions) Global Private Equity $ (3.8) $ 657.9 Global Credit 33.4 (34.0) Global Investment Solutions 131.2 86.3 Total $ 160.8 $ 710.2 Approximately (5)%, or $(7.6) million, of performance allocations for the three months ended March 31, 2023 are related to the following funds along with total revenue recognized (total revenue includes performance allocations, fund management fees, and principal investment income): • Carlyle Partners VII, L.P. (Global Private Equity segment) - $68.8 million, • Carlyle Europe Partners V, L.P. (Global Private Equity segment) - $61.0 million, • Carlyle US Equity Opportunities Fund II, L.P. (Global Private Equity segment) - $43.4 million, • Carlyle Credit Opportunities Fund II, L.P. (Global Credit segment) - $27.8 million, • AlpInvest ASF VII (Offshore) (Global Investment Solutions segment) - $19.0 million, • Carlyle Asia Partners V, L.P. (Global Private Equity segment) - $(11.1) million, • Carlyle International Energy Partners I (Global Private Equity segment) - $(23.0) million and • Carlyle Partners VI, L.P. (Global Private Equity segment) - $(74.4) million. Approximately 49%, or $350.4 million, of performance allocations for the three months ended March 31, 2022 are related to the following funds along with total revenue recognized (total revenue includes performance allocations, fund management fees, and principal investment income): • Carlyle Realty Partners VIII, L.P. (Global Private Equity segment) - $148.0 million, • Carlyle Partners VII, L.P. (Global Private Equity segment) - $122.6 million, • Carlyle International Energy Partners I (Global Private Equity segment) - $82.9 million, and • Carlyle Europe Partners IV, L.P. (Global Private Equity segment) - $80.3 million. Carlyle’s income (loss) from its principal equity method investments consists of: Three Months Ended March 31, 2023 2022 (Dollars in millions) Global Private Equity $ 17.8 $ 328.2 Global Credit (18.9) (2.7) Global Investment Solutions 9.4 2.6 Total $ 8.3 $ 328.1 Investments of Consolidated Funds The Company consolidates the financial positions and results of operations of certain CLOs in which it is the primary beneficiary. During the three months ended March 31, 2023, the Company did not form any new CLOs for which the Company is the primary beneficiary. Investments in Consolidated Funds as of March 31, 2023 also include $382.7 million related to investments that have been bridged by the Company to investment funds that are actively fundraising and are accounted for as consolidated VIEs. There were no individual investments with a fair value greater than five percent of the Company’s total assets for any period presented. Interest and Other Income of Consolidated Funds The components of interest and other income of Consolidated Funds are as follows: Three Months Ended 2023 2022 (Dollars in millions) Interest income from investments $ 109.8 $ 56.5 Other income 12.1 5.2 Total $ 121.9 $ 61.7 Net Investment Income of Consolidated Funds Net investment income (losses) of Consolidated Funds include net realized gains (losses) from sales of investments and unrealized gains (losses) resulting from changes in fair value of the Consolidated Funds’ investments. The components of net investment income (losses) of Consolidated Funds are as follows: Three Months Ended 2023 2022 (Dollars in millions) Gains (losses) from investments of Consolidated Funds $ 145.0 $ (43.4) Gains (losses) from liabilities of CLOs (141.4) 46.2 Total $ 3.6 $ 2.8 The following table presents realized and unrealized gains (losses) earned from investments of the Consolidated Funds: Three Months Ended 2023 2022 (Dollars in millions) Realized gains (losses) $ (17.4) $ 2.7 Net change in unrealized gains (losses) 162.4 (46.1) Total $ 145.0 $ (43.4)

Intangible Assets and Goodwill

Intangible Assets and Goodwill	3 Months Ended
Intangible Assets and Goodwill	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	5. Intangible Assets and Goodwill The following table summarizes the carrying amount of intangible assets as of March 31, 2023 and December 31, 2022: As of March 31, 2023 December 31, 2022 (Dollars in millions) Acquired contractual rights $ 921.7 $ 920.2 Accumulated amortization (159.3) (126.3) Finite-lived intangible assets, net 762.4 793.9 Goodwill 104.0 103.9 Intangible Assets, net $ 866.4 $ 897.8 As discussed in Note 2, the Company reviews its intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable, and considers factors including, but not limited to, expected cash flows from its interest in future management fees and the ability to raise new funds. No impairment losses were recorded during the three months ended March 31, 2023. During the three months ended March 31, 2022, the Company recorded an impairment charge of $4.0 million on certain acquired contractual rights related to Carlyle Aviation Partners as a result of impaired income streams from aircraft under lease in Russia. Intangible asset amortization expense was $32.8 million and $4.9 million for the three months ended March 31, 2023 and 2022, respectively, and is included in general, administrative, and other expenses in the unaudited condensed consolidated statements of operations. Certain intangible assets are held by entities of which the functional currency is not the U.S. dollar. Any corresponding currency translation is recorded in other comprehensive income. The following table summarizes the expected amortization expense for 2023 through 2027 and thereafter (Dollars in millions): 2023 (excluding the three months ended March 31, 2023) $ 98.6 2024 131.5 2025 131.4 2026 131.3 2027 121.2 Thereafter 148.4 $ 762.4

Borrowings

Borrowings	3 Months Ended
Borrowings	Mar. 31, 2023
Debt Disclosure [Abstract]
Borrowings	6. Borrowings The Company borrows and enters into credit agreements for its general operating and investment purposes. The Company’s debt obligations consist of the following: March 31, 2023 December 31, 2022 Borrowing Carrying Borrowing Carrying (Dollars in millions) CLO Borrowings (See below) $ 425.4 $ 421.8 $ 421.7 $ 418.1 5.625% Senior Notes Due 3/30/2043 600.0 600.6 600.0 600.6 5.650% Senior Notes Due 9/15/2048 350.0 346.3 350.0 346.3 3.500% Senior Notes Due 9/19/2029 425.0 422.1 425.0 422.0 4.625% Subordinated Notes Due 5/15/2061 500.0 484.8 500.0 484.7 Total debt obligations $ 2,300.4 $ 2,275.6 $ 2,296.7 $ 2,271.7 Senior Credit Facility As of March 31, 2023, the senior credit facility, which was amended on April 29, 2022, included $1.0 billion in a revolving credit facility. The Company’s borrowing capacity is subject to the ability of the financial institutions in the banking syndicate to fulfill their respective obligations under the revolving credit facility. The revolving credit facility is scheduled to mature on April 29, 2027, and principal amounts outstanding under the revolving credit facility accrue interest, at the option of the borrowers, either (a) at an alternate base rate plus an applicable margin not to exceed 0.50%, or (b) at SOFR (or similar benchmark for non-U.S. dollar borrowings) plus a 0.10% adjustment and an applicable margin not to exceed 1.50% (at March 31, 2023, the interest rate was 5.90%). Prior to the April 2022 amendment, the size of the revolving credit facility was $775.0 million, which was scheduled to mature February 11, 2024, and accrued interest either (a) at an alternate base rate plus an applicable margin not to exceed 0.50%, or (b) at LIBOR plus an applicable margin not to exceed 1.50%. The Company made no borrowings under the revolving credit facility during the three months ended March 31, 2023 and there were no amounts outstanding at March 31, 2023. Global Credit Revolving Credit Facility Certain subsidiaries of the Company are parties to a revolving line of credit, primarily intended to support certain lending activities within the Global Credit segment. The credit facility, as amended, is scheduled to mature in September 2024, and has a capacity of $250.0 million. The Company’s borrowing capacity is subject to the ability of the financial institutions in the banking syndicate to fulfill their respective obligations under the credit facility. Principal amounts outstanding under the facility accrue interest, at the option of the borrowers, either (a) at an alternate base rate plus an applicable margin not to exceed 1.00%, or (b) at the Eurocurrency rate plus an applicable margin, not to exceed 2.00%. The Company made no borrowings under the credit facility during the three months ended March 31, 2023, and there was no balance outstanding as of March 31, 2023. CLO Borrowings For certain of the Company’s CLOs, the Company finances a portion of its investment in the CLOs through the proceeds received from term loans and other financing arrangements with financial institutions. The Company’s outstanding CLO borrowings consist of the following (Dollars in millions): Formation Date Borrowing Outstanding March 31, 2023 Borrowing Outstanding December 31, 2022 Maturity Date (1) Interest Rate as of March 31, 2023 February 28, 2017 $ 39.3 $ 38.7 November 17, 2031 3.79% (2) June 29, 2017 54.1 54.8 July 20, 2030 6.47% (4) December 6, 2017 43.8 43.8 January 15, 2031 6.16% (5) March 15, 2019 1.8 1.8 March 15, 2032 11.06% (3) August 20, 2019 3.9 3.9 August 15, 2032 7.39% (3) September 15, 2020 19.3 19.1 April 15, 2033 3.87% (3) January 8, 2021 20.2 19.9 January 15, 2034 4.78% (3) March 9, 2021 19.0 19.1 August 15, 2030 4.03% (3) March 30, 2021 18.3 18.0 March 15, 2032 4.66% (3) April 21, 2021 3.5 3.4 April 15, 2033 8.14% (3) May 21, 2021 15.2 15.0 November 17, 2031 4.02% (3) June 4, 2021 20.3 20.0 January 16, 2034 4.57% (3) June 10, 2021 1.3 1.3 November 17, 2031 5.50% (3) July 15, 2021 15.2 15.0 July 15, 2034 4.58% (3) July 20, 2021 20.3 20.0 July 20, 2031 4.62% (3) August 4, 2021 16.4 16.2 August 15, 2032 4.40% (3) October 27, 2021 23.6 23.3 October 15, 2035 4.69% (3) November 5, 2021 14.1 13.8 January 14, 2034 4.37% (3) January 6, 2022 20.4 20.1 February 15, 2035 5.03% (3) February 22, 2022 20.4 20.1 November 10, 2035 5.06% (3) July 13, 2022 17.2 16.9 January 13, 2035 5.54% (3) October 25, 2022 17.8 17.5 October 25, 2035 5.62% (3) $ 425.4 $ 421.7 (1) Maturity date is earlier of date indicated or the date that the CLO is dissolved. (2) Outstanding borrowing of €36.1 million; incurs interest at EURIBOR plus applicable margins as defined in the agreement. (3) Incurs interest at the average effective interest rate of each class of purchased securities plus 0.50% spread percentage. (4) Incurs interest at LIBOR plus 1.66%. (5) Incurs interest at LIBOR plus 1.37%. The CLO term loans are secured by the Company’s investments in the respective CLO, have a general unsecured interest in the Carlyle entity that manages the CLO, and generally do not have recourse to any other Carlyle entity. Interest expense for the three months ended March 31, 2023 and 2022 was $5.2 million and $1.7 million, respectively. The fair value of the outstanding balance of the CLO term loans at March 31, 2023 approximated par value based on current market rates for similar debt instruments. These CLO term loans are classified as Level III within the fair value hierarchy. European CLO Financing - February 28, 2017 On February 28, 2017, a subsidiary of the Company entered into a financing agreement with several financial institutions under which these financial institutions provided a €36.1 million term loan ($39.3 million at March 31, 2023) to the Company. This term loan is secured by the Company’s investments in the retained notes in certain European CLOs that were formed in 2014 and 2015. This term loan will mature on the earlier of November 17, 2031 or the date that the certain European CLO retained notes have been redeemed. The Company may prepay the term loan in whole or in part at any time. Interest on this term loan accrues at EURIBOR plus applicable margins (3.79% at March 31, 2023). Master Credit Agreement - Term Loans The Company assumed liabilities under master credit agreements previously entered into by CBAM under which a financial institution provided term loans to CBAM for the purchase of eligible interests in CLOs (see Note 4 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022). Term loans issued under these master credit agreements are secured by the Company’s investment in the respective CLO as well as any senior management fee and subordinated management fee payable by each CLO. Term loans bear interest at LIBOR plus a weighted average spread over LIBOR on the CLO notes, which is due quarterly. As of March 31, 2023, term loans under these agreements had $97.8 million outstanding. The master credit agreements mature in July 2030 and January 2031, respectively. CLO Repurchase Agreements On February 5, 2019, the Company entered into a master credit facility agreement (the “Carlyle CLO Financing Facility”) to finance a portion of the risk retention investments in certain European CLOs managed by the Company. The initial maximum facility amount is €100.0 million, which has been, and may further be, expanded on such terms agreed upon by the Company and the counterparty subject to the terms and conditions of the Carlyle CLO Financing Facility. Each transaction entered into under the Carlyle CLO Financing Facility will bear interest at a rate based on the weighted average effective interest rate of each class of securities that have been sold plus a spread to be agreed upon by the parties. As of March 31, 2023, €203.2 million ($220.9 million) was outstanding under the Carlyle CLO Financing Facility. The Company assumed liabilities under a master credit facility agreement previously entered into by CBAM (the “CBAM CLO Financing Facility,” together with the Carlyle CLO Financing Facility, the “CLO Financing Facilities”) to finance a portion of the risk retention investments in certain European CLOs managed by CBAM (see Note 4 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022). The maximum facility amount is €100.0 million, but may be expanded on such terms agreed upon by the Company and the counterparty subject to the terms and conditions of the CBAM CLO Financing Facility. Each transaction entered into under the CBAM CLO Financing Facility will bear interest at a rate based on the weighted average effective interest rate of each class of securities that have been sold plus a spread to be agreed upon by the parties. As of March 31, 2023, €61.9 million ($67.3 million) was outstanding under the CBAM CLO Financing Facility. Each transaction entered into under the CLO Financing Facility provides for payment netting and, in the case of a default or similar event with respect to the counterparty to the CLO Financing Facility, provides for netting across transactions. Generally, upon a counterparty default, the Company can terminate all transactions under the CLO Financing Facility and offset amounts it owes in respect of any one transaction against collateral, if any, or other amounts it has received in respect of any other transactions under the CLO Financing Facility; provided, however, that in the case of certain defaults, the Company may only be able to terminate and offset solely with respect to the transaction affected by the default. During the term of a transaction entered into under the CLO Financing Facility, the Company will deliver cash or additional securities acceptable to the counterparty if the securities sold are in default. Upon termination of a transaction, the Company will repurchase the previously sold securities from the counterparty at a previously determined repurchase price. The CLO Financing Facility may be terminated at any time upon certain defaults or circumstances agreed upon by the parties. The repurchase agreements may result in credit exposure in the event the counterparty to the transaction is unable to fulfill its contractual obligations. The Company minimizes the credit risk associated with these activities by monitoring counterparty credit exposure and collateral values. Other than margin requirements, the Company is not subject to additional terms or contingencies which would expose the Company to additional obligations based upon the performance of the securities pledged as collateral. Senior Notes Certain indirect subsidiaries of the Company have issued long term borrowings in the form of senior notes, on which interest is payable semi-annually in arrears. The following table provides information regarding these senior notes (Dollars in millions): Interest Expense Fair Value (1) Three Months Ended Aggregate Principal Amount March 31, 2023 December 31, 2022 2023 2022 5.625% Senior Notes Due 3/30/2043 (2) $ 600.0 $ 560.9 $ 545.8 $ 8.4 $ 8.4 5.650% Senior Notes Due 9/15/2048 (3) 350.0 330.3 322.2 5.0 5.0 3.500% Senior Notes Due 9/19/2029 (4) 425.0 390.6 364.1 3.8 3.8 $ 17.2 $ 17.2 (1) Including accrued interest. Fair value is based on indicative quotes and the notes are classified as Level II within the fair value hierarchy. (2) Issued $400.0 million in aggregate principal at 99.583% of par in March 2013. An additional $200.0 million in aggregate principal was issued at 104.315% of par in March 2014, and is treated as a single class with the outstanding $400.0 million in senior notes previously issued. (3) Issued in September 2018 at 99.914% of par. (4) Issued in September 2019 at 99.841% of par. The issuers may redeem the senior notes, in whole at any time or in part from time to time, at a price equal to the greater of (i) 100% of the principal amount of the notes being redeemed and (ii) the sum of the present values of the remaining scheduled payments of principal and interest on any notes being redeemed discounted to the redemption date on a semiannual basis at the Treasury Rate plus 40 basis points (30 basis points in the case of the 3.500% senior notes), plus in each case accrued and unpaid interest on the principal amounts being redeemed. Subordinated Notes In May 2021, an indirect subsidiary of the Company issued $435.0 million aggregate principal amount of 4.625% Subordinated Notes due May 15, 2061 (the “Subordinated Notes”), on which interest is payable quarterly accruing from May 11, 2021. In June 2021, an additional $65.0 million aggregate principal amount of these Subordinated Notes were issued and are treated as a single series with the already outstanding $435.0 million aggregate principal amount. The Subordinated Notes are unsecured and subordinated obligations of the issuer, and are fully and unconditionally guaranteed (the “Guarantees”), jointly and severally, on a subordinated basis, by the Company, each of the Carlyle Holdings partnerships, and CG Subsidiary Holdings L.L.C., an indirect subsidiary of the Company (collectively, the “Guarantors”). The Consolidated Funds are not guarantors, and as such, the assets of the Consolidated Funds are not available to service the Subordinated Notes under the Guarantee. The Subordinated Notes may be redeemed at the issuer’s option in whole at any time or in part from time to time on or after June 15, 2026 at a redemption price equal to their principal amount plus any accrued and unpaid interest to, but excluding, the date of redemption. If interest due on the Subordinated Notes is deemed no longer to be deductible in the U.S., a “Tax Redemption Event,” the Subordinated Notes may be redeemed, in whole, but not in part, within 120 days of the occurrence of such event at a redemption price equal to their principal amount plus accrued and unpaid interest to, but excluding, the date of redemption. In addition, the Subordinated Notes may be redeemed, in whole, but not in part, at any time prior to May 15, 2026, within 90 days of the rating agencies determining that the Subordinated Notes should no longer receive partial equity treatment pursuant to the rating agency’s criteria, a “rating agency event,” at a redemption price equal to 102% of their principal amount plus any accrued and unpaid interest to, but excluding, the date of redemption. As of March 31, 2023 and December 31, 2022, the fair value of the Subordinated Notes was $368.0 million and $323.8 million, respectively. Fair value is based on active market quotes and the notes are classified as Level I within the fair value hierarchy. For both the three months ended March 31, 2023 and 2022, the Company incurred $5.9 million of interest expense on the Subordinated Notes. Debt Covenants The Company is subject to various financial covenants under its loan agreements including, among other items, maintenance of a minimum amount of management fee-earning assets. The Company is also subject to various non-financial covenants under its loan agreements and the indentures governing its senior notes. The Company was in compliance with all financial and non-financial covenants under its various loan agreements as of March 31, 2023. Loans Payable of Consolidated Funds Loans payable of Consolidated Funds primarily represent amounts due to holders of debt securities issued by the CLOs. As of March 31, 2023 and December 31, 2022, the following borrowings were outstanding, which includes preferred shares classified as liabilities (Dollars in millions): As of March 31, 2023 Borrowing Fair Value Weighted Weighted Senior secured notes (1) $ 5,909.0 $ 5,451.1 4.74 % 9.23 Subordinated notes (2) 254.9 196.8 N/A (3) 9.44 Total $ 6,163.9 $ 5,647.9 As of December 31, 2022 Borrowing Fair Value Weighted Weighted Senior secured notes (1) $ 5,849.2 $ 5,303.3 3.97 % 9.48 Subordinated notes (2) 234.0 188.3 N/A (3) 9.69 Total $ 6,083.2 $ 5,491.6 (1) Borrowing Outstanding as of March 31, 2023 and December 31, 2022 includes $280.5 million and $235.6 million of senior secured notes that are carried at par value, respectively. The fair value of these senior secured notes at March 31, 2023 and December 31, 2022, approximated par value based on current market rates for similar debt instruments. These senior secured notes are classified as Level III within the fair value hierarchy. (2) Borrowing Outstanding as of March 31, 2023 and December 31, 2022 includes $157.5 million and $178.0 million of revolving credit balances that are carried at amortized cost, respectively. (3) The subordinated notes do not have contractual interest rates, but instead receive distributions from the excess cash flows of the CLOs. Loans payable of the CLOs are collateralized by the assets held by the CLOs and the assets of one CLO may not be used to satisfy the liabilities of another. This collateral consisted of cash and cash equivalents, corporate loans, corporate bonds and other securities. As of March 31, 2023 and December 31, 2022, the fair value of the CLO assets was $6.3 billion and $6.2 billion, respectively.

Accrued Compensation and Benefi

Accrued Compensation and Benefits	3 Months Ended
Accrued Compensation and Benefits	Mar. 31, 2023
Retirement Benefits [Abstract]
Accrued Compensation and Benefits	7. Accrued Compensation and Benefits Accrued compensation and benefits consist of the following: As of March 31, 2023 December 31, 2022 (Dollars in millions) Accrued performance allocations and incentive fee related compensation $ 3,637.0 $ 3,625.3 Accrued bonuses (1) 132.8 466.6 Employment-based contingent cash consideration (2) 2.4 76.5 Accrued pension liability 7.3 9.5 Other (3) 114.7 143.0 Total $ 3,894.2 $ 4,320.9 (1) Includes $4.8 million related to make-whole cash incentive awards granted in connection with the appointment of the Company’s Chief Executive Officer as of March 31, 2023. (2) The acquisition of Carlyle Aviation Partners, Ltd. (“Carlyle Aviation Partners,” formerly known as Apollo Aviation Group) in December 2018 included an earn-out of up to $150.0 million that was payable upon the achievement of certain revenue and earnings performance targets during 2020 through 2025, which was accounted for as compensation expense. During the three months ended March 31, 2023, the Company entered into a termination and settlement agreement with respect to the earn-out, pursuant to which the Company paid $68.6 million, based on Carlyle Aviation’s performance, and will pay an aggregate $2.4 million in installments in 2024 and 2025. The acquisition of Abingworth LLP (“Abingworth”) in August 2022 included an earn-out of up to $130.0 million payable upon the achievement of certain revenue and earnings performance targets during 2023 through 2028, which is accounted for as compensation expense. No amount has been accrued as of March 31, 2023. See Note 4 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 for additional information on the Abingworth acquisition. (3) Includes $17.7 million and $26.7 million of realized performance allocations and incentive fee related compensation not yet paid to participants as of March 31, 2023 and December 31, 2022, respectively. The following table presents realized and unrealized performance allocations and incentive fee related compensation: Three Months Ended 2023 2022 (Dollars in millions) Realized $ 103.6 $ 137.6 Unrealized 2.1 233.1 Total $ 105.7 $ 370.7

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	8. Commitments and Contingencies Capital Commitments The Company and its unconsolidated affiliates have unfunded commitments to entities within the following segments as of March 31, 2023 (Dollars in millions): Unfunded Global Private Equity $ 3,509.1 Global Credit 453.3 Global Investment Solutions 213.5 Total $ 4,175.9 Of the $4.2 billion of unfunded commitments, approximately $3.5 billion is subscribed individually by senior Carlyle professionals, advisors and other professionals, with the balance funded directly by the Company. In addition to these unfunded commitments, the Company may from time to time exercise its right to purchase additional interests in its investment funds that become available in the ordinary course of their operations Under the Carlyle Global Capital Markets platform, certain subsidiaries of the Company may act as an underwriter, syndicator or placement agent for security offerings and loan originations. The Company earns fees in connection with these activities and bears the risk of the sale of such securities and placement of such loans, which may be longer dated. As of March 31, 2023, the Company had no unfunded commitments related to the origination and syndication of loans and securities under the Carlyle Global Capital Markets platform. Guaranteed Loans From time to time, the Company or its subsidiaries may enter into agreements to guarantee certain obligations of the investment funds related to, for example, credit facilities or equity commitments. Certain consolidated subsidiaries of the Company are the guarantors of revolving credit facilities for certain funds in the Global Investment Solutions segment. The guarantee is limited to the lesser of the total amount drawn under the credit facilities or the total of net asset value of the guarantor subsidiaries plus any uncalled capital of the applicable general partner, and was approximately $6.7 million as of March 31, 2023. The outstanding balances are secured by uncalled capital commitments from the underlying funds and the Company believes the likelihood of any material funding under this guarantee to be remote. Contingent Obligations (Giveback) A liability for potential repayment of previously received performance allocations of $40.9 million at March 31, 2023 was shown as accrued giveback obligations in the unaudited condensed consolidated balance sheets, representing the giveback obligation that would need to be paid if the funds were liquidated at their current fair values at March 31, 2023. However, the ultimate giveback obligation, if any, generally is not paid until the end of a fund’s life or earlier if the giveback becomes fixed and early payment is agreed upon by the fund’s partners (see Note 2). The Company had $10.0 million of unbilled receivables from former and current employees and senior Carlyle professionals as of March 31, 2023 related to giveback obligations. Any such receivables are collateralized by investments made by individual senior Carlyle professionals and employees in Carlyle-sponsored funds. In addition, $150.3 million have been withheld from distributions of carried interest to senior Carlyle professionals and employees for potential giveback obligations as of March 31, 2023. Such amounts are held on behalf of the respective current and former Carlyle employees to satisfy any givebacks they may owe and are held by entities not included in the accompanying unaudited condensed consolidated balance sheets. Current and former senior Carlyle professionals and employees are personally responsible for their giveback obligations. As of March 31, 2023, approximately $18.9 million of the Company’s accrued giveback obligation is the responsibility of various current and former senior Carlyle professionals and other former limited partners of the Carlyle Holdings partnerships, and the net accrued giveback obligation attributable to the Company is $22.0 million. If, at March 31, 2023, all of the investments held by the Company’s Funds were deemed worthless, a possibility that management views as remote, the amount of realized and distributed carried interest subject to potential giveback would be $1.5 billion, on an after-tax basis where applicable, of which approximately $0.7 billion would be the responsibility of current and former senior Carlyle professionals. Leases The Company’s leases primarily consist of operating leases for office space in various countries around the world, including its largest offices in Washington, D.C., New York City, London and Hong Kong. These leases have remaining lease terms of one year to 14 years, some of which include options to extend for up to five years and some of which include an option to terminate the leases within one year. The Company also has operating leases for office equipment and vehicles, which are not significant. The Company assesses its lease right-of-use assets for impairment consistent with its impairment assessment of other long-lived assets. The following table summarizes the Company’s lease cost, cash flows and other supplemental information related to its operating leases (Dollars in millions): Three Months Ended 2023 2022 Operating lease cost $ 14.1 $ 14.0 Sublease income (1.5) (1.5) Total operating lease cost $ 12.6 $ 12.5 Cash paid for amounts included in the measurement of operating lease liabilities $ 16.3 $ 16.0 Weighted-average remaining lease term 10.9 years 11.8 years Weighted-average discount rate 4.2 % 4.1 % Maturities of lease liabilities related to operating leases were as follows (Dollars in millions): Year ending December 31, 2023 (excluding the three months ended March 31, 2023) $ 51.4 2024 65.0 2025 61.0 2026 58.6 2027 59.2 Thereafter 340.0 Total lease payments $ 635.2 Less payments for leases that have not yet commenced (25.8) Less imputed interest (114.5) Total lease liabilities $ 494.9 Legal Matters In the ordinary course of business, the Company is a party to litigation, investigations, inquiries, employment-related matters, disputes and other potential claims. Certain of these matters are described below. The Company is not currently able to estimate the reasonably possible amount of loss or range of loss, in excess of amounts accrued, for the matters that have not been resolved. The Company does not believe it is probable that the outcome of any existing litigation, investigations, disputes or other potential claims will materially affect the Company or these financial statements in excess of amounts accrued. The Company believes that the claims alleged against it in the matters described below are without merit. The Authentix Matter Authentix, Inc. (“Authentix”) was a majority-owned portfolio company in one of the Company’s investment funds, Carlyle U.S. Growth Fund III, L.P. (“CGF III”). When Authentix was owned by CGF III, two of the Company’s employees served on Authentix’s board of directors. After a lengthy sale process, Authentix was sold for an aggregate sale price of $87.5 million. On August 7, 2020, certain of the former minority shareholders in Authentix filed suit in Delaware Chancery Court, alleging that the Authentix board of directors, CGF III, and the Company breached various fiduciary duties by agreeing to a sale of Authentix at an inopportune time and at a price that was too low. Plaintiffs seek damages for a portion of the lost profits from the sale—the difference between the actual sale price and the purported maximum amount for which Authentix could have sold, multiplied by plaintiff’s ownership percentage. Plaintiffs also seek disgorgement of any profits received by the Company stemming from the sale. A trial is scheduled to begin in Delaware in October 2023. The former directors of Authentix are covered by indemnification from Authentix and an Authentix insurance policy. The defendants intend to contest the claims vigorously. The Tax Receivable Agreement Matter The Company came into existence on January 1, 2020, when its predecessor, The Carlyle Group, L.P. (the “PTP”), converted from a partnership into a corporation (the “Conversion”). On July 29, 2022, an alleged stockholder of the Company, the City of Pittsburgh Comprehensive Municipal Trust Fund (the “Plaintiff”), filed suit in the Delaware Court of Chancery, alleging a direct claim against the Company for breach of its certificate of incorporation and a derivative claim on behalf of the Company against certain current and former officers and directors of the Company. Plaintiff challenges the receipt, by certain officers of the PTP and certain directors of the general partner of the PTP, of a right to cash payments associated with the elimination of a tax receivable agreement in connection with the Conversion. Plaintiff is seeking monetary damages, restitution, and an injunction preventing the Company from making any future cash payments for the elimination of the tax receivable agreement in connection with the Conversion. By virtue of the derivative nature of the primary claims (i.e., that the claims are aimed primarily at certain officers and directors), it is remote that the Company itself will pay material damage awards based on the Plaintiff’s claims, although the Company is expected to incur legal defense fees to the extent not covered by insurance. The defendants filed a motion to dismiss the complaint on October 28, 2022. The Plaintiff amended its complaint on January 31, 2023. The officer and director defendants intend to contest the claims vigorously. SEC Investigation As part of a sweep investigation of financial services and investment advisory firms, in October 2022, the Company received from the SEC a request for information related to the preservation of certain types of electronic business communications (e.g., text messages and messages on WhatsApp, WeChat, and similar applications). The Company intends to cooperate fully with the SEC’s inquiry. The Company currently is and expects to continue to be, from time to time, subject to examinations, formal and informal inquiries and investigations by various U.S. and non-U.S. governmental and regulatory agencies, including but not limited to, the SEC, Department of Justice, state attorneys general, FINRA, National Futures Association and the U.K. Financial Conduct Authority. The Company routinely cooperates with such examinations, inquiries and investigations, and they may result in the commencement of civil, criminal, or administrative or other proceedings against the Company or its personnel. It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings and employment-related matters, and some of the matters discussed above involve claims for potentially large and/or indeterminate amounts of damages. Based on information known by management, management does not believe that as of the date of this filing the final resolutions of the matters above will have a material effect upon the Company’s unaudited condensed consolidated financial statements. However, given the potentially large and/or indeterminate amounts of damages sought in certain of these matters and the inherent unpredictability of investigations and litigations, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect on the Company’s financial results in any particular period. The Company accrues an estimated loss contingency liability when it is probable that such a liability has been incurred and the amount of the loss can be reasonably estimated. As of March 31, 2023, the Company had recorded liabilities aggregating to approximately $35 million for litigation-related contingencies, regulatory examinations and inquiries, and other matters. The Company evaluates its outstanding legal and regulatory proceedings and other matters each quarter to assess its loss contingency accruals, and makes adjustments in such accruals, upward or downward, as appropriate, based on management’s best judgment after consultation with counsel. There is no assurance that the Company’s accruals for loss contingencies will not need to be adjusted in the future or that, in light of the uncertainties involved in such matters, the ultimate resolution of these matters will not significantly exceed the accruals that the Company has recorded. Indemnifications In the normal course of business, the Company and its subsidiaries enter into contracts that contain a variety of representations and warranties and provide general indemnifications. The Company’s maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Company that have not yet occurred. However, based on experience, the Company believes the risk of material loss to be remote. In connection with the sale of the Company’s interest in its local Brazilian management entity in August 2021, the Company provided a guarantee to the acquiring company of up to BRL 100.0 million ($19.7 million as of March 31, 2023) for liabilities arising from tax-related indemnifications. This guarantee, which will expire in August 2027, would only come into effect after all alternative remedies have been exhausted. The Company believes the likelihood of any material funding under this guarantee to be remote. Risks and Uncertainties Carlyle’s funds seek investment opportunities that offer the possibility of attaining substantial capital appreciation. Certain events particular to each industry in which the underlying investees conduct their operations, as well as general economic, political, regulatory and public health conditions, may have a significant negative impact on the Company’s investments and profitability. The funds managed by the Company may also experience a slowdown in the deployment of capital, which could adversely affect the Company’s ability to raise capital for new or successor funds and could also impact the management fees the Company earns on its carry funds and managed accounts, and/or result in the impairment of intangible assets and/or goodwill the case of the Company’s acquired businesses. Such events are beyond the Company’s control, and the likelihood that they may occur and the effect on the Company cannot be predicted. Furthermore, certain of the funds’ investments are made in private companies and there are generally no public markets for the underlying securities at the current time. The funds’ ability to liquidate their publicly-traded investments are often subject to limitations, including discounts that may be required to be taken on quoted prices due to the number of shares being sold. The funds’ ability to liquidate their investments and realize value is subject to significant limitations and uncertainties, including among others currency fluctuations and natural disasters. The Company and the funds make investments outside of the United States. Investments outside the United States may be subject to less developed bankruptcy, corporate, partnership and other laws (which may have the effect of disregarding or otherwise circumventing the limited liability structures potentially causing the actions or liabilities of one fund or a portfolio company to adversely impact the Company or an unrelated fund or portfolio company). Non-U.S. investments are subject to the same risks associated with the Company’s U.S. investments as well as additional risks, such as fluctuations in foreign currency exchange rates, unexpected changes in regulatory requirements, heightened risk of political and economic instability, difficulties in managing non-U.S. investments, potentially adverse tax consequences and the burden of complying with a wide variety of foreign laws. Furthermore, Carlyle is exposed to economic risk concentrations related to certain large investments as well as concentrations of investments in certain industries and geographies. Additionally, the Company encounters credit risk. Credit risk is the risk of default by a counterparty in the Company’s investments in debt securities, loans, leases and derivatives that result from a borrower’s, lessee’s or derivative counterparty’s inability or unwillingness to make required or expected payments. The Company is subject to credit risk should a financial institution be unable to fulfill its obligations. The Company considers cash, cash equivalents, securities, receivables, principal equity method investments, accounts payable, accrued expenses, other liabilities, loans, senior notes, assets and liabilities of Consolidated Funds and contingent and other consideration for acquisitions to be its financial instruments. Except for the senior notes, subordinated notes and compensatory contingent and other consideration for acquisitions, the carrying amounts reported in the unaudited condensed consolidated balance sheets for these financial instruments equal or closely approximate their fair values. The fair value of the senior and subordinated notes is disclosed in Note 6.

Related Party Transactions

Related Party Transactions	3 Months Ended
Related Party Transactions	Mar. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	9. Related Party Transactions Due from Affiliates and Other Receivables, Net The Company had the following due from affiliates and other receivables at March 31, 2023 and December 31, 2022: As of March 31, 2023 December 31, 2022 (Dollars in millions) Accrued incentive fees $ 17.5 $ 16.4 Unbilled receivable for giveback obligations from current and former employees 10.0 10.4 Notes receivable and accrued interest from affiliates 32.9 41.5 Management fee, reimbursable expenses and other receivables from unconsolidated funds and affiliates, net 438.9 511.1 Total $ 499.3 $ 579.4 Reimbursable expenses and other receivables from certain of the unconsolidated funds and portfolio companies relate to management fees receivable from limited partners, advisory fees receivable and expenses paid on behalf of these entities. These costs represent costs related to the pursuit of actual or proposed investments, professional fees and expenses associated with the acquisition, holding and disposition of the investments. The affiliates are obligated at the discretion of the Company to reimburse the expenses. Based on management’s determination, the Company accrues and charges interest on amounts due from affiliate accounts at interest rates ranging up to 7.02% as of March 31, 2023. The accrued and charged interest to the affiliates was not significant for any period presented. Notes receivable includes loans that the Company has provided to certain unconsolidated funds to meet short-term obligations to purchase investments. Notes receivable as of March 31, 2023 and December 31, 2022 also include interest-bearing loans of $21.8 million and $23.2 million, respectively, to certain eligible Carlyle employees, which excludes Section 16 officers and other members of senior management, to finance their investments in certain Carlyle sponsored funds. These advances accrue interest at the WSJ Prime Rate minus 1.00% floating with a floor rate of 3.50% (7.00% as of March 31, 2023) and are collateralized by each borrower’s interest in the Carlyle sponsored funds. These receivables are assessed regularly for collectability and amounts determined to be uncollectible are charged directly to general, administrative and other expenses in the condensed consolidated statements of operations. A corresponding allowance for doubtful accounts is recorded and such amounts were not significant for any period presented. Due to Affiliates The Company had the following due to affiliates balances at March 31, 2023 and December 31, 2022: As of March 31, 2023 December 31, 2022 (Dollars in millions) Due to affiliates of Consolidated Funds $ 11.6 $ 16.4 Due to non-consolidated affiliates 130.9 87.1 Amounts owed under the tax receivable agreement 79.6 100.0 Deferred consideration for Carlyle Holdings units 65.2 134.4 Other 26.8 24.6 Total $ 314.1 $ 362.5 The Company has recorded obligations for amounts due to certain of its affiliates. The Company periodically offsets expenses it has paid on behalf of its affiliates against these obligations. Deferred consideration for Carlyle Holdings units relates to the remaining obligation to the holders of Carlyle Holdings partnership units who will receive cash payments aggregating to $1.50 per Carlyle Holdings partnership unit exchanged in connection with the Conversion, payable in five In connection with the Company’s initial public offering, the Company entered into a tax receivable agreement with the limited partners of the Carlyle Holdings partnerships whereby certain subsidiaries of the Partnership agreed to pay to the limited partners of the Carlyle Holdings partnerships involved in any exchange transaction 85% of the amount of cash tax savings, if any, in U.S. federal, state and local income tax realized as a result of increases in tax basis resulting from exchanges of Carlyle Holdings Partnership units for common units of The Carlyle Group L.P. Other Related Party Transactions In the normal course of business, the Company has made use of aircraft owned by entities controlled by senior Carlyle professionals (see Note 11 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022). The Company terminated its remaining aircraft lease agreement in 2022 and as of March 31, 2023 the Company had no active aircraft lease agreements. During the three months ended March 31, 2023, the Company received a final reimbursement related to these aircraft totaling $0.4 million. During the three months ended March 31, 2022, the Company received net reimbursements related to these aircraft totaling $0.1 million. The accrual of aircraft fees is included in general, administrative, and other expenses in the unaudited condensed consolidated statements of operations. On May 5, 2020, the Company purchased 2,000,000 of the BDC Preferred Shares from CSL in a private placement at a price of $25 per share. Dividends are payable on a quarterly basis in an initial amount equal to 7.0% per annum payable in cash, or, at CSL’s option, 9.0% per annual payable in additional BDC Preferred Shares. The BDC Preferred Shares are convertible at the Company’s option, in whole or in part, into the number of shares of common stock equal to $25 per share plus any accumulated but unpaid dividends divided by an initial conversion price of $9.50 per share, subject to certain adjustments. At any time after May 5, 2023 and with the approval of its board of directors, CSL will have the option to redeem the BDC Preferred Shares, in whole or in part. In such case, the Company has the right to convert its shares, in whole or in part, prior to the date of redemption. For both the three months ended March 31, 2023 and 2022, the Company recorded dividend income of $0.9 million. Dividend income from the BDC Preferred Shares is included in interest and other income in the unaudited condensed consolidated statements of operations. The Company’s investment in the BDC Preferred Shares, which is recorded at fair value, was $73.6 million and $76.9 million as of March 31, 2023 and December 31, 2022, respectively, and is included in investments, including accrued performance allocations, in the unaudited condensed consolidated balance sheets. Senior Carlyle professionals and employees are permitted to participate in co-investment entities that invest in Carlyle funds or alongside Carlyle funds. In many cases, participation is limited by law to individuals who qualify under applicable legal requirements. These co-investment entities generally do not require senior Carlyle professionals and employees to pay management or performance allocations, however, Carlyle professionals and employees are required to pay their portion of partnership expenses. Carried interest income from certain funds can be distributed to senior Carlyle professionals and employees on a current basis, but is subject to repayment by the subsidiary of the Company that acts as general partner of the fund in the event that certain specified return thresholds are not ultimately achieved. The senior Carlyle professionals and certain other investment professionals have personally guaranteed, subject to certain limitations, the obligation of these subsidiaries in respect of this general partner obligation. Such guarantees are several and not joint and are limited to a particular individual’s distributions received. The Company does business with some of its portfolio companies; all such arrangements are on a negotiated basis.

Income Taxes

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	10. Income Taxes The Company’s provision (benefit) for income taxes was $34.3 million and $147.9 million for the three months ended March 31, 2023 and 2022, respectively. The Company’s effective tax rate was approximately 21% and 20% for the three months ended March 31, 2023 and 2022, respectively. The effective tax rate for the three months ended March 31, 2023 and 2022 is primarily comprised of the 21% U.S. federal corporate income tax rate plus U.S. state and foreign corporate income taxes and tax deductions resulting from the vesting of restricted stock units during the period, offset by disallowed executive compensation. The effective tax rate for the three months ended March 31, 2022 also reflects a deferred tax benefit resulting from a reduction in certain future foreign withholding taxes. As of March 31, 2023 and December 31, 2022, the Company had federal, state, local and foreign taxes payable of $33.9 million and $39.7 million, respectively, which is recorded as a component of accounts payable, accrued expenses and other liabilities on the accompanying unaudited condensed consolidated balance sheets. In the normal course of business, the Company is subject to examination by federal and certain state, local and foreign tax regulators. With a few exceptions, as of March 31, 2023, the Company’s U.S. federal income tax returns for the years 2019 through 2021 are open under the normal three-year statute of limitations and therefore subject to examination. State and local tax returns are generally subject to audit from 2017 to 2021. Foreign tax returns are generally subject to audit from 2011 to 2021. Certain of the Company’s affiliates are currently under audit by federal, state and foreign tax authorities. The Company does not believe that the outcome of the audits will require it to record material reserves for uncertain tax positions or that the outcome will have a material impact on the consolidated financial statements. The Company does not believe that it has any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within the next twelve months. On July 1, 2022, the State of New York issued proposed regulations, related to its 2015 law change, that may require corporate managers of investment funds (non-broker dealers) to change how they source income to New York state, which may result in an increase in the Company’s taxable income to New York. These regulations will not be effective until promulgated. The Company has not yet determined the effect of these proposed regulations on its tax provision.

Non-controlling Interests in Co

Non-controlling Interests in Consolidated Entities	3 Months Ended
Non-controlling Interests in Consolidated Entities	Mar. 31, 2023
Noncontrolling Interest [Abstract]
Non-controlling Interests in Consolidated Entities	11. Non-controlling Interests in Consolidated Entities The components of the Company’s non-controlling interests in consolidated entities are as follows: As of March 31, 2023 December 31, 2022 (Dollars in millions) Non-Carlyle interests in Consolidated Funds $ 444.5 $ 412.0 Non-Carlyle interests in majority-owned subsidiaries 189.4 186.9 Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions 2.8 1.4 Non-controlling interests in consolidated entities $ 636.7 $ 600.3 The components of the Company’s non-controlling interests in income of consolidated entities are as follows: Three Months Ended 2023 2022 (Dollars in millions) Non-Carlyle interests in Consolidated Funds $ 17.2 $ 25.1 Non-Carlyle interests in majority-owned subsidiaries 5.5 (2.4) Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions 1.9 0.5 Non-controlling interests in income of consolidated entities $ 24.6 $ 23.2

Earnings Per Common Share

Earnings Per Common Share	3 Months Ended
Earnings Per Common Share	Mar. 31, 2023
Earnings Per Share [Abstract]
Earnings Per Common Share	12. Earnings Per Common Share Basic and diluted net income (loss) per common share are calculated as follows: Three Months Ended Basic Diluted Net income attributable to common shares $ 100,700,000 $ 100,700,000 Weighted-average common shares outstanding 362,944,260 365,357,833 Net income per common share $ 0.28 $ 0.28 Three Months Ended Basic Diluted Net income attributable to common shares $ 571,600,000 $ 571,600,000 Weighted-average common shares outstanding 357,574,838 363,010,282 Net income per common share $ 1.60 $ 1.57 The weighted-average common shares outstanding, basic and diluted, are calculated as follows: Three Months Ended Basic Diluted The Carlyle Group Inc. weighted-average common shares outstanding 362,944,260 362,944,260 Unvested restricted stock units — 1,702,114 Issuable common shares and performance-vesting restricted stock units — 711,459 Weighted-average common shares outstanding 362,944,260 365,357,833 Three Months Ended Basic Diluted The Carlyle Group Inc. weighted-average common shares outstanding 357,574,838 357,574,838 Unvested restricted stock units — 3,695,350 Issuable common shares and performance-vesting restricted stock units — 1,740,094 Weighted-average common shares outstanding 357,574,838 363,010,282

Equity

Equity	3 Months Ended
Equity	Mar. 31, 2023
Equity [Abstract]
Equity	13. Equity Stock Repurchase Program In October 2021, the Board of Directors of the Company authorized the repurchase of up to $400 million of common stock. In February 2023, the Board of Directors replenished the repurchase program and expanded the limit to $500 million of common stock in aggregate, effective March 31, 2023. Under this repurchase program, shares of common stock may be repurchased from time to time in open market transactions, in privately negotiated transactions or otherwise, including through Rule 10b5-1 plans. The timing and actual number of shares of common stock repurchased will depend on a variety of factors, including legal requirements, price, and economic and market conditions. This repurchase program may be suspended or discontinued at any time and does not have a specified expiration date. During the three months ended March 31, 2023 and 2022, the Company paid an aggregate of $100.3 million and $80.4 million, respectively, to repurchase and retire approximately 3.0 million and 1.7 million shares, respectively, with all of the repurchases done via open market and brokered transactions. As of March 31, 2023, $500 million of repurchase capacity remained under the program. The IRA also enacted a 1% excise tax on certain actual and deemed stock repurchases by publicly traded U.S. corporations effective January 1, 2023. The value of repurchases subject to the tax is reduced by the value of any stock issued by the corporation during the tax year, including stock issued or provided to the employees of the corporation. The excise tax is accounted for in equity as an additional repurchase cost. Shares Issued in Connection with Acquisitions In March 2022, the Company issued 4.2 million shares of common stock, which represented $194.5 million of the purchase price paid in the acquisition of management contracts related to a portfolio of assets from CBAM. See Note 4 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Shares Issued for Performance Allocation Related Compensation In October 2021, the Company commenced a program under which, at the Company’s discretion, up to 20% of realized performance allocations and incentive fee related compensation over a certain threshold amount may be distributed in fully vested, newly issued shares of the Company’s common stock. Shares issued under the program are accounted for as performance allocations and incentive fee related compensation and do not result in incremental compensation expense. In the third quarter of 2022, the Company paused the issuance of shares pursuant to this program and the Company did not issue shares for performance allocation related compensation during the three months ended March 31, 2023. During the three months ended March 31, 2022, the Company distributed 636,461 fully vested, newly issued common shares, related to previously accrued performance allocations and incentive fee related compensation of $31.3 million. Dividends The table below presents information regarding the quarterly dividends on the common shares, which were made at the sole discretion of the Board of Directors of the Company. Dividend Record Date Dividend Payment Date Dividend per Common Share Dividend to Common Stockholders (Dollars in millions, except per share data) May 10, 2022 May 17, 2022 $ 0.325 $ 117.6 August 9, 2022 August 16, 2022 0.325 118.3 November 18, 2022 November 25, 2022 0.325 118.2 February 22, 2023 March 1, 2023 0.325 118.4 Total 2022 Dividend Year $ 1.30 $ 472.5 May 16, 2023 May 23, 2023 $ 0.35 $ 126.7 Total 2023 Dividend Year (through Q1 2023) $ 0.35 $ 126.7 The Board of Directors will take into account general economic and business conditions, as well as the Company’s strategic plans and prospects, business and investment opportunities, financial condition and obligations, legal, tax and regulatory restrictions, other constraints on the payment of dividends by the Company to its common stockholders or by subsidiaries to the Company, and other such factors as the Board of Directors may deem relevant. In addition, the terms of the Company’s credit facility provide certain limits on the Company’s ability to pay dividends.

Equity-Based Compensation

Equity-Based Compensation	3 Months Ended
Equity-Based Compensation	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Equity-Based Compensation	14. Equity-Based Compensation In May 2012, Carlyle Group Management L.L.C., the general partner of the Partnership, adopted the Equity Incentive Plan. The Equity Incentive Plan, which was amended on January 1, 2020 in connection with the Conversion to reflect shares of the Company’s common stock, is a source of equity-based awards permitting the Company to grant to Carlyle employees, directors and consultants non-qualified options, share appreciation rights, common shares, restricted stock units and other awards based on the Company’s common shares. On June 1, 2021, the shareholders of the Company approved an amended and restated Equity Incentive Plan that removed a provision providing for the automatic increase in the number of the Company’s common shares available for grant and reset the total number of shares of common stock available for grant to 16,000,000 for awards granted under the plan after June 1, 2021. As of March 31, 2023, the total number of the Company’s common shares available for grant under the amended and restated Equity Incentive Plan was 3,527,870. A summary of the status of the Company’s non-vested equity-based awards as of March 31, 2023 and a summary of changes for the three months ended March 31, 2023, are presented below: Unvested Shares Restricted Weighted- Unvested (1) Weighted- Balance, December 31, 2022 10,865,248 $ 35.78 452,880 $ 39.73 Granted (2) 16,729,897 $ 30.16 258,579 $ 34.65 Vested 2,756,607 $ 27.94 — $ — Forfeited 102,310 $ 35.62 — $ — Balance, March 31, 2023 24,736,228 $ 32.86 711,459 $ 37.88 (1) Includes common shares issued in connection with the Company’s investment in NGP. (2) Includes 6,762,219 shares related to equity inducement awards granted in connection with the appointment of the Company’s Chief Executive Officer, as well as 63,849 shares reserved for issuance upon the settlement of dividend-equivalent rights carried by certain restricted stock units concurrently with the settlement of the restricted stock units for shares. The Company recorded compensation expense, net of forfeitures, for restricted stock units of $54.4 million and $39.7 million for the three months ended March 31, 2023 and 2022, respectively, with $9.7 million and $7.9 million of corresponding deferred tax benefits, respectively. As of March 31, 2023, the total unrecognized equity-based compensation expense related to unvested restricted stock units was $683.1 million, which is expected to be recognized over a weighted-average term of 2.7 years.

Segment Reporting

Segment Reporting	3 Months Ended
Segment Reporting	Mar. 31, 2023
Segment Reporting [Abstract]
Segment Reporting	15. Segment Reporting Carlyle conducts its operations through three reportable segments: Global Private Equity – The Global Private Equity segment advises the Company’s buyout, middle market and growth capital funds, its U.S. and internationally focused real estate funds, and its infrastructure and natural resources funds. The segment also includes the NGP Carry Funds advised by NGP. Global Credit – The Global Credit segment advises funds and vehicles that pursue investment strategies including loans and structured credit, direct lending, opportunistic credit, distressed credit, aircraft financing and servicing, infrastructure debt, insurance solutions and global capital markets. Global Investment Solutions – The Global Investment Solutions segment advises global private equity programs and related co-investment and secondary activities. The Company’s reportable business segments are differentiated by their various investment focuses and strategies. Overhead costs are generally allocated based on cash-based compensation and benefits expense for each segment. The Company’s earnings from its investment in NGP are presented in the respective operating captions within the Global Private Equity segment. Distributable Earnings . Distributable Earnings, or “DE,” is a key performance benchmark used in the Company’s industry and is evaluated regularly by management in making resource deployment and compensation decisions and in assessing performance of the Company’s three reportable segments. Management also uses DE in budgeting, forecasting, and the overall management of the Company’s segments. Management believes that reporting DE is helpful to understanding the Company’s business and that investors should review the same supplemental financial measure that management uses to analyze the Company’s segment performance. DE is intended to show the amount of net realized earnings without the effects of the consolidation of the Consolidated Funds. DE is derived from the Company’s segment reported results and is used to assess performance. Distributable Earnings differs from income (loss) before provision for income taxes computed in accordance with U.S. GAAP in that it includes certain tax expenses associated with certain foreign performance revenues (comprised of performance allocations and incentive fees), and does not include unrealized performance allocations and related compensation expense, unrealized principal investment income, equity-based compensation expense, net income (loss) attributable to non-Carlyle interests in consolidated entities, or charges (credits) related to Carlyle corporate actions and non-recurring items. Charges (credits) related to Carlyle corporate actions and non-recurring items include: charges (credits) associated with acquisitions, dispositions or strategic investments, changes in the tax receivable agreement liability, amortization and any impairment charges associated with acquired intangible assets, transaction costs associated with acquisitions and dispositions, charges associated with earn-outs and contingent consideration including gains and losses associated with the estimated fair value of contingent considerations issued in conjunction with acquisitions or strategic investments, impairment charges associated with lease right-of-use assets, gains and losses from the retirement of debt, charges associated with contract terminations and employee severance. Management believes the inclusion or exclusion of these items provides investors with a meaningful indication of the Company’s core operating performance. Fee Related Earnings . Fee Related Earnings, or “FRE,” is used to assess the ability of the business to cover direct base compensation and operating expenses from total fee revenues. FRE differs from income (loss) before provision for income taxes computed in accordance with U.S. GAAP in that it adjusts for the items included in the calculation of DE and also adjusts DE to exclude net realized performance revenues, realized principal investment income, net interest (interest income less interest expense), and certain general, administrative and other expenses when the timing of any future payment is uncertain. The following tables present the financial data for the Company’s three reportable segments for the three months ended March 31, 2023: Three Months Ended March 31, 2023 Global Global Global Total (Dollars in millions) Segment Revenues Fund level fee revenues Fund management fees $ 326.9 $ 122.6 $ 56.7 $ 506.2 Portfolio advisory and transaction fees, net and other 5.4 11.0 — 16.4 Fee related performance revenues 9.6 18.4 0.8 28.8 Total fund level fee revenues 341.9 152.0 57.5 551.4 Realized performance revenues 99.0 27.7 38.4 165.1 Realized principal investment income 11.9 9.0 2.9 23.8 Interest income 5.4 7.2 1.3 13.9 Total revenues 458.2 195.9 100.1 754.2 Segment Expenses Compensation and benefits Cash-based compensation and benefits 148.7 80.4 31.5 260.6 Realized performance revenues related compensation 46.3 12.7 36.6 95.6 Total compensation and benefits 195.0 93.1 68.1 356.2 General, administrative, and other indirect expenses 57.1 21.7 8.7 87.5 Depreciation and amortization expense 6.7 2.0 1.2 9.9 Interest expense 16.6 10.2 2.2 29.0 Total expenses 275.4 127.0 80.2 482.6 Distributable Earnings $ 182.8 $ 68.9 $ 19.9 $ 271.6 (-) Realized net performance revenues 52.7 15.0 1.8 69.5 (-) Realized principal investment income 11.9 9.0 2.9 23.8 (+) Net interest 11.2 3.0 0.9 15.1 (=) Fee Related Earnings $ 129.4 $ 47.9 $ 16.1 $ 193.4 Segment assets as of March 31, 2023 $ 9,459.8 $ 3,075.2 $ 1,948.9 $ 14,483.9 The following tables present the financial data for the Company’s three reportable segments for the three months ended March 31, 2022: Three Months Ended March 31, 2022 Global Global Global Total (Dollars in millions) Segment Revenues Fund level fee revenues Fund management fees $ 304.2 $ 93.7 $ 56.3 $ 454.2 Portfolio advisory and transaction fees, net and other 6.1 10.1 — 16.2 Fee related performance revenues 30.6 13.9 — 44.5 Total fund level fee revenues 340.9 117.7 56.3 514.9 Realized performance revenues 199.9 13.7 22.7 236.3 Realized principal investment income 14.2 10.3 1.8 26.3 Interest income 0.4 1.5 0.1 2.0 Total revenues 555.4 143.2 80.9 779.5 Segment Expenses Compensation and benefits Cash-based compensation and benefits 153.0 67.2 25.6 245.8 Realized performance revenues related compensation 90.7 6.7 20.9 118.3 Total compensation and benefits 243.7 73.9 46.5 364.1 General, administrative, and other indirect expenses 45.5 23.5 7.3 76.3 Depreciation and amortization expense 6.3 2.0 1.2 9.5 Interest expense 15.8 8.2 2.8 26.8 Total expenses 311.3 107.6 57.8 476.7 Distributable Earnings $ 244.1 $ 35.6 $ 23.1 $ 302.8 (-) Realized net performance revenues 109.2 7.0 1.8 118.0 (-) Realized principal investment income 14.2 10.3 1.8 26.3 (+) Net interest 15.4 6.7 2.7 24.8 (=) Fee Related Earnings $ 136.1 $ 25.0 $ 22.2 $ 183.3 The following tables reconcile the Total Segments to the Company’s Income (Loss) Before Provision for Taxes for the three months ended March 31, 2023 and 2022, and Total Assets as of March 31, 2023. Three Months Ended March 31, 2023 Total Reportable Segments Consolidated Funds Reconciling Items Carlyle Consolidated (Dollars in millions) Revenues $ 754.2 $ 121.9 $ (17.1) (a) $ 859.0 Expenses $ 482.6 $ 97.2 $ 123.2 (b) $ 703.0 Other income (loss) $ — $ 3.6 $ — (c) $ 3.6 Distributable earnings $ 271.6 $ 28.3 $ (140.3) (d) $ 159.6 Total assets $ 14,483.9 $ 7,403.1 $ (613.1) (e) $ 21,273.9 Three Months Ended March 31, 2022 Total Reportable Segments Consolidated Funds Reconciling Items Carlyle Consolidated (Dollars in millions) Revenues $ 779.5 $ 61.7 $ 740.6 (a) $ 1,581.8 Expenses $ 476.7 $ 52.9 $ 312.3 (b) $ 841.9 Other income (loss) $ — $ 2.8 $ — (c) $ 2.8 Distributable earnings $ 302.8 $ 11.6 $ 428.3 (d) $ 742.7 (a) The Revenues adjustment principally represents unrealized performance revenues, unrealized principal investment income (loss) (including Fortitude), revenues earned from the Consolidated Funds which were eliminated in consolidation to arrive at the Company’s total revenues, adjustments for amounts attributable to non-controlling interests in consolidated entities, adjustments related to expenses associated with the investments in NGP Management and its affiliates that are included in operating captions or are excluded from the segment results, adjustments to reflect the reimbursement of certain costs incurred on behalf of Carlyle funds on a net basis, and the inclusion of tax expenses associated with certain foreign performance revenues, as detailed below: Three Months Ended 2023 2022 (Dollars in millions) Unrealized performance and fee related performance revenues $ (20.7) $ 698.8 Unrealized principal investment income (loss) (29.0) 23.7 Adjustments related to expenses associated with investments in NGP Management and its affiliates (3.4) (3.1) Tax expense associated with certain foreign performance revenues — (0.1) Non-controlling interests and other adjustments to present certain costs on a net basis 50.8 17.9 Elimination of revenues of Consolidated Funds (14.8) 3.4 $ (17.1) $ 740.6 The following table reconciles the total segments fund level fee revenue to the most directly comparable U.S. GAAP measure, the Company’s consolidated fund management fees, for the three months ended March 31, 2023 and 2022. Three Months Ended 2023 2022 (Dollars in millions) Total Reportable Segments - Fund level fee revenues $ 551.4 $ 514.9 Adjustments (1) (50.6) (64.4) Carlyle Consolidated - Fund management fees $ 500.8 $ 450.5 (1) Adjustments represent the reclassification of NGP management fees from principal investment income, the reclassification of fee related performance revenues from business development companies and other products, management fees earned from consolidated CLOs which were eliminated in consolidation to arrive at the Company’s fund management fees, and the reclassification of certain amounts included in portfolio advisory fees, net and other in the segment results that are included in interest and other income in the U.S. GAAP results. (b) The Expenses adjustment represents the elimination of intercompany expenses of the Consolidated Funds payable to the Company, the inclusion of equity-based compensation, certain tax expenses associated with realized performance revenues related compensation, and unrealized performance revenues related compensation, adjustments related to expenses associated with the investment in NGP Management that are included in operating captions, adjustments to reflect the reimbursement of certain costs incurred on behalf of Carlyle funds on a net basis, changes in the tax receivable agreement liability, and charges and credits associated with Carlyle corporate actions and non-recurring items, as detailed below: Three Months Ended March 31, 2023 2022 (Dollars in millions) Unrealized performance and fee related performance revenue compensation expense $ (2.3) $ 232.2 Equity-based compensation 57.1 40.7 Acquisition or disposition-related charges (credits) and amortization of intangibles and impairment 28.7 29.1 Tax expense associated with certain foreign performance revenues related compensation (0.5) (0.7) Non-controlling interests and other adjustments to present certain costs on a net basis 40.0 16.5 Other adjustments including severance 3.9 4.6 Elimination of expenses of Consolidated Funds (3.7) (10.1) $ 123.2 $ 312.3 (c) The Other Income (Loss) adjustment results from the Consolidated Funds which were eliminated in consolidation to arrive at the Company’s total Other Income (Loss). (d) The following table is a reconciliation of Income (Loss) Before Provision for Income Taxes to Distributable Earnings and to Fee Related Earnings: Three Months Ended March 31, 2023 2022 (Dollars in millions) Income (loss) before provision for income taxes $ 159.6 $ 742.7 Adjustments: Net unrealized performance and fee related performance revenues 18.4 (466.6) Unrealized principal investment (income) loss 29.0 (23.7) Equity-based compensation (1) 57.1 40.7 Acquisition or disposition-related charges (credits), including amortization of intangibles and impairment 28.7 29.1 Tax expense associated with certain foreign performance revenues (0.5) (0.8) Net income attributable to non-controlling interests in consolidated entities (24.6) (23.2) Other adjustments including severance 3.9 4.6 Distributable Earnings $ 271.6 $ 302.8 Realized performance revenues, net of related compensation (2) 69.5 118.0 Realized principal investment income (2) 23.8 26.3 Net interest 15.1 24.8 Fee Related Earnings $ 193.4 $ 183.3 (1) Equity-based compensation for the three months ended March 31, 2023 and 2022 includes amounts that are presented in principal investment income and general, administrative and other expenses in the Company’s U.S. GAAP statement of operations. (2) See reconciliation to most directly comparable U.S. GAAP measure below: Three Months Ended March 31, 2023 Carlyle Adjustments (3) Total (Dollars in millions) Performance revenues $ 160.8 $ 4.3 $ 165.1 Performance revenues related compensation expense 105.7 (10.1) 95.6 Net performance revenues $ 55.1 $ 14.4 $ 69.5 Principal investment income (loss) $ 11.7 $ 12.1 $ 23.8 Three Months Ended March 31, 2022 Carlyle Adjustments (3) Total (Dollars in millions) Performance revenues $ 710.2 $ (473.9) $ 236.3 Performance revenues related compensation expense 370.7 (252.4) 118.3 Net performance revenues $ 339.5 $ (221.5) $ 118.0 Principal investment income (loss) $ 319.6 $ (293.3) $ 26.3 ( 3) Adjustments to performance revenues and principal investment income (loss) relate to (i) unrealized performance allocations net of related compensation expense and unrealized principal investment income, which are excluded from the segment results, (ii) amounts earned from the Consolidated Funds, which were eliminated in the U.S. GAAP consolidation but were included in the segment results, (iii) amounts attributable to non-controlling interests in consolidated entities, which were excluded from the segment results, (iv) the reclassification of NGP performance revenues, which are included in principal investment income in the U.S. GAAP financial statements, (v) the reclassification of fee related performance revenues, which are included in fund level fee revenues in the segment results, and (vi) the reclassification of tax expenses associated with certain foreign performance revenues. Adjustments to principal investment income (loss) also include the reclassification of earnings for the investments in NGP Management and its affiliates to the appropriate operating captions for the segment results, and the exclusion of charges associated with the investment in NGP Management and its affiliates that are excluded from the segment results. (e) The Total Assets adjustment represents the addition of the assets of the Consolidated Funds that were eliminated in consolidation to arrive at the Company’s total assets.

Subsequent Events

Subsequent Events	3 Months Ended
Subsequent Events	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	16. Subsequent Events Dividends In May 2023, the Company’s Board of Directors declared a quarterly dividend of $0.35 per share of common stock to common stockholders of record at the close of business on May 16, 2023, payable on May 23, 2023.

Supplemental Financial Informat

Supplemental Financial Information	3 Months Ended
Supplemental Financial Information	Mar. 31, 2023
Condensed Financial Information Disclosure [Abstract]
Supplemental Financial Information	17. Supplemental Financial Information The following supplemental financial information illustrates the consolidating effects of the Consolidated Funds on the Company’s financial position as of March 31, 2023 and December 31, 2022 and results of operations for the three months ended March 31, 2023 and 2022. The supplemental statement of cash flows is presented without effects of the Consolidated Funds. As of March 31, 2023 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Assets Cash and cash equivalents $ 1,010.1 $ — $ — $ 1,010.1 Cash and cash equivalents held at Consolidated Funds — 228.8 — 228.8 Restricted cash 16.8 — — 16.8 Corporate treasury investments 102.0 — — 102.0 Investments, including performance allocations of $7,134.0 million 11,013.5 — (229.4) 10,784.1 Investments of Consolidated Funds — 7,067.3 — 7,067.3 Due from affiliates and other receivables, net 883.0 — (383.7) 499.3 Due from affiliates and other receivables of Consolidated Funds, net — 100.6 — 100.6 Fixed assets, net 141.8 — — 141.8 Lease right-of-use assets, net 331.5 — — 331.5 Deposits and other 104.7 6.4 — 111.1 Intangible assets, net 866.4 — — 866.4 Deferred tax assets 14.1 — — 14.1 Total assets $ 14,483.9 $ 7,403.1 $ (613.1) $ 21,273.9 Liabilities and equity Debt obligations $ 2,275.6 $ — $ — $ 2,275.6 Loans payable of Consolidated Funds — 6,462.4 (376.5) 6,085.9 Accounts payable, accrued expenses and other liabilities 304.8 — — 304.8 Accrued compensation and benefits 3,894.2 — — 3,894.2 Due to affiliates 302.5 11.6 — 314.1 Deferred revenue 411.7 — — 411.7 Deferred tax liabilities 389.5 — — 389.5 Other liabilities of Consolidated Funds — 251.7 (0.9) 250.8 Lease liabilities 494.9 — — 494.9 Accrued giveback obligations 40.9 — — 40.9 Total liabilities 8,114.1 6,725.7 (377.4) 14,462.4 Common stock 3.6 — — 3.6 Additional paid-in capital 3,195.5 244.9 (244.9) 3,195.5 Retained earnings 3,280.9 — — 3,280.9 Accumulated other comprehensive loss (302.4) (12.0) 9.2 (305.2) Non-controlling interests in consolidated entities 192.2 444.5 — 636.7 Total equity 6,369.8 677.4 (235.7) 6,811.5 Total liabilities and equity $ 14,483.9 $ 7,403.1 $ (613.1) $ 21,273.9 As of December 31, 2022 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Assets Cash and cash equivalents $ 1,360.7 $ — $ — $ 1,360.7 Cash and cash equivalents held at Consolidated Funds — 209.0 — 209.0 Restricted cash 0.8 — — 0.8 Corporate treasury investments 20.0 — — 20.0 Investments, including performance allocations of $7,117.7 million 10,989.9 — (222.0) 10,767.9 Investments of Consolidated Funds — 6,894.4 — 6,894.4 Due from affiliates and other receivables, net 960.5 — (381.1) 579.4 Due from affiliates and other receivables of Consolidated Funds, net — 101.9 — 101.9 Fixed assets, net 139.9 — — 139.9 Lease right-of-use assets, net 337.0 — — 337.0 Deposits and other 70.4 8.0 — 78.4 Intangible assets, net 897.8 — — 897.8 Deferred tax assets 15.8 — — 15.8 Total assets $ 14,792.8 $ 7,213.3 $ (603.1) $ 21,403.0 Liabilities and equity Debt obligations $ 2,271.7 $ — $ — $ 2,271.7 Loans payable of Consolidated Funds — 6,279.7 (374.5) 5,905.2 Accounts payable, accrued expenses and other liabilities 369.2 — — 369.2 Accrued compensation and benefits 4,320.9 — — 4,320.9 Due to affiliates 346.1 16.5 (0.1) 362.5 Deferred revenue 126.4 — — 126.4 Deferred tax liabilities 402.7 — — 402.7 Other liabilities of Consolidated Funds — 279.7 (0.4) 279.3 Lease liabilities 502.9 — — 502.9 Accrued giveback obligations 40.9 — — 40.9 Total liabilities 8,380.8 6,575.9 (375.0) 14,581.7 Common stock 3.6 — — 3.6 Additional paid-in capital 3,138.5 238.7 (238.7) 3,138.5 Retained earnings 3,401.1 — — 3,401.1 Accumulated other comprehensive loss (319.5) (13.3) 10.6 (322.2) Non-controlling interests in consolidated entities 188.3 412.0 — 600.3 Total equity 6,412.0 637.4 (228.1) 6,821.3 Total liabilities and equity $ 14,792.8 $ 7,213.3 $ (603.1) $ 21,403.0 Three Months Ended March 31, 2023 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Revenues Fund management fees $ 508.4 $ — $ (7.6) $ 500.8 Incentive fees 19.9 — (0.1) 19.8 Investment income Performance allocations 162.3 — (1.5) 160.8 Principal investment income 14.7 — (3.0) 11.7 Total investment income 177.0 — (4.5) 172.5 Interest and other income 46.6 — (2.6) 44.0 Interest and other income of Consolidated Funds — 121.9 — 121.9 Total revenues 751.9 121.9 (14.8) 859.0 Expenses Compensation and benefits Cash-based compensation and benefits 260.2 — — 260.2 Equity-based compensation 54.4 — — 54.4 Performance allocations and incentive fee related compensation 105.7 — — 105.7 Total compensation and benefits 420.3 — — 420.3 General, administrative and other expenses 159.4 — (0.2) 159.2 Interest 29.7 — — 29.7 Interest and other expenses of Consolidated Funds — 97.2 (3.5) 93.7 Other non-operating expenses 0.1 — — 0.1 Total expenses 609.5 97.2 (3.7) 703.0 Other income Net investment income of Consolidated Funds — 3.6 — 3.6 Income before provision for income taxes 142.4 28.3 (11.1) 159.6 Provision for income taxes 34.3 — — 34.3 Net income 108.1 28.3 (11.1) 125.3 Net income attributable to non-controlling interests in consolidated entities 7.4 — 17.2 24.6 Net income attributable to The Carlyle Group Inc. $ 100.7 $ 28.3 $ (28.3) $ 100.7 Three Months Ended March 31, 2022 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Revenues Fund management fees $ 456.9 $ — $ (6.4) $ 450.5 Incentive fees 14.0 — — 14.0 Investment income Performance allocations 710.2 — — 710.2 Principal investment income 302.3 — 17.3 319.6 Total investment income 1,012.5 — 17.3 1,029.8 Interest and other income 33.3 — (7.5) 25.8 Interest and other income of Consolidated Funds — 61.7 — 61.7 Total revenues 1,516.7 61.7 3.4 1,581.8 Expenses Compensation and benefits Cash-based compensation and benefits 254.3 — — 254.3 Equity-based compensation 39.7 — — 39.7 Performance allocations and incentive fee related compensation 370.7 — — 370.7 Total compensation and benefits 664.7 — — 664.7 General, administrative and other expenses 106.3 — — 106.3 Interest 27.8 — — 27.8 Interest and other expenses of Consolidated Funds — 52.9 (10.1) 42.8 Other non-operating expenses 0.3 — — 0.3 Total expenses 799.1 52.9 (10.1) 841.9 Other income Net investment income of Consolidated Funds — 2.8 — 2.8 Income before provision for income taxes 717.6 11.6 13.5 742.7 Provision for income taxes 147.9 — — 147.9 Net income 569.7 11.6 13.5 594.8 Net income (loss) attributable to non-controlling interests in consolidated entities (1.9) — 25.1 23.2 Net income attributable to The Carlyle Group Inc. $ 571.6 $ 11.6 $ (11.6) $ 571.6 Three Months Ended March 31, 2023 2022 (Dollars in millions) Cash flows from operating activities Net income $ 108.1 $ 569.7 Adjustments to reconcile net income to net cash flows from operating activities: Depreciation and amortization 44.0 19.4 Equity-based compensation 54.4 39.7 Non-cash performance allocations and incentive fees (38.2) (300.8) Non-cash principal investment income (8.7) (295.4) Other non-cash amounts 10.8 5.3 Purchases of investments (19.0) (294.1) Proceeds from the sale of investments 78.9 169.5 Payments of contingent consideration (68.6) (5.7) Change in deferred taxes, net (15.1) 110.9 Change in due from affiliates and other receivables 17.0 (8.8) Change in deposits and other (33.9) (39.8) Change in accounts payable, accrued expenses and other liabilities (63.9) (14.3) Change in accrued compensation and benefits (371.9) (580.1) Change in due to affiliates (0.2) (0.2) Change in lease right-of-use asset and lease liability (2.8) (2.5) Change in deferred revenue 284.7 254.5 Net cash used in operating activities (24.4) (372.7) Cash flows from investing activities Purchases of corporate treasury investments (101.1) — Proceeds from corporate treasury investments 20.1 — Purchases of fixed assets, net (12.9) (12.3) Purchase of CBAM intangibles and investments, net — (618.4) Net cash used in investing activities (93.9) (630.7) Cash flows from financing activities Payments on CLO borrowings (1.1) (8.9) Proceeds from CLO borrowings, net of financing costs — 40.8 Dividends to common stockholders (118.4) (89.5) Payment of deferred consideration for Carlyle Holdings units (68.8) (68.8) Contributions from non-controlling interest holders 2.0 5.8 Distributions to non-controlling interest holders (8.5) (27.1) Common shares issued for performance allocations — 31.3 Common shares repurchased (100.3) (80.4) Change in due to/from affiliates financing activities 73.0 33.1 Net cash used in financing activities (222.1) (163.7) Effect of foreign exchange rate changes 5.8 (17.2) Decrease in cash, cash equivalents and restricted cash (334.6) (1,184.3) Cash, cash equivalents and restricted cash, beginning of period 1,361.5 2,475.1 Cash, cash equivalents and restricted cash, end of period $ 1,026.9 $ 1,290.8 Supplemental non-cash disclosures Issuance of common shares related to the acquisition of CBAM $ — $ 194.5 Reconciliation of cash, cash equivalents and restricted cash, end of period: Cash and cash equivalents $ 1,010.1 $ 1,290.2 Restricted cash 16.8 0.6 Total cash, cash equivalents and restricted cash, end of period $ 1,026.9 $ 1,290.8 Cash and cash equivalents held at Consolidated Funds $ 228.8 $ 168.9

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
Summary of Significant Accounting Policies (Policies)	Mar. 31, 2023
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The Company consolidates all entities that it controls either through a majority voting interest or as the primary beneficiary of variable interest entities (“VIEs”). The Company evaluates (1) whether it holds a variable interest in an entity, (2) whether the entity is a VIE, and (3) whether the Company’s involvement would make it the primary beneficiary. In evaluating whether the Company holds a variable interest, fees (including management fees, incentive fees and performance allocations) that are customary and commensurate with the level of services provided, and where the Company does not hold other economic interests in the entity that would absorb more than an insignificant amount of the expected losses or returns of the entity, are not considered variable interests. The Company considers all economic interests, including indirect interests, to determine if a fee is considered a variable interest. For those entities where the Company holds a variable interest, the Company determines whether each of these entities qualifies as a VIE and, if so, whether or not the Company is the primary beneficiary. The assessment of whether the entity is a VIE is generally performed qualitatively, which requires judgment. These judgments include: (a) determining whether the equity investment at risk is sufficient to permit the entity to finance its activities without additional subordinated financial support, (b) evaluating whether the equity holders, as a group, can make decisions that have a significant effect on the economic performance of the entity, (c) determining whether two or more parties’ equity interests should be aggregated, and (d) determining whether the equity investors have proportionate voting rights to their obligations to absorb losses or rights to receive returns from an entity. For entities that are determined to be VIEs, the Company consolidates those entities where it has concluded it is the primary beneficiary. The primary beneficiary is defined as the variable interest holder with (a) the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and (b) the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. In evaluating whether the Company is the primary beneficiary, the Company evaluates its economic interests in the entity held either directly or indirectly by the Company. As of March 31, 2023, assets and liabilities of the consolidated VIEs reflected in the unaudited condensed consolidated balance sheets were $7.4 billion and $6.3 billion, respectively. As of December 31, 2022, assets and liabilities of the consolidated VIEs reflected in the unaudited condensed consolidated balance sheets were $7.2 billion and $6.2 billion, respectively. Except to the extent of the consolidated assets of the VIEs, the holders of the consolidated VIEs’ liabilities generally do not have recourse to the Company. The Company’s Consolidated Funds are primarily CLOs, which are VIEs that issue loans payable that are backed by diversified collateral asset portfolios consisting primarily of loans or structured debt. In exchange for managing the collateral for the CLOs, the Company earns investment management fees, including in some cases subordinated management fees and contingent incentive fees. In cases where the Company consolidates the CLOs (primarily because of a retained interest that is significant to the CLO), those management fees and contingent incentive fees have been eliminated as intercompany transactions. As of March 31, 2023, the Company held $112.7 million of investments in these CLOs which represents its maximum risk of loss. The Company’s investments in these CLOs are generally subordinated to other interests in the entities and entitle the Company to receive a pro rata portion of the residual cash flows, if any, from the entities. Investors in the CLOs have no recourse against the Company for any losses sustained in the CLO structure. The Company’s Consolidated Funds also include certain investment funds in our Global Private Equity segment that are accounted for as consolidated VIEs due to the Company providing financing to bridge investment purchases. As of March 31, 2023, the Company held $376.5 million of notes receivable from these investment funds which represents its maximum risk of loss. Entities that do not qualify as VIEs are generally assessed for consolidation as voting interest entities. Under the voting interest entity model, the Company consolidates those entities it controls through a majority voting interest. All significant inter-entity transactions and balances of entities consolidated have been eliminated.
Investments in Unconsolidated Variable Interest Entities	Investments in Unconsolidated Variable Interest Entities The Company holds variable interests in certain VIEs that are not consolidated because the Company is not the primary beneficiary, including its investments in certain CLOs and certain AlpInvest vehicles, as well as its strategic investment in NGP Management Company, L.L.C. (“NGP Management” and, together with its affiliates, “NGP”). Refer to Note 4 for information on the strategic investment in NGP. The Company’s involvement with such entities is in the form of direct or indirect equity interests and fee arrangements. The maximum exposure to loss represents the loss of assets recognized by the Company relating to its variable interests in these unconsolidated entities.
Basis of Accounting	Basis of Accounting The accompanying financial statements are prepared in accordance with U.S. GAAP. Management has determined that the Company’s Funds are investment companies under U.S. GAAP for the purposes of financial reporting. U.S. GAAP for an investment company requires investments to be recorded at estimated fair value and the unrealized gains and/or losses in an investment’s fair value are recognized on a current basis in the statements of operations. Additionally, the Funds do not consolidate their majority-owned and controlled investments (the “Portfolio Companies”). In the preparation of these unaudited condensed consolidated financial statements, the Company has retained the specialized accounting for the Funds.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management’s estimates are based on historical experiences and other factors, including expectations of future events that management believes to be reasonable under the circumstances. It also requires management to exercise judgment in the process of applying the Company’s accounting policies. Assumptions and estimates regarding the valuation of investments and their resulting impact on performance allocations and incentive fees involve a higher degree of judgment and complexity and these assumptions and estimates may be significant to the consolidated financial statements and the resulting impact on performance allocations and incentive fees. Actual results could differ from these estimates and such differences could be material.
Business Combinations	Business Combinations The Company accounts for business combinations using the acquisition method of accounting, under which the purchase price of the acquisition is allocated to the assets acquired and liabilities assumed using the fair values determined by management as of the acquisition date. Contingent consideration obligations that are elements of consideration transferred are recognized as of the acquisition date as part of the fair value transferred in exchange for the acquired business. Acquisition-related costs incurred in connection with a business combination are expensed as incurred.
Revenue Recognition and Deferred Revenue	Revenue Recognition The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers . Revenue is recognized when the Company transfers promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those goods or services. ASC 606 includes a five-step framework that requires an entity to: (i) identify the contract(s) with a customer, which includes assessing the collectability of the consideration to which it will be entitled in exchange for the goods or services transferred to the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when the entity satisfies a performance obligation. The Company accounts for performance allocations that represent a performance-based capital allocation from fund limited partners to the Company (commonly known as “carried interest”) as earnings from financial assets within the scope of ASC 323, Investments — Equity Method and Joint Ventures , and therefore are not in the scope of ASC 606. In accordance with ASC 323, the Company records equity method income (losses) as a component of investment income based on the change in its proportionate claim on net assets of the investment fund, including performance allocations, assuming the investment fund was liquidated as of each reporting date pursuant to each fund’s governing agreements. See Note 4 for additional information on the components of investments and investment income. Performance fees that do not meet the definition of performance-based capital allocations are in the scope of ASC 606 and are included in incentive fees in the unaudited condensed consolidated statements of operations. The calculation of unrealized performance revenues utilizes investment valuations of the funds’ underlying investments, which are derived using the policies, methodologies and templates prepared by the Company’s valuation group, as described in Note 3, Fair Value Measurement. While the determination of who is the customer in a contractual arrangement will be made on a contract-by-contract basis, the customer will generally be the investment fund for the Company’s significant management and advisory contracts. The customer determination impacts the Company’s analysis of the accounting for contract costs. Fund Management Fees The Company provides management services to funds in which it holds a general partner interest or to funds or certain portfolio companies with which it has an investment advisory or investment management agreement. The Company considers the performance obligations in its contracts with its funds to be the promise to provide (or to arrange for third parties to provide) investment management services related to the management, policies and operations of the funds. As it relates to the Company’s performance obligation to provide investment management services, the Company typically satisfies this performance obligation over time as the services are rendered, since the funds simultaneously receive and consume the benefits provided as the Company performs the service. The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised services to the funds. Management fees earned from each investment management contract over the contract life represent variable consideration because the consideration the Company is entitled to varies based on fluctuations in the basis for the management fee, for example fund net asset value (“NAV”) or assets under management (“AUM”). Given that the management fee basis is susceptible to market factors outside of the Company’s influence, management fees are constrained and, therefore, estimates of future period management fees are generally not included in the transaction price. Revenue recognized for the investment management services provided is generally the amount determined at the end of the period because that is when the uncertainty for that period is resolved. For closed-end carry funds in the Global Private Equity and Global Credit segments, management fees generally range from 1.0% to 2.0% of commitments during the fund’s investment period based on limited partners’ capital commitments to the funds. Following the expiration or termination of the investment period, management fees generally are based on the lower of cost or fair value of invested capital and the rate charged may also be reduced. These terms may vary for certain separately managed accounts, longer-dated carry funds, and other closed-end funds. The Company will receive management fees during a specified period of time, which is generally ten years from the initial closing date, or, in some instances, from the final closing date, but such termination date may be earlier in certain limited circumstances or later if extended for successive one-year periods, typically up to a maximum of two years. Depending upon the contracted terms of investment advisory or investment management and related agreements, these fees are generally called semi-annually in advance and are recognized as earned over the subsequent six month period. For certain longer-dated carry funds and certain other closed-end funds, management fees are called quarterly over the life of the funds. Within the Global Credit segment, for CLOs and other structured products, management fees generally range from 0.4% to 0.5% based on the total par amount of assets or the aggregate principal amount of the notes in the CLO and are generally due quarterly in arrears based on the terms and recognized over the respective period. Management fees for the CLOs and other structured products are governed by indentures and collateral management agreements. The Company will receive management fees for the CLOs until redemption of the securities issued by the CLOs, which is generally five Under the strategic advisory services agreement with Fortitude, the Company earns a recurring management fee based on Fortitude’s general account assets, which adjusts within an agreed range based on Fortitude’s overall profitability and which is due quarterly in arrears. Management fees for the Company’s carry fund vehicles in the Global Investment Solutions segment generally range from 0.25% to 1.0% of the vehicle’s capital commitments during the commitment fee period of the relevant fund. Following the expiration of the commitment fee period, the management fees generally range from 0.25% to 1.0% on (i) the net invested capital; (ii) the lower of cost or net asset value of the capital invested, or (iii) the net asset value for unrealized investments. Management fees for the Global Investment Solutions carry fund vehicles are generally due quarterly in advance and recognized over the related quarter. unconsummated investments, professional fees, expenses associated with the acquisition, holding and disposition of investments, and other fund administrative expenses. For the professional fees that the Company arranges for the investment funds, the Company concluded that the nature of its promise is to arrange for the services to be provided and it does not control the services provided by third parties before they are transferred to the customer. Therefore, the Company concluded it is acting in the capacity of an agent. Accordingly, the reimbursement for these professional fees paid on behalf of the investment funds is presented on a net basis in general, administrative and other expenses in the unaudited condensed consolidated statements of operations. The Company also incurs certain costs, primarily employee travel and entertainment costs, employee compensation and systems costs, for which it receives reimbursement from the investment funds in connection with its performance obligation to provide investment and management services. For reimbursable travel, compensation and systems costs, the Company concluded it controls the services provided by its employees and the resources used to develop applicable systems before they are transferred to the customer and therefore is a principal. Accordingly, the reimbursement for these costs incurred by the Company to manage the fund limited partnerships are presented on a gross basis in interest and other income in the unaudited condensed consolidated statements of operations and the expense in general, administrative and other expenses or cash-based compensation and benefits expenses in the unaudited condensed consolidated statements of operations. Incentive Fees In connection with management contracts from certain of its Global Credit funds, the Company is also entitled to receive performance-based incentive fees when the return on assets under management exceeds certain benchmark returns or other performance targets. In such arrangements, incentive fees are recognized when the performance benchmark has been achieved. Incentive fees are variable consideration because they are contingent upon the investment vehicle achieving stipulated investment return hurdles. Investment returns are highly susceptible to market factors outside of the Company’s influence. Accordingly, incentive fees are constrained until all uncertainty is resolved. Estimates of future period incentive fees are generally not included in the transaction price because these estimates are constrained. The transaction price for incentive fees is generally the amount determined at the end of each accounting period to which they relate because that is when the uncertainty for that period is resolved, as these fees are not subject to clawback. Investment Income (Loss), including Performance Allocations Investment income (loss) represents the unrealized and realized gains and losses resulting from the Company’s equity method investments, including any associated general partner performance allocations, and other principal investments, including CLOs. General partner performance allocations consist of the allocation of profits from certain of the funds to which the Company is entitled (commonly known as carried interest). For closed-end carry funds in the Global Private Equity and Global Credit segments, the Company is generally entitled to a 20% allocation (or approximately 2% to 12.5% for most of the Global Investment Solutions segment carry fund vehicles) of the net realized income or gain as a carried interest after returning the invested capital, the allocation of preferred returns of generally 7% to 9% and return of certain fund costs (generally subject to catch-up provisions as set forth in the fund limited partnership agreement). These terms may vary on longer-dated funds, certain credit funds, and external co-investment vehicles. Carried interest is recognized upon appreciation of the funds’ investment values above certain return hurdles set forth in each respective partnership agreement. The Company recognizes revenues attributable to performance allocations based upon the amount that would be due pursuant to the fund partnership agreement at each period end as if the funds were terminated at that date. Accordingly, the amount recognized as investment income for performance allocations reflects the Company’s share of the gains and losses of the associated funds’ underlying investments measured at their then-current fair values relative to the fair values as of the end of the prior period. Because of the inherent uncertainty, these estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and it is reasonably possible that the difference could be material. Carried interest is ultimately realized when: (i) an underlying investment is profitably disposed of, (ii) certain costs borne by the limited partner investors have been reimbursed, (iii) the fund’s cumulative returns are in excess of the preferred return and (iv) the Company has decided to collect carry rather than return additional capital to limited partner investors. Realized carried interest may be required to be returned by the Company in future periods if the fund’s investment values decline below certain levels. When the fair value of a fund’s investments remains constant or falls below certain return hurdles, previously recognized performance allocations are reversed. In all cases, each fund is considered separately in this regard, and for a given fund, performance allocations can never be negative over the life of a fund. If upon a hypothetical liquidation of a fund’s Principal investment income (loss) is realized when the Company redeems all or a portion of its investment or when the Company receives or is due cash income, such as dividends or distributions. Unrealized principal investment income (loss) results from the Company’s proportionate share of the investee’s unrealized earnings, including changes in the fair value of the underlying investment, as well as the reversal of unrealized gain (loss) at the time an investment is realized. As it relates to the Company’s investments in NGP (see Note 4), principal investment income includes the related amortization of the basis difference between the Company’s carrying value of its investment and the Company’s share of underlying net assets of the investee, as well as the compensation expense associated with compensatory arrangements provided by the Company to employees of its equity method investee. Interest Income Deferred Revenue Deferred revenue represents management fees and other revenue received prior to the balance sheet date, which has not yet been earned. Deferred revenue also includes transaction and portfolio advisory fees received by the Company that are required to offset fund management fees pursuant to the related fund agreements. The increase in the deferred revenue balance for the three months ended March 31, 2023 was primarily driven by cash payments received in advance of the Company satisfying its performance obligations, partially offset by revenues recognized that were included in the deferred revenue balance at the beginning of the period.
Credit Losses	Credit Losses The Company measures all expected credit losses for financial assets held at the reporting date in accordance with ASC 326, Financial Instruments — Credit Losses , based on historical experience, current conditions, and reasonable and supportable forecasts. The Company assesses the collection risk characteristics of the outstanding amounts in its due from affiliates balance into the following pools of receivables: • Reimbursable fund expenses receivables, • Management fee receivables, • Incentive fee receivables, • Transaction fee receivables, • Portfolio fee receivables, and • Notes receivable.
Compensation and Benefits	Compensation and Benefits Cash-based Compensation and Benefits – Cash-based compensation and benefits includes salaries, bonuses (discretionary awards and guaranteed amounts), performance payment arrangements and benefits paid and payable to Carlyle employees. Bonuses are accrued over the service period to which they relate. Equity-Based Compensation – Compensation expense relating to the issuance of equity-based awards is measured at fair value on the grant date. The compensation expense for awards that vest over a future service period is recognized over the relevant service period on a straight-line basis. The compensation expense for awards that do not require future service is recognized immediately. Cash settled equity-based awards are classified as liabilities and are re-measured at the end of each reporting period. The compensation expense for awards that contain performance conditions is recognized when it is probable that the performance conditions will be achieved; in certain instances, such compensation expense may be recognized prior to the grant date of the award. The compensation expense for awards that contain market conditions is based on a grant-date fair value that factors in the probability that the market conditions will be achieved and is recognized over the requisite service period on a straight-line basis. Certain equity-based awards contain dividend-equivalent rights, which are subject to the same terms and conditions, including with respect to vesting and settlement, that apply to the related award. Dividend-equivalents are accounted for as a reclassification from retained earnings to additional paid-in capital at the time dividends are declared and do not result in incremental compensation expense. Equity-based awards issued to non-employees are generally recognized as general, administrative and other expenses, except to the extent they are recognized as part of the Company’s equity method earnings because they are issued to employees of equity method investees. The Company recognizes equity-based award forfeitures in the period they occur as a reversal of previously recognized compensation expense. The reduction in compensation expense is determined based on the specific awards forfeited during that period. Furthermore, the Company recognizes all excess tax benefits and deficiencies as income tax benefit or expense in the unaudited condensed consolidated statements of operations.
Income Taxes	Income Taxes The Carlyle Group Inc. is a corporation for U.S. federal income tax purposes and thus is subject to U.S. federal, state and local corporate income taxes. Tax positions taken by the Company are subject to periodic audit by U.S. federal, state, local and foreign taxing authorities. The interim provision for income taxes is calculated using the discrete effective tax rate method as allowed by ASC 740, Accounting for Income Taxes . The discrete method is applied when the application of the estimated annual effective tax rate is impractical because it is not possible to reliably estimate the annual effective tax rate. In addition, the discrete method treats the year to date period as if it was the annual period and determines the income tax expense or benefit on that basis. The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement reporting and the tax basis of assets and liabilities using enacted tax rates in effect for the period in which the difference is expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the period of the change in the provision for income taxes. Further, deferred tax assets are recognized for the expected realization of available net operating loss and tax credit carry forwards. A valuation allowance is recorded on the Company’s gross deferred tax assets when it is “more likely than not” that such asset will not be realized. When evaluating the realizability of the Company’s deferred tax assets, all evidence, both positive and negative, is evaluated. Items considered in this analysis include the ability to carry back losses, the reversal of temporary differences, tax planning strategies, and expectations of future earnings. The Company accounts for the valuation allowance assessment on its deferred tax assets and without regard to the Company’s potential future corporate alternative minimum tax (“CAMT”) status. Lastly, the Company accounts for the tax on global intangible low-taxed income (“GILTI”) as incurred and therefore has not recorded deferred taxes related to GILTI on its foreign subsidiaries. Under U.S. GAAP for income taxes, the amount of tax benefit to be recognized is the amount of benefit that is “more likely than not” to be sustained upon examination. The Company analyzes its tax filing positions in all of the U.S. federal, state, local and foreign tax jurisdictions where it is required to file income tax returns, as well as for all open tax years in these jurisdictions. If, based on this analysis, the Company determines that uncertainties in tax positions exist, a liability is established, which is included in accounts payable, accrued expenses and other liabilities in the unaudited condensed consolidated financial statements. The Company recognizes accrued interest and penalties related to unrecognized tax positions in the provision for income taxes. If recognized, the entire amount of unrecognized tax positions would be recorded as a reduction in the provision for income taxes.
Non-controlling Interests	Non-controlling Interests Non-controlling interests in consolidated entities represent the component of equity in consolidated entities held by third-party investors. These interests are adjusted for general partner allocations which occur during the reporting period. Any change
Earnings Per Common Share	Earnings Per Common Share The Company computes earnings per common share in accordance with ASC 260, Earnings Per Share . Basic earnings per common share is calculated by dividing net income (loss) attributable to the common shares of the Company by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share reflects the assumed conversion of all dilutive securities. The Company applies the treasury stock method to determine the dilutive weighted-average common shares outstanding for certain equity-based compensation awards. For certain equity-based compensation awards that contain performance or market conditions, the number of contingently issuable common shares is included in diluted earnings per common share based on the number of common shares, if any, that would be issuable under the terms of the awards if the end of the reporting period were the end of the contingency period, if the result is dilutive.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The underlying entities that the Company manages and invests in (and in certain cases, consolidates) are primarily investment companies which account for their investments at estimated fair value. The fair value measurement accounting guidance under ASC Topic 820, Fair Value Measurement (“ASC 820”), establishes a hierarchical disclosure framework which ranks the observability of market price inputs used in measuring financial instruments at fair value. The observability of inputs is impacted by a number of factors, including the type of financial instrument, the characteristics specific to the financial instrument and the state of the marketplace, including the existence and transparency of transactions between market participants. Financial instruments with readily available quoted prices, or for which fair value can be measured from quoted prices in active markets, will generally have a higher degree of market price observability and a lesser degree of judgment applied in determining fair value. Financial instruments measured and reported at fair value are classified and disclosed based on the observability of inputs used in the determination of fair values, as follows: • Level I – inputs to the valuation methodology are quoted prices available in active markets for identical instruments as of the reporting date. The type of financial instruments in this category include unrestricted securities, such as equities and derivatives, listed in active markets. The Company does not adjust the quoted price for these instruments, even in situations where the Company holds a large position and a sale could reasonably impact the quoted price. • Level II – inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. The types of financial instruments in this category include less liquid and restricted securities listed in active markets, securities traded in other than active markets, government and agency securities, and certain over-the-counter derivatives where the fair value is based on observable inputs. • Level III – inputs to the valuation methodology are unobservable and significant to overall fair value measurement. The inputs into the determination of fair value require significant management judgment or estimation. The types of financial instruments in this category include investments in privately-held entities, non-investment grade residual interests in securitizations, collateralized loan obligations, and certain over-the-counter derivatives where the fair value is based on unobservable inputs. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the determination of which category within the fair value hierarchy is appropriate for any given financial instrument is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. In certain cases, debt and equity securities (including corporate treasury investments) are valued on the basis of prices from an orderly transaction between market participants provided by reputable dealers or pricing services. In determining the value of a particular investment, pricing services may use certain information with respect to transactions in such investments, quotations from dealers, pricing matrices, market transactions in comparable investments and various relationships between investments. In the absence of observable market prices, the Company values its investments and its funds’ investments using valuation methodologies applied on a consistent basis. For some investments little market activity may exist. Management’s determination of fair value is then based on the best information available in the circumstances and may incorporate management’s own assumptions and involve a significant degree of judgment, taking into consideration a combination of internal and external factors, including the appropriate risk adjustments for non-performance and liquidity risks. Investments for which market prices are not observable include private investments in the equity and debt of operating companies and real assets, CLO investments and CLO loans payable and fund investments. The valuation technique for each of these investments is described below: Investments in Operating Companies and Real Assets – The fair values of private investments in operating companies and real assets are generally determined by reference to the income approach (including the discounted cash flow method and the income capitalization method) and the market approach (including the comparable publicly traded company method and the comparable transaction method). Valuations under these approaches are typically derived by reference to investment-specific inputs (such as projected cash flows, earnings before interest, taxes, depreciation and amortization (“EBITDA”), and net operating income) combined with market-based inputs (such as discount rates, EBITDA multiples and capitalization rates). In many cases the investment-specific inputs are unaudited at the time received. Management may also adjust the market-based inputs to account for differences between the subject investment and the companies, asset or investments used to derive the market-based inputs. Adjustments to observable valuation measures are frequently made upon the initial investment to calibrate the initial investment valuation to industry observable inputs. Such adjustments are made to align the investment to observable industry inputs for differences in size, profitability, projected growth rates, geography, capital structure, and other factors as applicable. The adjustments are then reviewed with each subsequent valuation to assess how the investment has evolved relative to the observable inputs. Additionally, the investment may be subject to certain specific risks and/or development milestones which are also taken into account in the valuation assessment. Option pricing models and similar tools may also be considered but do not currently drive a significant portion of operating company or real asset valuations and are used primarily to value warrants, derivatives, certain restrictions and other atypical investment instruments. Credit-Oriented Investments – The fair values of credit-oriented investments (including corporate treasury investments) are generally determined on the basis of prices between market participants provided by reputable dealers or pricing services. In determining the value of a particular investment, pricing services may use certain information with respect to transactions in such investments, quotations from dealers, pricing matrices, market transactions in comparable investments and various relationships between investments. Specifically, for investments in distressed debt and corporate loans and bonds, the fair values are generally determined by valuations of comparable investments. In some instances, the Company may utilize other valuation techniques, including the discounted cash flow method. CLO Investments and CLO Loans Payable – The Company measures the financial liabilities of its consolidated CLOs based on the fair value of the financial assets of its consolidated CLOs, as the Company believes the fair value of the financial assets are more observable. The fair values of the CLO loan and bond assets are primarily based on quotations from reputable dealers or relevant pricing services. In situations where valuation quotations are unavailable, the assets are valued based on similar securities, market index changes, and other factors. The Company performs certain procedures to ensure the reliability of the quotations from pricing services for its CLO assets and CLO structured asset positions, which generally includes corroborating prices with a discounted cash flow analysis. Generally, the loan and bond assets of the CLOs are not publicly traded and are classified as Level III. The fair values of the CLO structured asset positions are determined based on both discounted cash flow analyses and third party quotes. Those analyses consider the position size, liquidity, current financial condition of the CLOs, the third party financing environment, reinvestment rates, recovery lags, discount rates and default forecasts and are compared to broker quotations from market makers and third party dealers. The Company measures the CLO loan payables held by third party beneficial interest holders on the basis of the fair value of the financial assets of the CLO and the beneficial interests held by the Company. The Company continues to measure the CLO loans payable that it holds at fair value based on relevant pricing services or discounted cash flow analyses, as described above. Fund Investments – The Company’s primary and secondary investments in external funds are generally valued as its proportionate share of the most recent net asset value provided by the third-party general partners of the underlying fund partnerships, adjusted for subsequent cash flows received from or distributed to the underlying fund partnerships. The Company also adjusts for any changes in the market prices of public securities held by the underlying fund partnerships and may also apply a market adjustment to reflect the estimated change in the fair value of the underlying fund partnerships’ non-public investments from the date of the most recent net asset value provided by the third-party general partners. Investment professionals with responsibility for the underlying investments are responsible for preparing the investment valuations pursuant to the policies, methodologies and templates prepared by the Company’s valuation group, which is a team made up of dedicated valuation professionals reporting to the Company’s chief accounting officer. The valuation group is responsible for maintaining the Company’s valuation policy and related guidance, templates and systems that are designed to be consistent with the guidance found in ASC 820. These valuations, inputs and preliminary conclusions are reviewed by the fund accounting teams. The valuations are then reviewed and approved by the respective fund valuation subcommittees, which include the respective fund head(s), segment head, chief financial officer and chief accounting officer, as well as members of the valuation group. The valuation group compiles the aggregate results and significant matters and presents them for review and approval by the global valuation committee, which includes the Company’s Chief Executive Officer, chief risk officer, chief financial officer, chief accounting officer, and the business segment heads, and observed by the chief compliance officer, the director of internal audit, the Company’s audit committee and others. Additionally, each quarter a sample of valuations are reviewed by external valuation firms. Valuations of the funds’ investments are used in the calculation of accrued performance allocations, or “carried interest.”
Investments, at Fair Value and Corporate Treasury Investments	Investments, at Fair Value Investments include (i) the Company’s ownership interests (typically general partner interests) in the Funds, including the Company’s investment in Fortitude, (which are accounted for as equity method investments) (ii) the Company’s investment in NGP (which is accounted for as an equity method investment), (iii) the investments held by the Consolidated Funds (which are presented at fair value in the Company’s unaudited condensed consolidated financial statements), and (iv) certain credit-oriented investments, including investments in the CLOs and the preferred securities of Carlyle Secured Lending, Inc. (“CSL,” formerly known as “TCG BDC, Inc.,” the preferred securities of which are referred to as the “BDC Preferred Shares”) (which are accounted for as trading securities). Upon the sale of a security or other investment, the realized net gain or loss is computed on a weighted average cost basis, with the exception of the investments held by the CLOs, which compute the realized net gain or loss on a first in, first out basis. Securities transactions are recorded on a trade date basis. Corporate Treasury Investments Corporate treasury investments represent investments in U.S. Treasury and government agency obligations, commercial paper, certificates of deposit, other investment grade securities and other investments with original maturities of greater than three months when purchased. These investments are accounted for as trading securities in which changes in the fair value of each investment are recorded through investment income (loss). Any interest earned on debt investments is recorded through interest and other income.
Equity Method Investments	Equity Method Investments The Company accounts for all investments in which it has or is otherwise presumed to have significant influence, including investments in the unconsolidated Funds and the Company’s investment in NGP, using the equity method of accounting. The carrying value of equity method investments is determined based on amounts invested by the Company, adjusted for the equity in earnings or losses of the investee (including performance allocations) allocated based on the respective partnership agreement, less distributions received. The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may not be recoverable.
Cash and Cash Equivalents	Cash and Cash EquivalentsCash and cash equivalents include cash held at banks and cash held for distributions, including investments with original maturities of less than three months when purchased.
Cash and Cash Equivalents Held at Consolidated Funds	Cash and Cash Equivalents Held at Consolidated Funds Cash and cash equivalents held at Consolidated Funds consists of cash and cash equivalents held by the Consolidated Funds, which, although not legally restricted, is not available to fund the general liquidity needs of the Company.
Restricted Cash	Restricted CashRestricted cash primarily represents cash held by the Company’s foreign subsidiaries due to certain government regulatory capital requirements as well as certain amounts held on behalf of Carlyle funds.
Derivative Instruments	Derivative InstrumentsThe Company uses derivative instruments primarily to reduce its exposure to changes in foreign currency exchange rates. Derivative instruments are recognized at fair value in the unaudited condensed consolidated balance sheets with changes in fair value recognized in the unaudited condensed consolidated statements of operations for all derivatives not designated as hedging instruments.
Securities Sold Under Agreements to Repurchase	Securities Sold Under Agreements to Repurchase As it relates to certain European CLOs sponsored by the Company, securities sold under agreements to repurchase (“repurchase agreements”) are accounted for as collateralized financing transactions. The Company provides securities to counterparties to collateralize amounts borrowed under repurchase agreements on terms that permit the counterparties to repledge or resell the securities to others. As of March 31, 2023, $288.2 million of securities were transferred to counterparties under repurchase agreements and are included within investments in the unaudited condensed consolidated balance sheets. Cash received under repurchase agreements is recognized as a liability within debt obligations in the unaudited condensed consolidated balance sheets.
Fixed Assets	Fixed Assets Fixed assets consist of furniture, fixtures and equipment, leasehold improvements, and computer hardware and software and are stated at cost, less accumulated depreciation and amortization. Depreciation is recognized on a straight-line method over the assets’ estimated useful lives, which for leasehold improvements are the lesser of the lease terms or the life of the asset, and three
Leases	Leases The Company accounts for its leases in accordance with ASC 842, Leases , and recognizes a lease liability and right-of-use asset in the condensed consolidated balance sheet for contracts that it determines are leases or contain a lease. The Company’s leases primarily consist of operating leases for office space in various countries around the world. The Company also has operating leases for office equipment and vehicles, which are not significant. The Company does not separate non-lease components from lease components for its office space and equipment operating leases and instead accounts for each separate lease component and its associated non-lease component as a single lease component. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the leases. The Company’s right-of-use assets and lease liabilities are recognized at lease commencement based on the present value of lease payments over the lease term. Lease right-of-use assets include initial direct costs incurred by the Company and are presented net of deferred rent and lease incentives. Absent an implicit interest rate in the lease, the Company uses its incremental borrowing rate, adjusted for the effects of collateralization, based on the information available at commencement in determining the present value of lease payments. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Lease right-of-use assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. The Company does not recognize a lease liability or right-of-use asset on the balance sheet for short-term leases. Instead, the Company recognizes short-term lease payments as an expense on a straight-line basis over the lease term. A short-term lease is defined as a lease that, at the commencement date, has a lease term of 12 months or less and does not include an option to purchase the underlying asset that the lessee is reasonably certain to exercise. When determining whether a lease qualifies as a short-term lease, the Company evaluates the lease term and the purchase option in the same manner as all other leases.
Intangible Assets and Goodwill	Intangible Assets and Goodwill The Company’s intangible assets consist of acquired contractual rights to earn future fee income, including management and advisory fees, customer relationships, and acquired trademarks. Finite-lived intangible assets are amortized over their estimated useful lives, which range from four
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss)The Company’s accumulated other comprehensive income (loss) is comprised of foreign currency translation adjustments and gains and losses on defined benefit plans sponsored by AlpInvest.
Foreign Currency Translation	Foreign Currency TranslationNon-U.S. dollar denominated assets and liabilities are translated at period-end rates of exchange, and the unaudited condensed consolidated statements of operations are translated at rates of exchange in effect throughout the period.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company considers the applicability and impact of all accounting standard updates (“ASU”) issued by the Financial Accounting Standards Board (“FASB”). ASUs not listed below were assessed and either determined to be not applicable or expected to have minimal impact on the Company’s consolidated financial statements. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendments in this update clarify the guidance in Topic 820 when measuring the fair value of an equity security subject to contractual sale restrictions and introduce new disclosure requirements related to such equity securities. The amendments are effective for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company does not expect the impact of this guidance to be material to its consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
Summary of Significant Accounting Policies (Tables)	Mar. 31, 2023
Accounting Policies [Abstract]
Assets recognized in consolidated balance sheets related to non-consolidated VIEs	The assets recognized in the Company’s unaudited condensed consolidated balance sheets related to the Company’s variable interests in these non-consolidated VIEs were as follows: As of March 31, 2023 December 31, 2022 (Dollars in millions) Investments $ 1,084.9 $ 1,124.0 Accrued performance allocations 455.0 406.0 Management fee receivables 43.3 49.6 Total $ 1,583.2 $ 1,579.6
Components of accumulated other comprehensive income (loss)	The components of accumulated other comprehensive income (loss) as of March 31, 2023 and December 31, 2022 were as follows: As of March 31, 2023 December 31, 2022 (Dollars in millions) Currency translation adjustments $ (305.2) $ (322.0) Unrealized losses on defined benefit plans — (0.2) Total $ (305.2) $ (322.2)

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	3 Months Ended
Fair Value Measurement (Tables)	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Summary of assets and liabilities measured at fair value on recurring basis	The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the above fair value hierarchy levels as of March 31, 2023: (Dollars in millions) Level I Level II Level III Total Assets Investments of Consolidated Funds (1) : Equity securities (2) $ — $ — $ 435.5 $ 435.5 Bonds — — 593.2 593.2 Loans — — 5,481.7 5,481.7 — — 6,510.4 6,510.4 Investments in CLOs and other: Investments in CLOs — — 544.8 544.8 Other investments (3) 1.5 41.9 76.1 119.5 1.5 41.9 620.9 664.3 Corporate treasury investments Commercial paper and other — 102.0 — 102.0 — 102.0 — 102.0 Foreign currency forward contracts — 2.1 — 2.1 Subtotal $ 1.5 $ 146.0 $ 7,131.3 $ 7,278.8 Investments measured at net asset value 569.6 Total $ 7,848.4 Liabilities Loans payable of Consolidated Funds (4) $ — $ — $ 5,647.9 $ 5,647.9 Foreign currency forward contracts — 1.6 — 1.6 Total (5) $ — $ 1.6 $ 5,647.9 $ 5,649.5 (1) This balance excludes $556.9 million related to investments of consolidated funds that are included in investments measured at net asset value. (2) This balance includes $382.7 million related to investments that have been bridged by the Company to investment funds and are accounted for as consolidated VIEs as of March 31, 2023. (3) The Level III balance excludes $50.3 million related to three corporate investments in equity securities which the Company has elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to ASC 321, Investments – Equity Securities . As a non-recurring fair value measurement, the fair value of these equity securities is excluded from the tabular Level III rollforward disclosures. (4) Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interest held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. (5) Total liabilities balance excludes $280.5 million of senior notes measured at amortized cost and a $157.5 million revolving credit balance, both related to loans payable of Consolidated Funds. The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the above fair value hierarchy levels as of December 31, 2022: (Dollars in millions) Level I Level II Level III Total Assets Investments of Consolidated Funds (1) : Equity securities (2) $ — $ — $ 430.6 $ 430.6 Bonds — — 594.9 594.9 Loans — — 5,352.9 5,352.9 — — 6,378.4 6,378.4 Investments in CLOs — — 526.1 526.1 Other investments (3) 1.6 41.6 79.4 122.6 Corporate treasury investments Commercial paper and other — 20.0 — 20.0 — 20.0 — 20.0 Foreign currency forward contracts — 2.2 — 2.2 Subtotal $ 1.6 $ 63.8 $ 6,983.9 $ 7,049.3 Investments measured at net asset value 528.5 Total $ 7,577.8 Liabilities Loans payable of Consolidated Funds (4) $ — $ — $ 5,491.6 $ 5,491.6 Foreign currency forward contracts — 3.2 — 3.2 Total (5) $ — $ 3.2 $ 5,491.6 $ 5,494.8 (1) This balance excludes $516.0 million related to investments of consolidated funds that are included in investments measured at net asset value. (2) This balance includes $377.4 million related to investments that have been bridged by the Company to investment funds and are accounted for as consolidated VIEs as of December 31, 2022. (3) The Level III balance excludes $58.2 million related to two corporate investments in equity securities which the Company has elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to ASC 321, Investments – Equity Securities . As a non-recurring fair value measurement, the fair value of these equity securities is excluded from the tabular Level III rollforward disclosures. (4) Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. (5) Total liabilities balance excludes $235.6 million of senior notes measured at amortized cost and a $178.0 million revolving credit balance related to loans payable of Consolidated Funds.
Changes in Level III financial assets measured at fair value	The changes in financial instruments measured at fair value for which the Company has used Level III inputs to determine fair value are as follows (Dollars in millions): Financial Assets Three Months Ended March 31, 2023 Investments of Consolidated Funds Equity Bonds Loans Investments in CLOs Other investments Total Balance, beginning of period $ 430.6 $ 594.9 $ 5,352.9 $ 526.1 $ 79.4 $ 6,983.9 Purchases 5.4 29.8 237.3 — — 272.5 Sales and distributions — (47.0) (169.7) (7.9) (0.9) (225.5) Settlements — (4.1) (101.6) — — (105.7) Realized and unrealized gains (losses), net Included in earnings (0.5) 11.4 116.0 19.1 (2.4) 143.6 Included in other comprehensive income — 8.2 46.8 7.5 — 62.5 Balance, end of period $ 435.5 $ 593.2 $ 5,481.7 $ 544.8 $ 76.1 $ 7,131.3 Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date $ (0.4) $ 8.5 $ 107.3 $ 19.1 $ (3.3) $ 131.2 Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date $ — $ 8.7 $ 48.6 $ 7.5 $ — $ 64.8 Financial Assets Three Months Ended March 31, 2022 Investments of Consolidated Funds Equity Bonds Loans Investments in CLOs Other investments Total Balance, beginning of period $ 17.9 $ 599.5 $ 5,898.1 $ 361.1 $ 78.7 $ 6,955.3 Purchases 0.1 182.5 766.0 227.6 0.9 1,177.1 Sales and distributions (6.8) (186.9) (731.0) (14.1) (2.0) (940.8) Settlements — (0.3) (162.8) — — (163.1) Realized and unrealized gains (losses), net Included in earnings 0.4 (13.8) (53.9) (9.6) (1.6) (78.5) Included in other comprehensive income (0.3) (15.8) (103.9) (4.6) — (124.6) Balance, end of period $ 11.3 $ 565.2 $ 5,612.5 $ 560.4 $ 76.0 $ 6,825.4 Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date $ 0.3 $ (14.5) $ (59.4) $ (9.6) $ (1.6) $ (84.8) Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date $ (0.2) $ (10.8) $ (87.0) $ (4.6) $ — $ (102.6)
Changes in Level III financial liabilities measured at fair value	Financial Liabilities Loans Payable of Consolidated Funds Three Months Ended March 31, 2023 2022 Balance, beginning of period $ 5,491.6 $ 5,811.0 Borrowings 0.6 1,108.4 Paydowns (2.1) (415.4) Sales (38.1) (669.5) Realized and unrealized (gains) losses, net Included in earnings 141.4 (46.2) Included in other comprehensive income 54.5 (106.2) Balance, end of period $ 5,647.9 $ 5,682.1 Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date $ 142.4 $ (49.8) Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date $ 54.5 $ (102.6)
Summary of quantitative information about Level III inputs	The following table summarizes quantitative information about the Company’s Level III inputs as of March 31, 2023: Fair Value at Valuation Technique(s) Unobservable Input(s) Range (Dollars in millions) March 31, 2023 Assets Investments of Consolidated Funds: Equity securities $ 2.5 Consensus Pricing Indicative Quotes ($ per share) 0.00 - 392.50 (0.08) 365.4 Discounted Cash Flow Discount Rates 10% - 10% (10%) Terminal Growth Rate 0% - 7% (5%) Comparable Multiple EBITDA Multiple 12.7x - 12.7x (12.7x) TCF Multiple 24.5x - 24.5x (24.5x) 50.0 Discounted Cash Flow Discount Rates 10% - 10% (10%) Terminal Growth Rate 0% - 7% (5%) Comparable Multiple TCF Multiple 24.5x - 24.5x (24.5x) 0.3 Comparable Multiple EBITDA Multiple 13.8x - 19.0x (17.8x) 17.3 Other (1) N/A N/A Bonds 593.2 Consensus Pricing Indicative Quotes (% of Par) 40 - 107 (89) Loans 5,121.2 Consensus Pricing Indicative Quotes (% of Par) 0 - 102 (94) 11.4 Discounted Cash Flow Discount Rates 8% - 13% (13%) 329.7 Discounted Cash Flow Discount Rates 7% - 10% (8%) 8.4 Consensus Pricing Indicative Quotes (% of Par) 98% -98% (98%) 10.5 Consensus Pricing Indicative Quotes (% of Par) 86% - 86% (86%) 0.5 Other (1) N/A N/A 6,510.4 Investments in CLOs: Senior secured notes 476.6 Consensus Pricing with Discounted Cash Flow Indicative Quotes (% of Par) 72 - 100 (95) Discount Margins (Basis Points) 170 - 1,365 (314) Default Rates 2% - 3% (2%) Recovery Rates 60% - 60% (60%) Subordinated notes and preferred shares 68.2 Consensus Pricing with Discounted Cash Flow Indicative Quotes (% of Par) 0 - 86 (55) Discount Rates 15% - 25% (20%) Default Rates 2% - 3% (2%) Recovery Rates 60% - 60% (60%) Other investments: BDC preferred shares 73.6 Market Yield Analysis Market Yields 11% - 11% (11%) Aviation subordinated notes 2.5 Discounted Cash Flow Discount Rates 21% - 21% (21%) Total $ 7,131.3 Liabilities Loans payable of Consolidated Funds: Senior secured notes $ 5,451.1 Other (1) N/A N/A Subordinated notes and preferred shares 196.8 Consensus Pricing with Discounted Cash Flow Indicative Quotes (% of Par) 21 - 99 (39) Discount Rates 15% - 25% (20%) Default Rates 2% - 3% (3%) Recovery Rates 60% - 60% (60%) Total $ 5,647.9 (1) Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. The following table summarizes quantitative information about the Company’s Level III inputs as of December 31, 2022: Fair Value at Valuation Technique(s) Unobservable Input(s) Range (Dollars in millions) December 31, 2022 Assets Investments of Consolidated Funds: Equity securities $ 3.1 Consensus Pricing Indicative Quotes ($ per share) 0.00 - 4.73 (0.18) 363.5 Discounted Cash Flow Discount Rates 10% - 10% (10%) Terminal Growth Rate 0% - 7% (5%) Comparable Multiple EBITDA Multiple 12.7x - 12.7x (12.7x) TCF Multiple 23.8x - 23.8x (23.8x) 64.0 Other (1) N/A N/A Bonds 594.9 Consensus Pricing Indicative Quotes (% of Par) 46 - 105 (88) Loans 5,043.4 Consensus Pricing Indicative Quotes (% of Par) 0 - 100 (91) 11.8 Discounted Cash Flow Discount Rates 0% - 9% (1%) 248.7 Discounted Cash Flow Discount Rates 7% - 10% (8%) 37.4 Consensus Pricing Indicative Quotes (% of Par) 97% - 98% (97%) 11.1 Consensus Pricing Indicative Quotes (% of Par) 91% - 91% (91%) 0.5 Other (1) N/A N/A 6,378.4 Investments in CLOs: Senior secured notes 462.1 Discounted Cash Flow with Consensus Pricing Indicative Quotes (% of Par) 67 - 100 (93) Discount Margins (Basis Points) 170 - 1,800 (386) Default Rates 2% - 3% (2%) Recovery Rates 50% - 70% (60%) Subordinated notes and preferred shares 64.0 Discounted Cash Flow with Consensus Pricing Indicative Quotes (% of Par) 0 - 82 (40) Discount Rate 15% - 25% (20%) Default Rates 2% - 3% (2%) Recovery Rates 50% - 70% (60%) Other investments: BDC preferred shares 76.9 Market Yield Analysis Market Yields 11% - 11% (11%) Aviation subordinated notes 2.5 Discounted Cash Flow Discount Rates 21% - 21% (21%) Total $ 6,983.9 Liabilities Loans payable of Consolidated Funds: Senior secured notes $ 5,303.3 Other (2) N/A N/A Subordinated notes and preferred shares 188.3 Discounted Cash Flow with Consensus Pricing Indicative Quotes (% of Par) 21 - 96 (38) Discount Rates 15% - 25% (20%) Default Rates 2% - 3% (3%) Recovery Rates 50% - 70% (60%) Total $ 5,491.6 (1) Fair value approximates transaction price that was in close proximity to the reporting date. (2) Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services.

Investments (Tables)

Investments (Tables)	3 Months Ended
Investments (Tables)	Mar. 31, 2023
Investments [Abstract]
Schedule of investments	Investments consist of the following: As of March 31, 2023 December 31, 2022 (Dollars in millions) Accrued performance allocations $ 7,134.0 $ 7,117.7 Principal equity method investments, excluding performance allocations 2,915.6 2,922.0 Principal investments in CLOs 544.8 526.1 Other investments 189.7 202.1 Total $ 10,784.1 $ 10,767.9
Components of accrued performance fees	The components of accrued performance allocations are as follows: As of March 31, 2023 December 31, 2022 (Dollars in millions) Global Private Equity $ 5,484.4 $ 5,577.1 Global Credit 226.3 193.9 Global Investment Solutions 1,423.3 1,346.7 Total $ 7,134.0 $ 7,117.7
Components of accrued giveback obligations	The components of the accrued giveback obligations are as follows: As of March 31, 2023 December 31, 2022 (Dollars in millions) Global Private Equity $ (18.4) $ (18.4) Global Credit (22.5) (22.5) Total $ (40.9) $ (40.9)
Schedule of equity method investments	Principal investments are related to the following segments: As of March 31, 2023 December 31, 2022 (Dollars in millions) Global Private Equity (1) $ 1,826.3 $ 1,853.5 Global Credit (2) 987.5 974.2 Global Investment Solutions 101.8 94.3 Total $ 2,915.6 $ 2,922.0 (1) The balance includes $1,011.2 million and $1,015.7 million as of March 31, 2023 and December 31, 2022, respectively, related to the Company’s equity method investments in NGP. (2) As of March 31, 2023 and December 31, 2022, the balance includes $619.7 million and $646.0 million, respectively, related to the Company’s investments in Fortitude. The Company’s investments in NGP as of March 31, 2023 and December 31, 2022 are as follows: As of March 31, 2023 December 31, 2022 (Dollars in millions) Investment in NGP Management $ 370.1 $ 369.7 Investments in NGP general partners - accrued performance allocations 566.1 564.5 Principal investments in NGP funds 75.0 81.5 Total investments in NGP $ 1,011.2 $ 1,015.7 Carlyle’s income (loss) from its principal equity method investments consists of: Three Months Ended March 31, 2023 2022 (Dollars in millions) Global Private Equity $ 17.8 $ 328.2 Global Credit (18.9) (2.7) Global Investment Solutions 9.4 2.6 Total $ 8.3 $ 328.1
Schedule of net investment income (loss)	The net investment income (loss) recognized in the Company’s unaudited condensed consolidated statements of operations for the three months ended March 31, 2023 and 2022 were as follows: Three Months Ended March 31, 2023 2022 (Dollars in millions) Management fee related revenues from NGP Management $ 18.1 $ 17.0 Expenses related to the investment in NGP Management (3.4) (2.8) Amortization of basis differences from the investment in NGP Management — (0.3) Net investment income from NGP Management $ 14.7 $ 13.9
Components of investment income (loss)	The components of investment income (loss) are as follows: Three Months Ended March 31, 2023 2022 (Dollars in millions) Performance allocations Realized $ 179.6 $ 266.9 Unrealized (18.8) 443.3 160.8 710.2 Principal investment income (loss) from equity method investments (excluding performance allocations) Realized 38.5 32.8 Unrealized (30.2) 295.3 8.3 328.1 Principal investment income (loss) from investments in CLOs and other investments Realized (1.1) 2.3 Unrealized (1) 4.5 (10.8) 3.4 (8.5) Total $ 172.5 $ 1,029.8 (1) The three months ended March 31, 2023 includes investment loss of $13.3 million associated with the remeasurement of a corporate investment, which was previously carried at cost, resulting from observable price changes pursuant to ASC 321, Investments - Equity Securities .
Performance allocations included in revenues	The performance allocations included in revenues are derived from the following segments: Three Months Ended March 31, 2023 2022 (Dollars in millions) Global Private Equity $ (3.8) $ 657.9 Global Credit 33.4 (34.0) Global Investment Solutions 131.2 86.3 Total $ 160.8 $ 710.2
Components of interest and other income of consolidated funds	The components of interest and other income of Consolidated Funds are as follows: Three Months Ended 2023 2022 (Dollars in millions) Interest income from investments $ 109.8 $ 56.5 Other income 12.1 5.2 Total $ 121.9 $ 61.7
Components of net investment gains (losses) of consolidated funds	The components of net investment income (losses) of Consolidated Funds are as follows: Three Months Ended 2023 2022 (Dollars in millions) Gains (losses) from investments of Consolidated Funds $ 145.0 $ (43.4) Gains (losses) from liabilities of CLOs (141.4) 46.2 Total $ 3.6 $ 2.8
Schedule of realized and unrealized gains (losses) earned from investments of consolidated funds	The following table presents realized and unrealized gains (losses) earned from investments of the Consolidated Funds: Three Months Ended 2023 2022 (Dollars in millions) Realized gains (losses) $ (17.4) $ 2.7 Net change in unrealized gains (losses) 162.4 (46.1) Total $ 145.0 $ (43.4)

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	3 Months Ended
Intangible Assets and Goodwill (Tables)	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Carrying amount of intangible assets	The following table summarizes the carrying amount of intangible assets as of March 31, 2023 and December 31, 2022: As of March 31, 2023 December 31, 2022 (Dollars in millions) Acquired contractual rights $ 921.7 $ 920.2 Accumulated amortization (159.3) (126.3) Finite-lived intangible assets, net 762.4 793.9 Goodwill 104.0 103.9 Intangible Assets, net $ 866.4 $ 897.8
Schedule of estimated amortization expense	The following table summarizes the expected amortization expense for 2023 through 2027 and thereafter (Dollars in millions): 2023 (excluding the three months ended March 31, 2023) $ 98.6 2024 131.5 2025 131.4 2026 131.3 2027 121.2 Thereafter 148.4 $ 762.4

Borrowings (Tables)

Borrowings (Tables)	3 Months Ended
Borrowings (Tables)	Mar. 31, 2023
Debt Instrument [Line Items]
Schedule of debt obligations	The Company’s debt obligations consist of the following: March 31, 2023 December 31, 2022 Borrowing Carrying Borrowing Carrying (Dollars in millions) CLO Borrowings (See below) $ 425.4 $ 421.8 $ 421.7 $ 418.1 5.625% Senior Notes Due 3/30/2043 600.0 600.6 600.0 600.6 5.650% Senior Notes Due 9/15/2048 350.0 346.3 350.0 346.3 3.500% Senior Notes Due 9/19/2029 425.0 422.1 425.0 422.0 4.625% Subordinated Notes Due 5/15/2061 500.0 484.8 500.0 484.7 Total debt obligations $ 2,300.4 $ 2,275.6 $ 2,296.7 $ 2,271.7
Summary of loans payable of consolidated funds	As of March 31, 2023 and December 31, 2022, the following borrowings were outstanding, which includes preferred shares classified as liabilities (Dollars in millions): As of March 31, 2023 Borrowing Fair Value Weighted Weighted Senior secured notes (1) $ 5,909.0 $ 5,451.1 4.74 % 9.23 Subordinated notes (2) 254.9 196.8 N/A (3) 9.44 Total $ 6,163.9 $ 5,647.9 As of December 31, 2022 Borrowing Fair Value Weighted Weighted Senior secured notes (1) $ 5,849.2 $ 5,303.3 3.97 % 9.48 Subordinated notes (2) 234.0 188.3 N/A (3) 9.69 Total $ 6,083.2 $ 5,491.6 (1) Borrowing Outstanding as of March 31, 2023 and December 31, 2022 includes $280.5 million and $235.6 million of senior secured notes that are carried at par value, respectively. The fair value of these senior secured notes at March 31, 2023 and December 31, 2022, approximated par value based on current market rates for similar debt instruments. These senior secured notes are classified as Level III within the fair value hierarchy. (2) Borrowing Outstanding as of March 31, 2023 and December 31, 2022 includes $157.5 million and $178.0 million of revolving credit balances that are carried at amortized cost, respectively. (3) The subordinated notes do not have contractual interest rates, but instead receive distributions from the excess cash flows of the CLOs.
CLO Borrowings
Debt Instrument [Line Items]
Schedule of debt obligations	The Company’s outstanding CLO borrowings consist of the following (Dollars in millions): Formation Date Borrowing Outstanding March 31, 2023 Borrowing Outstanding December 31, 2022 Maturity Date (1) Interest Rate as of March 31, 2023 February 28, 2017 $ 39.3 $ 38.7 November 17, 2031 3.79% (2) June 29, 2017 54.1 54.8 July 20, 2030 6.47% (4) December 6, 2017 43.8 43.8 January 15, 2031 6.16% (5) March 15, 2019 1.8 1.8 March 15, 2032 11.06% (3) August 20, 2019 3.9 3.9 August 15, 2032 7.39% (3) September 15, 2020 19.3 19.1 April 15, 2033 3.87% (3) January 8, 2021 20.2 19.9 January 15, 2034 4.78% (3) March 9, 2021 19.0 19.1 August 15, 2030 4.03% (3) March 30, 2021 18.3 18.0 March 15, 2032 4.66% (3) April 21, 2021 3.5 3.4 April 15, 2033 8.14% (3) May 21, 2021 15.2 15.0 November 17, 2031 4.02% (3) June 4, 2021 20.3 20.0 January 16, 2034 4.57% (3) June 10, 2021 1.3 1.3 November 17, 2031 5.50% (3) July 15, 2021 15.2 15.0 July 15, 2034 4.58% (3) July 20, 2021 20.3 20.0 July 20, 2031 4.62% (3) August 4, 2021 16.4 16.2 August 15, 2032 4.40% (3) October 27, 2021 23.6 23.3 October 15, 2035 4.69% (3) November 5, 2021 14.1 13.8 January 14, 2034 4.37% (3) January 6, 2022 20.4 20.1 February 15, 2035 5.03% (3) February 22, 2022 20.4 20.1 November 10, 2035 5.06% (3) July 13, 2022 17.2 16.9 January 13, 2035 5.54% (3) October 25, 2022 17.8 17.5 October 25, 2035 5.62% (3) $ 425.4 $ 421.7 (1) Maturity date is earlier of date indicated or the date that the CLO is dissolved. (2) Outstanding borrowing of €36.1 million; incurs interest at EURIBOR plus applicable margins as defined in the agreement. (3) Incurs interest at the average effective interest rate of each class of purchased securities plus 0.50% spread percentage. (4) Incurs interest at LIBOR plus 1.66%. (5) Incurs interest at LIBOR plus 1.37%.
Senior Notes
Debt Instrument [Line Items]
Schedule of debt obligations	Senior Notes Certain indirect subsidiaries of the Company have issued long term borrowings in the form of senior notes, on which interest is payable semi-annually in arrears. The following table provides information regarding these senior notes (Dollars in millions): Interest Expense Fair Value (1) Three Months Ended Aggregate Principal Amount March 31, 2023 December 31, 2022 2023 2022 5.625% Senior Notes Due 3/30/2043 (2) $ 600.0 $ 560.9 $ 545.8 $ 8.4 $ 8.4 5.650% Senior Notes Due 9/15/2048 (3) 350.0 330.3 322.2 5.0 5.0 3.500% Senior Notes Due 9/19/2029 (4) 425.0 390.6 364.1 3.8 3.8 $ 17.2 $ 17.2 (1) Including accrued interest. Fair value is based on indicative quotes and the notes are classified as Level II within the fair value hierarchy. (2) Issued $400.0 million in aggregate principal at 99.583% of par in March 2013. An additional $200.0 million in aggregate principal was issued at 104.315% of par in March 2014, and is treated as a single class with the outstanding $400.0 million in senior notes previously issued. (3) Issued in September 2018 at 99.914% of par. (4) Issued in September 2019 at 99.841% of par.

Accrued Compensation and Bene_2

Accrued Compensation and Benefits (Tables)	3 Months Ended
Accrued Compensation and Benefits (Tables)	Mar. 31, 2023
Retirement Benefits [Abstract]
Components of accrued compensation and benefits	Accrued compensation and benefits consist of the following: As of March 31, 2023 December 31, 2022 (Dollars in millions) Accrued performance allocations and incentive fee related compensation $ 3,637.0 $ 3,625.3 Accrued bonuses (1) 132.8 466.6 Employment-based contingent cash consideration (2) 2.4 76.5 Accrued pension liability 7.3 9.5 Other (3) 114.7 143.0 Total $ 3,894.2 $ 4,320.9 (1) Includes $4.8 million related to make-whole cash incentive awards granted in connection with the appointment of the Company’s Chief Executive Officer as of March 31, 2023. (2) The acquisition of Carlyle Aviation Partners, Ltd. (“Carlyle Aviation Partners,” formerly known as Apollo Aviation Group) in December 2018 included an earn-out of up to $150.0 million that was payable upon the achievement of certain revenue and earnings performance targets during 2020 through 2025, which was accounted for as compensation expense. During the three months ended March 31, 2023, the Company entered into a termination and settlement agreement with respect to the earn-out, pursuant to which the Company paid $68.6 million, based on Carlyle Aviation’s performance, and will pay an aggregate $2.4 million in installments in 2024 and 2025. The acquisition of Abingworth LLP (“Abingworth”) in August 2022 included an earn-out of up to $130.0 million payable upon the achievement of certain revenue and earnings performance targets during 2023 through 2028, which is accounted for as compensation expense. No amount has been accrued as of March 31, 2023. See Note 4 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 for additional information on the Abingworth acquisition.
Schedule of performance allocations and incentive fee related compensation	The following table presents realized and unrealized performance allocations and incentive fee related compensation: Three Months Ended 2023 2022 (Dollars in millions) Realized $ 103.6 $ 137.6 Unrealized 2.1 233.1 Total $ 105.7 $ 370.7

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
Commitments and Contingencies (Tables)	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of unfunded commitments	The Company and its unconsolidated affiliates have unfunded commitments to entities within the following segments as of March 31, 2023 (Dollars in millions): Unfunded Global Private Equity $ 3,509.1 Global Credit 453.3 Global Investment Solutions 213.5 Total $ 4,175.9
Lease cost, cash flows and other supplemental information related to operating leases	The following table summarizes the Company’s lease cost, cash flows and other supplemental information related to its operating leases (Dollars in millions): Three Months Ended 2023 2022 Operating lease cost $ 14.1 $ 14.0 Sublease income (1.5) (1.5) Total operating lease cost $ 12.6 $ 12.5 Cash paid for amounts included in the measurement of operating lease liabilities $ 16.3 $ 16.0 Weighted-average remaining lease term 10.9 years 11.8 years Weighted-average discount rate 4.2 % 4.1 %
Maturities of operating lease liabilities	Maturities of lease liabilities related to operating leases were as follows (Dollars in millions): Year ending December 31, 2023 (excluding the three months ended March 31, 2023) $ 51.4 2024 65.0 2025 61.0 2026 58.6 2027 59.2 Thereafter 340.0 Total lease payments $ 635.2 Less payments for leases that have not yet commenced (25.8) Less imputed interest (114.5) Total lease liabilities $ 494.9

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
Related Party Transactions (Tables)	Mar. 31, 2023
Related Party Transactions [Abstract]
Amounts due from affiliates and other receivables	The Company had the following due from affiliates and other receivables at March 31, 2023 and December 31, 2022: As of March 31, 2023 December 31, 2022 (Dollars in millions) Accrued incentive fees $ 17.5 $ 16.4 Unbilled receivable for giveback obligations from current and former employees 10.0 10.4 Notes receivable and accrued interest from affiliates 32.9 41.5 Management fee, reimbursable expenses and other receivables from unconsolidated funds and affiliates, net 438.9 511.1 Total $ 499.3 $ 579.4
Amounts due to affiliates	The Company had the following due to affiliates balances at March 31, 2023 and December 31, 2022: As of March 31, 2023 December 31, 2022 (Dollars in millions) Due to affiliates of Consolidated Funds $ 11.6 $ 16.4 Due to non-consolidated affiliates 130.9 87.1 Amounts owed under the tax receivable agreement 79.6 100.0 Deferred consideration for Carlyle Holdings units 65.2 134.4 Other 26.8 24.6 Total $ 314.1 $ 362.5

Non-controlling Interests in _2

Non-controlling Interests in Consolidated Entities (Tables)	3 Months Ended
Non-controlling Interests in Consolidated Entities (Tables)	Mar. 31, 2023
Noncontrolling Interest [Abstract]
Components of non-controlling interests in consolidated entities	The components of the Company’s non-controlling interests in consolidated entities are as follows: As of March 31, 2023 December 31, 2022 (Dollars in millions) Non-Carlyle interests in Consolidated Funds $ 444.5 $ 412.0 Non-Carlyle interests in majority-owned subsidiaries 189.4 186.9 Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions 2.8 1.4 Non-controlling interests in consolidated entities $ 636.7 $ 600.3
Components of non-controlling interests in income (loss) of consolidated entities	The components of the Company’s non-controlling interests in income of consolidated entities are as follows: Three Months Ended 2023 2022 (Dollars in millions) Non-Carlyle interests in Consolidated Funds $ 17.2 $ 25.1 Non-Carlyle interests in majority-owned subsidiaries 5.5 (2.4) Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions 1.9 0.5 Non-controlling interests in income of consolidated entities $ 24.6 $ 23.2

Earnings Per Common Share (Tabl

Earnings Per Common Share (Tables)	3 Months Ended
Earnings Per Common Share (Tables)	Mar. 31, 2023
Earnings Per Share [Abstract]
Summary of basic and diluted net income (loss) per common unit	Basic and diluted net income (loss) per common share are calculated as follows: Three Months Ended Basic Diluted Net income attributable to common shares $ 100,700,000 $ 100,700,000 Weighted-average common shares outstanding 362,944,260 365,357,833 Net income per common share $ 0.28 $ 0.28 Three Months Ended Basic Diluted Net income attributable to common shares $ 571,600,000 $ 571,600,000 Weighted-average common shares outstanding 357,574,838 363,010,282 Net income per common share $ 1.60 $ 1.57
Summary of weighted-average common units outstanding, basic and diluted	The weighted-average common shares outstanding, basic and diluted, are calculated as follows: Three Months Ended Basic Diluted The Carlyle Group Inc. weighted-average common shares outstanding 362,944,260 362,944,260 Unvested restricted stock units — 1,702,114 Issuable common shares and performance-vesting restricted stock units — 711,459 Weighted-average common shares outstanding 362,944,260 365,357,833 Three Months Ended Basic Diluted The Carlyle Group Inc. weighted-average common shares outstanding 357,574,838 357,574,838 Unvested restricted stock units — 3,695,350 Issuable common shares and performance-vesting restricted stock units — 1,740,094 Weighted-average common shares outstanding 357,574,838 363,010,282

Equity (Tables)

Equity (Tables)	3 Months Ended
Equity (Tables)	Mar. 31, 2023
Equity [Abstract]
Quarterly distributions on common units	The table below presents information regarding the quarterly dividends on the common shares, which were made at the sole discretion of the Board of Directors of the Company. Dividend Record Date Dividend Payment Date Dividend per Common Share Dividend to Common Stockholders (Dollars in millions, except per share data) May 10, 2022 May 17, 2022 $ 0.325 $ 117.6 August 9, 2022 August 16, 2022 0.325 118.3 November 18, 2022 November 25, 2022 0.325 118.2 February 22, 2023 March 1, 2023 0.325 118.4 Total 2022 Dividend Year $ 1.30 $ 472.5 May 16, 2023 May 23, 2023 $ 0.35 $ 126.7 Total 2023 Dividend Year (through Q1 2023) $ 0.35 $ 126.7

Equity-Based Compensation (Tabl

Equity-Based Compensation (Tables)	3 Months Ended
Equity-Based Compensation (Tables)	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Summary of status of non-vested equity-based awards	A summary of the status of the Company’s non-vested equity-based awards as of March 31, 2023 and a summary of changes for the three months ended March 31, 2023, are presented below: Unvested Shares Restricted Weighted- Unvested (1) Weighted- Balance, December 31, 2022 10,865,248 $ 35.78 452,880 $ 39.73 Granted (2) 16,729,897 $ 30.16 258,579 $ 34.65 Vested 2,756,607 $ 27.94 — $ — Forfeited 102,310 $ 35.62 — $ — Balance, March 31, 2023 24,736,228 $ 32.86 711,459 $ 37.88 (1) Includes common shares issued in connection with the Company’s investment in NGP. (2) Includes 6,762,219 shares related to equity inducement awards granted in connection with the appointment of the Company’s Chief Executive Officer, as well as 63,849 shares reserved for issuance upon the settlement of dividend-equivalent rights carried by certain restricted stock units concurrently with the settlement of the restricted stock units for shares.

Segment Reporting (Tables)

Segment Reporting (Tables)	3 Months Ended
Segment Reporting (Tables)	Mar. 31, 2023
Segment Reporting [Abstract]
Reportable segments financial data	The following tables present the financial data for the Company’s three reportable segments for the three months ended March 31, 2023: Three Months Ended March 31, 2023 Global Global Global Total (Dollars in millions) Segment Revenues Fund level fee revenues Fund management fees $ 326.9 $ 122.6 $ 56.7 $ 506.2 Portfolio advisory and transaction fees, net and other 5.4 11.0 — 16.4 Fee related performance revenues 9.6 18.4 0.8 28.8 Total fund level fee revenues 341.9 152.0 57.5 551.4 Realized performance revenues 99.0 27.7 38.4 165.1 Realized principal investment income 11.9 9.0 2.9 23.8 Interest income 5.4 7.2 1.3 13.9 Total revenues 458.2 195.9 100.1 754.2 Segment Expenses Compensation and benefits Cash-based compensation and benefits 148.7 80.4 31.5 260.6 Realized performance revenues related compensation 46.3 12.7 36.6 95.6 Total compensation and benefits 195.0 93.1 68.1 356.2 General, administrative, and other indirect expenses 57.1 21.7 8.7 87.5 Depreciation and amortization expense 6.7 2.0 1.2 9.9 Interest expense 16.6 10.2 2.2 29.0 Total expenses 275.4 127.0 80.2 482.6 Distributable Earnings $ 182.8 $ 68.9 $ 19.9 $ 271.6 (-) Realized net performance revenues 52.7 15.0 1.8 69.5 (-) Realized principal investment income 11.9 9.0 2.9 23.8 (+) Net interest 11.2 3.0 0.9 15.1 (=) Fee Related Earnings $ 129.4 $ 47.9 $ 16.1 $ 193.4 Segment assets as of March 31, 2023 $ 9,459.8 $ 3,075.2 $ 1,948.9 $ 14,483.9 The following tables present the financial data for the Company’s three reportable segments for the three months ended March 31, 2022: Three Months Ended March 31, 2022 Global Global Global Total (Dollars in millions) Segment Revenues Fund level fee revenues Fund management fees $ 304.2 $ 93.7 $ 56.3 $ 454.2 Portfolio advisory and transaction fees, net and other 6.1 10.1 — 16.2 Fee related performance revenues 30.6 13.9 — 44.5 Total fund level fee revenues 340.9 117.7 56.3 514.9 Realized performance revenues 199.9 13.7 22.7 236.3 Realized principal investment income 14.2 10.3 1.8 26.3 Interest income 0.4 1.5 0.1 2.0 Total revenues 555.4 143.2 80.9 779.5 Segment Expenses Compensation and benefits Cash-based compensation and benefits 153.0 67.2 25.6 245.8 Realized performance revenues related compensation 90.7 6.7 20.9 118.3 Total compensation and benefits 243.7 73.9 46.5 364.1 General, administrative, and other indirect expenses 45.5 23.5 7.3 76.3 Depreciation and amortization expense 6.3 2.0 1.2 9.5 Interest expense 15.8 8.2 2.8 26.8 Total expenses 311.3 107.6 57.8 476.7 Distributable Earnings $ 244.1 $ 35.6 $ 23.1 $ 302.8 (-) Realized net performance revenues 109.2 7.0 1.8 118.0 (-) Realized principal investment income 14.2 10.3 1.8 26.3 (+) Net interest 15.4 6.7 2.7 24.8 (=) Fee Related Earnings $ 136.1 $ 25.0 $ 22.2 $ 183.3
Reconciliation of total segments to income before provision for taxes	The following tables reconcile the Total Segments to the Company’s Income (Loss) Before Provision for Taxes for the three months ended March 31, 2023 and 2022, and Total Assets as of March 31, 2023. Three Months Ended March 31, 2023 Total Reportable Segments Consolidated Funds Reconciling Items Carlyle Consolidated (Dollars in millions) Revenues $ 754.2 $ 121.9 $ (17.1) (a) $ 859.0 Expenses $ 482.6 $ 97.2 $ 123.2 (b) $ 703.0 Other income (loss) $ — $ 3.6 $ — (c) $ 3.6 Distributable earnings $ 271.6 $ 28.3 $ (140.3) (d) $ 159.6 Total assets $ 14,483.9 $ 7,403.1 $ (613.1) (e) $ 21,273.9 Three Months Ended March 31, 2022 Total Reportable Segments Consolidated Funds Reconciling Items Carlyle Consolidated (Dollars in millions) Revenues $ 779.5 $ 61.7 $ 740.6 (a) $ 1,581.8 Expenses $ 476.7 $ 52.9 $ 312.3 (b) $ 841.9 Other income (loss) $ — $ 2.8 $ — (c) $ 2.8 Distributable earnings $ 302.8 $ 11.6 $ 428.3 (d) $ 742.7 (a) The Revenues adjustment principally represents unrealized performance revenues, unrealized principal investment income (loss) (including Fortitude), revenues earned from the Consolidated Funds which were eliminated in consolidation to arrive at the Company’s total revenues, adjustments for amounts attributable to non-controlling interests in consolidated entities, adjustments related to expenses associated with the investments in NGP Management and its affiliates that are included in operating captions or are excluded from the segment results, adjustments to reflect the reimbursement of certain costs incurred on behalf of Carlyle funds on a net basis, and the inclusion of tax expenses associated with certain foreign performance revenues, as detailed below: Three Months Ended 2023 2022 (Dollars in millions) Unrealized performance and fee related performance revenues $ (20.7) $ 698.8 Unrealized principal investment income (loss) (29.0) 23.7 Adjustments related to expenses associated with investments in NGP Management and its affiliates (3.4) (3.1) Tax expense associated with certain foreign performance revenues — (0.1) Non-controlling interests and other adjustments to present certain costs on a net basis 50.8 17.9 Elimination of revenues of Consolidated Funds (14.8) 3.4 $ (17.1) $ 740.6 The following table reconciles the total segments fund level fee revenue to the most directly comparable U.S. GAAP measure, the Company’s consolidated fund management fees, for the three months ended March 31, 2023 and 2022. Three Months Ended 2023 2022 (Dollars in millions) Total Reportable Segments - Fund level fee revenues $ 551.4 $ 514.9 Adjustments (1) (50.6) (64.4) Carlyle Consolidated - Fund management fees $ 500.8 $ 450.5 (1) Adjustments represent the reclassification of NGP management fees from principal investment income, the reclassification of fee related performance revenues from business development companies and other products, management fees earned from consolidated CLOs which were eliminated in consolidation to arrive at the Company’s fund management fees, and the reclassification of certain amounts included in portfolio advisory fees, net and other in the segment results that are included in interest and other income in the U.S. GAAP results. (b) The Expenses adjustment represents the elimination of intercompany expenses of the Consolidated Funds payable to the Company, the inclusion of equity-based compensation, certain tax expenses associated with realized performance revenues related compensation, and unrealized performance revenues related compensation, adjustments related to expenses associated with the investment in NGP Management that are included in operating captions, adjustments to reflect the reimbursement of certain costs incurred on behalf of Carlyle funds on a net basis, changes in the tax receivable agreement liability, and charges and credits associated with Carlyle corporate actions and non-recurring items, as detailed below: Three Months Ended March 31, 2023 2022 (Dollars in millions) Unrealized performance and fee related performance revenue compensation expense $ (2.3) $ 232.2 Equity-based compensation 57.1 40.7 Acquisition or disposition-related charges (credits) and amortization of intangibles and impairment 28.7 29.1 Tax expense associated with certain foreign performance revenues related compensation (0.5) (0.7) Non-controlling interests and other adjustments to present certain costs on a net basis 40.0 16.5 Other adjustments including severance 3.9 4.6 Elimination of expenses of Consolidated Funds (3.7) (10.1) $ 123.2 $ 312.3 (c) The Other Income (Loss) adjustment results from the Consolidated Funds which were eliminated in consolidation to arrive at the Company’s total Other Income (Loss). (d) The following table is a reconciliation of Income (Loss) Before Provision for Income Taxes to Distributable Earnings and to Fee Related Earnings: Three Months Ended March 31, 2023 2022 (Dollars in millions) Income (loss) before provision for income taxes $ 159.6 $ 742.7 Adjustments: Net unrealized performance and fee related performance revenues 18.4 (466.6) Unrealized principal investment (income) loss 29.0 (23.7) Equity-based compensation (1) 57.1 40.7 Acquisition or disposition-related charges (credits), including amortization of intangibles and impairment 28.7 29.1 Tax expense associated with certain foreign performance revenues (0.5) (0.8) Net income attributable to non-controlling interests in consolidated entities (24.6) (23.2) Other adjustments including severance 3.9 4.6 Distributable Earnings $ 271.6 $ 302.8 Realized performance revenues, net of related compensation (2) 69.5 118.0 Realized principal investment income (2) 23.8 26.3 Net interest 15.1 24.8 Fee Related Earnings $ 193.4 $ 183.3 (1) Equity-based compensation for the three months ended March 31, 2023 and 2022 includes amounts that are presented in principal investment income and general, administrative and other expenses in the Company’s U.S. GAAP statement of operations. (2) See reconciliation to most directly comparable U.S. GAAP measure below: Three Months Ended March 31, 2023 Carlyle Adjustments (3) Total (Dollars in millions) Performance revenues $ 160.8 $ 4.3 $ 165.1 Performance revenues related compensation expense 105.7 (10.1) 95.6 Net performance revenues $ 55.1 $ 14.4 $ 69.5 Principal investment income (loss) $ 11.7 $ 12.1 $ 23.8 Three Months Ended March 31, 2022 Carlyle Adjustments (3) Total (Dollars in millions) Performance revenues $ 710.2 $ (473.9) $ 236.3 Performance revenues related compensation expense 370.7 (252.4) 118.3 Net performance revenues $ 339.5 $ (221.5) $ 118.0 Principal investment income (loss) $ 319.6 $ (293.3) $ 26.3 ( 3) Adjustments to performance revenues and principal investment income (loss) relate to (i) unrealized performance allocations net of related compensation expense and unrealized principal investment income, which are excluded from the segment results, (ii) amounts earned from the Consolidated Funds, which were eliminated in the U.S. GAAP consolidation but were included in the segment results, (iii) amounts attributable to non-controlling interests in consolidated entities, which were excluded from the segment results, (iv) the reclassification of NGP performance revenues, which are included in principal investment income in the U.S. GAAP financial statements, (v) the reclassification of fee related performance revenues, which are included in fund level fee revenues in the segment results, and (vi) the reclassification of tax expenses associated with certain foreign performance revenues. Adjustments to principal investment income (loss) also include the reclassification of earnings for the investments in NGP Management and its affiliates to the appropriate operating captions for the segment results, and the exclusion of charges associated with the investment in NGP Management and its affiliates that are excluded from the segment results. (e) The Total Assets adjustment represents the addition of the assets of the Consolidated Funds that were eliminated in consolidation to arrive at the Company’s total assets.

Supplemental Financial Inform_2

Supplemental Financial Information (Tables)	3 Months Ended
Supplemental Financial Information (Tables)	Mar. 31, 2023
Condensed Financial Information Disclosure [Abstract]
Supplemental financial position	As of March 31, 2023 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Assets Cash and cash equivalents $ 1,010.1 $ — $ — $ 1,010.1 Cash and cash equivalents held at Consolidated Funds — 228.8 — 228.8 Restricted cash 16.8 — — 16.8 Corporate treasury investments 102.0 — — 102.0 Investments, including performance allocations of $7,134.0 million 11,013.5 — (229.4) 10,784.1 Investments of Consolidated Funds — 7,067.3 — 7,067.3 Due from affiliates and other receivables, net 883.0 — (383.7) 499.3 Due from affiliates and other receivables of Consolidated Funds, net — 100.6 — 100.6 Fixed assets, net 141.8 — — 141.8 Lease right-of-use assets, net 331.5 — — 331.5 Deposits and other 104.7 6.4 — 111.1 Intangible assets, net 866.4 — — 866.4 Deferred tax assets 14.1 — — 14.1 Total assets $ 14,483.9 $ 7,403.1 $ (613.1) $ 21,273.9 Liabilities and equity Debt obligations $ 2,275.6 $ — $ — $ 2,275.6 Loans payable of Consolidated Funds — 6,462.4 (376.5) 6,085.9 Accounts payable, accrued expenses and other liabilities 304.8 — — 304.8 Accrued compensation and benefits 3,894.2 — — 3,894.2 Due to affiliates 302.5 11.6 — 314.1 Deferred revenue 411.7 — — 411.7 Deferred tax liabilities 389.5 — — 389.5 Other liabilities of Consolidated Funds — 251.7 (0.9) 250.8 Lease liabilities 494.9 — — 494.9 Accrued giveback obligations 40.9 — — 40.9 Total liabilities 8,114.1 6,725.7 (377.4) 14,462.4 Common stock 3.6 — — 3.6 Additional paid-in capital 3,195.5 244.9 (244.9) 3,195.5 Retained earnings 3,280.9 — — 3,280.9 Accumulated other comprehensive loss (302.4) (12.0) 9.2 (305.2) Non-controlling interests in consolidated entities 192.2 444.5 — 636.7 Total equity 6,369.8 677.4 (235.7) 6,811.5 Total liabilities and equity $ 14,483.9 $ 7,403.1 $ (613.1) $ 21,273.9 As of December 31, 2022 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Assets Cash and cash equivalents $ 1,360.7 $ — $ — $ 1,360.7 Cash and cash equivalents held at Consolidated Funds — 209.0 — 209.0 Restricted cash 0.8 — — 0.8 Corporate treasury investments 20.0 — — 20.0 Investments, including performance allocations of $7,117.7 million 10,989.9 — (222.0) 10,767.9 Investments of Consolidated Funds — 6,894.4 — 6,894.4 Due from affiliates and other receivables, net 960.5 — (381.1) 579.4 Due from affiliates and other receivables of Consolidated Funds, net — 101.9 — 101.9 Fixed assets, net 139.9 — — 139.9 Lease right-of-use assets, net 337.0 — — 337.0 Deposits and other 70.4 8.0 — 78.4 Intangible assets, net 897.8 — — 897.8 Deferred tax assets 15.8 — — 15.8 Total assets $ 14,792.8 $ 7,213.3 $ (603.1) $ 21,403.0 Liabilities and equity Debt obligations $ 2,271.7 $ — $ — $ 2,271.7 Loans payable of Consolidated Funds — 6,279.7 (374.5) 5,905.2 Accounts payable, accrued expenses and other liabilities 369.2 — — 369.2 Accrued compensation and benefits 4,320.9 — — 4,320.9 Due to affiliates 346.1 16.5 (0.1) 362.5 Deferred revenue 126.4 — — 126.4 Deferred tax liabilities 402.7 — — 402.7 Other liabilities of Consolidated Funds — 279.7 (0.4) 279.3 Lease liabilities 502.9 — — 502.9 Accrued giveback obligations 40.9 — — 40.9 Total liabilities 8,380.8 6,575.9 (375.0) 14,581.7 Common stock 3.6 — — 3.6 Additional paid-in capital 3,138.5 238.7 (238.7) 3,138.5 Retained earnings 3,401.1 — — 3,401.1 Accumulated other comprehensive loss (319.5) (13.3) 10.6 (322.2) Non-controlling interests in consolidated entities 188.3 412.0 — 600.3 Total equity 6,412.0 637.4 (228.1) 6,821.3 Total liabilities and equity $ 14,792.8 $ 7,213.3 $ (603.1) $ 21,403.0
Supplemental results of operations	Three Months Ended March 31, 2023 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Revenues Fund management fees $ 508.4 $ — $ (7.6) $ 500.8 Incentive fees 19.9 — (0.1) 19.8 Investment income Performance allocations 162.3 — (1.5) 160.8 Principal investment income 14.7 — (3.0) 11.7 Total investment income 177.0 — (4.5) 172.5 Interest and other income 46.6 — (2.6) 44.0 Interest and other income of Consolidated Funds — 121.9 — 121.9 Total revenues 751.9 121.9 (14.8) 859.0 Expenses Compensation and benefits Cash-based compensation and benefits 260.2 — — 260.2 Equity-based compensation 54.4 — — 54.4 Performance allocations and incentive fee related compensation 105.7 — — 105.7 Total compensation and benefits 420.3 — — 420.3 General, administrative and other expenses 159.4 — (0.2) 159.2 Interest 29.7 — — 29.7 Interest and other expenses of Consolidated Funds — 97.2 (3.5) 93.7 Other non-operating expenses 0.1 — — 0.1 Total expenses 609.5 97.2 (3.7) 703.0 Other income Net investment income of Consolidated Funds — 3.6 — 3.6 Income before provision for income taxes 142.4 28.3 (11.1) 159.6 Provision for income taxes 34.3 — — 34.3 Net income 108.1 28.3 (11.1) 125.3 Net income attributable to non-controlling interests in consolidated entities 7.4 — 17.2 24.6 Net income attributable to The Carlyle Group Inc. $ 100.7 $ 28.3 $ (28.3) $ 100.7 Three Months Ended March 31, 2022 Consolidated Consolidated Eliminations Consolidated (Dollars in millions) Revenues Fund management fees $ 456.9 $ — $ (6.4) $ 450.5 Incentive fees 14.0 — — 14.0 Investment income Performance allocations 710.2 — — 710.2 Principal investment income 302.3 — 17.3 319.6 Total investment income 1,012.5 — 17.3 1,029.8 Interest and other income 33.3 — (7.5) 25.8 Interest and other income of Consolidated Funds — 61.7 — 61.7 Total revenues 1,516.7 61.7 3.4 1,581.8 Expenses Compensation and benefits Cash-based compensation and benefits 254.3 — — 254.3 Equity-based compensation 39.7 — — 39.7 Performance allocations and incentive fee related compensation 370.7 — — 370.7 Total compensation and benefits 664.7 — — 664.7 General, administrative and other expenses 106.3 — — 106.3 Interest 27.8 — — 27.8 Interest and other expenses of Consolidated Funds — 52.9 (10.1) 42.8 Other non-operating expenses 0.3 — — 0.3 Total expenses 799.1 52.9 (10.1) 841.9 Other income Net investment income of Consolidated Funds — 2.8 — 2.8 Income before provision for income taxes 717.6 11.6 13.5 742.7 Provision for income taxes 147.9 — — 147.9 Net income 569.7 11.6 13.5 594.8 Net income (loss) attributable to non-controlling interests in consolidated entities (1.9) — 25.1 23.2 Net income attributable to The Carlyle Group Inc. $ 571.6 $ 11.6 $ (11.6) $ 571.6
Supplemental statement of cash flows	Three Months Ended March 31, 2023 2022 (Dollars in millions) Cash flows from operating activities Net income $ 108.1 $ 569.7 Adjustments to reconcile net income to net cash flows from operating activities: Depreciation and amortization 44.0 19.4 Equity-based compensation 54.4 39.7 Non-cash performance allocations and incentive fees (38.2) (300.8) Non-cash principal investment income (8.7) (295.4) Other non-cash amounts 10.8 5.3 Purchases of investments (19.0) (294.1) Proceeds from the sale of investments 78.9 169.5 Payments of contingent consideration (68.6) (5.7) Change in deferred taxes, net (15.1) 110.9 Change in due from affiliates and other receivables 17.0 (8.8) Change in deposits and other (33.9) (39.8) Change in accounts payable, accrued expenses and other liabilities (63.9) (14.3) Change in accrued compensation and benefits (371.9) (580.1) Change in due to affiliates (0.2) (0.2) Change in lease right-of-use asset and lease liability (2.8) (2.5) Change in deferred revenue 284.7 254.5 Net cash used in operating activities (24.4) (372.7) Cash flows from investing activities Purchases of corporate treasury investments (101.1) — Proceeds from corporate treasury investments 20.1 — Purchases of fixed assets, net (12.9) (12.3) Purchase of CBAM intangibles and investments, net — (618.4) Net cash used in investing activities (93.9) (630.7) Cash flows from financing activities Payments on CLO borrowings (1.1) (8.9) Proceeds from CLO borrowings, net of financing costs — 40.8 Dividends to common stockholders (118.4) (89.5) Payment of deferred consideration for Carlyle Holdings units (68.8) (68.8) Contributions from non-controlling interest holders 2.0 5.8 Distributions to non-controlling interest holders (8.5) (27.1) Common shares issued for performance allocations — 31.3 Common shares repurchased (100.3) (80.4) Change in due to/from affiliates financing activities 73.0 33.1 Net cash used in financing activities (222.1) (163.7) Effect of foreign exchange rate changes 5.8 (17.2) Decrease in cash, cash equivalents and restricted cash (334.6) (1,184.3) Cash, cash equivalents and restricted cash, beginning of period 1,361.5 2,475.1 Cash, cash equivalents and restricted cash, end of period $ 1,026.9 $ 1,290.8 Supplemental non-cash disclosures Issuance of common shares related to the acquisition of CBAM $ — $ 194.5 Reconciliation of cash, cash equivalents and restricted cash, end of period: Cash and cash equivalents $ 1,010.1 $ 1,290.2 Restricted cash 16.8 0.6 Total cash, cash equivalents and restricted cash, end of period $ 1,026.9 $ 1,290.8 Cash and cash equivalents held at Consolidated Funds $ 228.8 $ 168.9

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details) - segment	3 Months Ended
Organization and Basis of Presentation (Details) - segment	Mar. 31, 2023	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments	3	3

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Variable Interest Entities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Variable Interest Entity [Line Items]
Consolidated VIEs, assets	$ 21,273.9	$ 21,403
Consolidated VIEs, liabilities	14,462.4	14,581.7
Investment fund	376.5
Collateralized Loan Obligations
Variable Interest Entity [Line Items]
Investments in CLOs	112.7
Consolidated VIEs
Variable Interest Entity [Line Items]
Consolidated VIEs, assets	7,400	7,200
Consolidated VIEs, liabilities	$ 6,300	$ 6,200

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Investments in Unconsolidated Variable Interest Entities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Variable Interest Entity [Line Items]
Investments	$ 10,784.1	$ 10,767.9
Total assets	21,273.9	21,403
Unconsolidated VIEs
Variable Interest Entity [Line Items]
Investments	1,084.9	1,124
Accrued performance allocations	455	406
Management fee receivables	43.3	49.6
Total assets	$ 1,583.2	$ 1,579.6

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Net Investment Income [Line Items]
Period of time for which management fees will be received by partners from the initial closing date	10 years
Subsequent period in which management fees are recognized after these fees are called	6 months
Percentage of management fees for CLOs on the total par amount of assets in the fund	1%
Management fee receivable	$ 169.5		$ 236.9
Transaction and advisory fees	$ 13.4	$ 14.6
Incentive Fees
Performance fees allocation percentage to partnership (percent)	20%
Accrued giveback obligations	$ 40.9		$ 40.9
Interest Income
Interest income from investments	$ 109.8	$ 56.5
Minimum
Net Investment Income [Line Items]
Percentage of management fees earned	1%
Extension period for fund closing	1 year
Percentage of management fees for CLOs on the total par amount of assets in the fund	0.40%
Period of management fees related to collateralized loan obligation	5 years
Percentage of management fees for business development companies	1%
Percentage of management fees from funds of funds during the commitment fee period	0.25%
Percentage of management fees from funds of funds following the expiration of the weighted average investment period	0.25%
Transaction and portfolio advisory fee, rebate offset percentage	80%
Incentive Fees
Percentage of allocation based performance fees related to fund of funds vehicles (percent)	2%
Percent of preferred returns (percent)	7%
Maximum
Net Investment Income [Line Items]
Percentage of management fees earned	2%
Extension period for fund closing	2 years
Percentage of management fees for CLOs on the total par amount of assets in the fund	0.50%
Period of management fees related to collateralized loan obligation	10 years
Percentage of management fees for business development companies	1.50%
Percentage of management fees from funds of funds during the commitment fee period	1%
Percentage of management fees from funds of funds following the expiration of the weighted average investment period	1%
Transaction and portfolio advisory fee, rebate offset percentage	100%
Incentive Fees
Percentage of allocation based performance fees related to fund of funds vehicles (percent)	12.50%
Percent of preferred returns (percent)	9%

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Accounting Policies [Abstract]
Accrued performance allocations and incentive fee related compensation	$ 3,637		$ 3,625.3
Securities transferred to counterparties under repurchase agreements	288.2
Foreign currency transaction (loss) gain	$ (11.8)	$ 6.4

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Fixed Assets (Details)	3 Months Ended
	Mar. 31, 2023
Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life of other fixed assets	3 years
Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life of other fixed assets	7 years

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)	3 Months Ended
	Mar. 31, 2023
Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite lived intangible assets	4 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite lived intangible assets	8 years

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	$ (305.2)	$ (322.2)
Currency translation adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	(305.2)	(322)
Unrealized losses on defined benefit plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	$ 0	$ (0.2)

Fair Value Measurement - Assets

Fair Value Measurement - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Assets
Subtotal	$ 7,848.4	$ 7,049.3
Investments measured at net asset value		7,577.8
Liabilities
Loans payable of Consolidated Funds	5,647.9	5,491.6
Foreign currency forward contracts	1.6	3.2
Total	5,649.5	5,494.8
Revolving Credit Facility
Liabilities
Total	157.5	178
Senior secured notes
Liabilities
Total	280.5	235.6
Equity securities
Assets
Investments		430.6
Equity securities \| Consolidated VIEs
Assets
Investments measured at net asset value	382.7	377.4
Bonds
Assets
Investments		594.9
Loans
Assets
Investments		5,352.9
Investments of Consolidated Funds
Assets
Investments		6,378.4
Investments in CLOs
Assets
Investments		526.1
Other investments
Assets
Investments		122.6
Foreign currency forward contracts
Assets
Foreign currency forward contracts		2.2
Investments In CLOs and other, and Partnership and LLC interests
Assets
Investments	664.3
Level I
Assets
Subtotal	1.5	1.6
Liabilities
Loans payable of Consolidated Funds	0	0
Foreign currency forward contracts	0	0
Total	0	0
Level I \| Equity securities
Assets
Investments	0	0
Level I \| Bonds
Assets
Investments	0	0
Level I \| Loans
Assets
Investments	0	0
Level I \| Investments of Consolidated Funds
Assets
Investments	0	0
Level I \| Investments in CLOs
Assets
Investments	0	0
Level I \| Other investments
Assets
Investments	1.5	1.6
Level I \| Corporate treasury investments
Assets
Subtotal	0	0
Level I \| Foreign currency forward contracts
Assets
Foreign currency forward contracts	0	0
Level I \| Investments In CLOs and other, and Partnership and LLC interests
Assets
Investments	1.5
Level I \| Commercial paper and other
Assets
Subtotal	0	0
Level II
Assets
Subtotal	146	63.8
Liabilities
Loans payable of Consolidated Funds	0	0
Foreign currency forward contracts	1.6	3.2
Total	1.6	3.2
Level II \| Equity securities
Assets
Investments	0	0
Level II \| Bonds
Assets
Investments	0	0
Level II \| Loans
Assets
Investments	0	0
Level II \| Investments of Consolidated Funds
Assets
Investments	0	0
Level II \| Investments in CLOs
Assets
Investments	0	0
Level II \| Other investments
Assets
Investments	41.9	41.6
Level II \| Corporate treasury investments
Assets
Subtotal	102	20
Level II \| Foreign currency forward contracts
Assets
Foreign currency forward contracts	2.1	2.2
Level II \| Investments In CLOs and other, and Partnership and LLC interests
Assets
Investments	41.9
Level II \| Commercial paper and other
Assets
Subtotal	102	20
Level III
Assets
Subtotal	7,131.3	6,983.9
Liabilities
Loans payable of Consolidated Funds	5,647.9	5,491.6
Foreign currency forward contracts	0	0
Total	5,647.9	5,491.6
Level III \| Equity securities
Assets
Investments	435.5	430.6
Subtotal	17.3
Investments measured at net asset value	50.3	58.2
Level III \| Bonds
Assets
Investments	593.2	594.9
Level III \| Loans
Assets
Investments	5,481.7	5,352.9
Level III \| Investments of Consolidated Funds
Assets
Investments	6,510.4	6,378.4
Subtotal	6,510.4	6,378.4
Level III \| Investments in CLOs
Assets
Investments	544.8	526.1
Level III \| Other investments
Assets
Investments	76.1	79.4
Level III \| Corporate treasury investments
Assets
Subtotal	0	0
Level III \| Foreign currency forward contracts
Assets
Foreign currency forward contracts	0	0
Level III \| Investments In CLOs and other, and Partnership and LLC interests
Assets
Investments	620.9
Level III \| Commercial paper and other
Assets
Subtotal	0	0
Fair Value, Inputs, Level 1, 2 and 3
Assets
Subtotal	7,278.8
Fair Value, Inputs, Level 1, 2 and 3 \| Equity securities
Assets
Investments	435.5
Fair Value, Inputs, Level 1, 2 and 3 \| Bonds
Assets
Investments	593.2
Fair Value, Inputs, Level 1, 2 and 3 \| Loans
Assets
Investments	5,481.7
Fair Value, Inputs, Level 1, 2 and 3 \| Investments of Consolidated Funds
Assets
Investments	6,510.4
Fair Value, Inputs, Level 1, 2 and 3 \| Investments in CLOs
Assets
Investments	544.8
Fair Value, Inputs, Level 1, 2 and 3 \| Other investments
Assets
Investments	119.5
Fair Value, Inputs, Level 1, 2 and 3 \| Corporate treasury investments
Assets
Subtotal	102	20
Fair Value, Inputs, Level 1, 2 and 3 \| Foreign currency forward contracts
Assets
Foreign currency forward contracts	2.1
Fair Value, Inputs, Level 1, 2 and 3 \| Commercial paper and other
Assets
Subtotal	102	20
Fair Value Measured at NAV
Assets
Investments measured at net asset value	569.6	528.5
Fair Value Measured at NAV \| Investments of Consolidated Funds
Assets
Investments	$ 556.9	$ 516

Fair Value Measurement - Level

Fair Value Measurement - Level III Financial Assets Measured at Fair Value (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Realized and unrealized gains (losses), net
Fair value of assets	$ 7,848.4		$ 7,049.3
Equity securities
Realized and unrealized gains (losses), net
Fair value, asset, recurring basis, unobservable input reconciliation, gain (loss), statement of income or comprehensive income	Net investment income of Consolidated Funds	Net investment income of Consolidated Funds
Fair value, asset, recurring basis, unobservable input reconciliation, asset, gain (loss), statement of other comprehensive income or comprehensive income	Other Comprehensive Income (Loss), Net of Tax	Other Comprehensive Income (Loss), Net of Tax
Fair value, asset, recurring basis, still held, unrealized gain (loss), statement of income or comprehensive income	Net investment income of Consolidated Funds	Net investment income of Consolidated Funds
Bonds
Realized and unrealized gains (losses), net
Fair value, asset, recurring basis, unobservable input reconciliation, gain (loss), statement of income or comprehensive income	Net investment income of Consolidated Funds	Net investment income of Consolidated Funds
Fair value, asset, recurring basis, unobservable input reconciliation, asset, gain (loss), statement of other comprehensive income or comprehensive income	Other Comprehensive Income (Loss), Net of Tax	Other Comprehensive Income (Loss), Net of Tax
Fair value, asset, recurring basis, still held, unrealized gain (loss), statement of income or comprehensive income	Net investment income of Consolidated Funds	Net investment income of Consolidated Funds
Loans
Realized and unrealized gains (losses), net
Fair value, asset, recurring basis, unobservable input reconciliation, gain (loss), statement of income or comprehensive income	Net investment income of Consolidated Funds	Net investment income of Consolidated Funds
Fair value, asset, recurring basis, unobservable input reconciliation, asset, gain (loss), statement of other comprehensive income or comprehensive income	Other Comprehensive Income (Loss), Net of Tax	Other Comprehensive Income (Loss), Net of Tax
Fair value, asset, recurring basis, still held, unrealized gain (loss), statement of income or comprehensive income	Net investment income of Consolidated Funds	Net investment income of Consolidated Funds
Investments in CLOs
Realized and unrealized gains (losses), net
Fair value, asset, recurring basis, unobservable input reconciliation, gain (loss), statement of income or comprehensive income	Net investment income of Consolidated Funds	Net investment income of Consolidated Funds
Fair value, asset, recurring basis, unobservable input reconciliation, asset, gain (loss), statement of other comprehensive income or comprehensive income	Other Comprehensive Income (Loss), Net of Tax	Other Comprehensive Income (Loss), Net of Tax
Fair value, asset, recurring basis, still held, unrealized gain (loss), statement of income or comprehensive income	Net investment income of Consolidated Funds	Net investment income of Consolidated Funds
Other investments
Realized and unrealized gains (losses), net
Fair value, asset, recurring basis, unobservable input reconciliation, gain (loss), statement of income or comprehensive income	Net investment income of Consolidated Funds	Net investment income of Consolidated Funds
Fair value, asset, recurring basis, unobservable input reconciliation, asset, gain (loss), statement of other comprehensive income or comprehensive income	Other Comprehensive Income (Loss), Net of Tax	Other Comprehensive Income (Loss), Net of Tax
Fair value, asset, recurring basis, still held, unrealized gain (loss), statement of income or comprehensive income	Net investment income of Consolidated Funds	Net investment income of Consolidated Funds
Level III
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	$ 6,983.9	$ 6,955.3
Purchases	272.5	1,177.1
Sales and distributions	(225.5)	(940.8)
Settlements	(105.7)	(163.1)
Realized and unrealized gains (losses), net
Included in earnings	143.6	(78.5)
Included in other comprehensive income	62.5	(124.6)
Balance, end of period	7,131.3	6,825.4
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date	131.2	(84.8)
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date	64.8	(102.6)
Fair value of assets	7,131.3		$ 6,983.9
Level III \| Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	430.6	17.9
Purchases	5.4	0.1
Sales and distributions	0	(6.8)
Settlements	0	0
Realized and unrealized gains (losses), net
Included in earnings	(0.5)	0.4
Included in other comprehensive income	0	(0.3)
Balance, end of period	435.5	11.3
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date	(0.4)	0.3
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date	0	(0.2)
Fair value of assets	17.3
Level III \| Bonds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	594.9	599.5
Purchases	29.8	182.5
Sales and distributions	(47)	(186.9)
Settlements	(4.1)	(0.3)
Realized and unrealized gains (losses), net
Included in earnings	11.4	(13.8)
Included in other comprehensive income	8.2	(15.8)
Balance, end of period	593.2	565.2
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date	8.5	(14.5)
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date	8.7	(10.8)
Level III \| Loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	5,352.9	5,898.1
Purchases	237.3	766
Sales and distributions	(169.7)	(731)
Settlements	(101.6)	(162.8)
Realized and unrealized gains (losses), net
Included in earnings	116	(53.9)
Included in other comprehensive income	46.8	(103.9)
Balance, end of period	5,481.7	5,612.5
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date	107.3	(59.4)
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date	48.6	(87)
Level III \| Investments in CLOs
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	526.1	361.1
Purchases	0	227.6
Sales and distributions	(7.9)	(14.1)
Settlements	0	0
Realized and unrealized gains (losses), net
Included in earnings	19.1	(9.6)
Included in other comprehensive income	7.5	(4.6)
Balance, end of period	544.8	560.4
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date	19.1	(9.6)
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date	7.5	(4.6)
Level III \| Other investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	79.4	78.7
Purchases	0	0.9
Sales and distributions	(0.9)	(2)
Settlements	0	0
Realized and unrealized gains (losses), net
Included in earnings	(2.4)	(1.6)
Included in other comprehensive income	0	0
Balance, end of period	76.1	76
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date	(3.3)	(1.6)
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date	$ 0	$ 0

Fair Value Measurement - Leve_2

Fair Value Measurement - Level III Financial Liabilities Measured at Fair Value (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Realized and unrealized (gains) losses, net
Fair value, liability, recurring basis, unobservable input reconciliation, gain (loss), statement of income or comprehensive income	Net investment income of Consolidated Funds	Net investment income of Consolidated Funds
Level III \| Loans Payable of Consolidated Funds
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	$ 5,491.6	$ 5,811
Borrowings	0.6	1,108.4
Paydowns	(2.1)	(415.4)
Sales	(38.1)	(669.5)
Realized and unrealized (gains) losses, net
Included in earnings	141.4	(46.2)
Included in other comprehensive income	54.5	(106.2)
Balance, end of period	5,647.9	5,682.1
Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date	142.4	(49.8)
Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date	$ 54.5	$ (102.6)

Fair Value Measurement - Summar

Fair Value Measurement - Summary of Quantitative Information about Level III Inputs (Details) $ in Millions	Mar. 31, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($) $ / shares
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 7,848.4	$ 7,049.3
Fair value of liabilities	5,649.5	5,494.8
Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	7,131.3	6,983.9
Fair value of liabilities	5,647.9	5,491.6
Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of liabilities		5,303.3
Investments of Consolidated Funds \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	6,510.4	6,378.4
Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	17.3
BDC preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	73.6	76.9
Consensus Pricing \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	2.5	3.1
Consensus Pricing \| Bonds \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	593.2	594.9
Consensus Pricing \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	5,121.2	5,043.4
Consensus Pricing \| Loan two \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	10.5	37.4
Consensus Pricing \| Loan three \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 8.4	$ 11.1
Consensus Pricing \| Indicative Quotes \| Minimum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0	0
Consensus Pricing \| Indicative Quotes \| Minimum \| Bonds \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	40	0.46
Consensus Pricing \| Indicative Quotes \| Minimum \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0	0
Consensus Pricing \| Indicative Quotes \| Minimum \| Loan two \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input \| $ / shares	0.86
Consensus Pricing \| Indicative Quotes \| Minimum \| Loan three \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input \| $ / shares	0.98	0.91
Consensus Pricing \| Indicative Quotes \| Maximum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	392.50	4.73
Consensus Pricing \| Indicative Quotes \| Maximum \| Bonds \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	1.07	1.05
Consensus Pricing \| Indicative Quotes \| Maximum \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	1.02	1
Consensus Pricing \| Indicative Quotes \| Maximum \| Loan two \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input \| $ / shares	0.86
Consensus Pricing \| Indicative Quotes \| Maximum \| Loan three \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input \| $ / shares	0.98	0.91
Consensus Pricing \| Indicative Quotes \| Weighted Average \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.08	0.18
Consensus Pricing \| Indicative Quotes \| Weighted Average \| Bonds \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.89	0.88
Consensus Pricing \| Indicative Quotes \| Weighted Average \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.94	0.91
Consensus Pricing \| Indicative Quotes \| Weighted Average \| Loan two \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input \| $ / shares	0.86
Consensus Pricing \| Indicative Quotes \| Weighted Average \| Loan three \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input \| $ / shares	0.98	0.91
Consensus Pricing \| Market Yields \| Minimum \| Loan two \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input \| $ / shares		0.97
Consensus Pricing \| Market Yields \| Maximum \| Loan two \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input \| $ / shares		0.98
Consensus Pricing \| Market Yields \| Weighted Average \| Loan two \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input \| $ / shares		0.97
Discounted Cash Flow \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 365.4	$ 363.5
Discounted Cash Flow \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	50
Discounted Cash Flow \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	11.4	11.8
Discounted Cash Flow \| Loan two \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	329.7	248.7
Discounted Cash Flow \| Aviation subordinated notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 2.5	$ 2.5
Discounted Cash Flow \| Discount Rates \| Minimum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.10	0.10
Discounted Cash Flow \| Discount Rates \| Minimum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.10
Discounted Cash Flow \| Discount Rates \| Minimum \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.08	0
Discounted Cash Flow \| Discount Rates \| Minimum \| Loan two \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.07	0.07
Discounted Cash Flow \| Discount Rates \| Minimum \| Aviation subordinated notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.21	0.21
Discounted Cash Flow \| Discount Rates \| Maximum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.10	0.10
Discounted Cash Flow \| Discount Rates \| Maximum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.10
Discounted Cash Flow \| Discount Rates \| Maximum \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.13	0.09
Discounted Cash Flow \| Discount Rates \| Maximum \| Loan two \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.10	0.10
Discounted Cash Flow \| Discount Rates \| Maximum \| Aviation subordinated notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.21	0.21
Discounted Cash Flow \| Discount Rates \| Weighted Average \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.10	0.10
Discounted Cash Flow \| Discount Rates \| Weighted Average \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.10
Discounted Cash Flow \| Discount Rates \| Weighted Average \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.13	0.01
Discounted Cash Flow \| Discount Rates \| Weighted Average \| Loan two \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.08	0.08
Discounted Cash Flow \| Discount Rates \| Weighted Average \| Aviation subordinated notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.21	0.21
Discounted Cash Flow \| Terminal Growth Rate \| Minimum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0	0
Discounted Cash Flow \| Terminal Growth Rate \| Minimum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0
Discounted Cash Flow \| Terminal Growth Rate \| Maximum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.07	0.07
Discounted Cash Flow \| Terminal Growth Rate \| Maximum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.07
Discounted Cash Flow \| Terminal Growth Rate \| Weighted Average \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.05	0.05
Discounted Cash Flow \| Terminal Growth Rate \| Weighted Average \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.05
Comparable Multiple \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 0.3
Comparable Multiple \| EBITDA Multiple \| Minimum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	12.7	12.7
Comparable Multiple \| EBITDA Multiple \| Minimum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	13.8
Comparable Multiple \| EBITDA Multiple \| Maximum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	12.7	12.7
Comparable Multiple \| EBITDA Multiple \| Maximum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	19
Comparable Multiple \| EBITDA Multiple \| Weighted Average \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	12.7	12.7
Comparable Multiple \| EBITDA Multiple \| Weighted Average \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	17.8
Comparable Multiple \| TCF Multiple \| Minimum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	24.5	23.8
Comparable Multiple \| TCF Multiple \| Minimum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	24.5
Comparable Multiple \| TCF Multiple \| Maximum \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	24.5	23.8
Comparable Multiple \| TCF Multiple \| Weighted Average \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	24.5	23.8
Consensus Pricing with Discounted Cash Flow \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of liabilities	$ 196.8	$ 188.3
Consensus Pricing with Discounted Cash Flow \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	476.6	462.1
Consensus Pricing with Discounted Cash Flow \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 68.2	$ 64
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.21	0.21
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Minimum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.72	0.67
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0	0
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.99	0.96
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Maximum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	1	1
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.86	0.82
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.39	0.38
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Weighted Average \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.95	0.93
Consensus Pricing with Discounted Cash Flow \| Indicative Quotes \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.55	0.40
Consensus Pricing with Discounted Cash Flow \| Discount Rates \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.15	0.15
Consensus Pricing with Discounted Cash Flow \| Discount Rates \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.15	0.15
Consensus Pricing with Discounted Cash Flow \| Discount Rates \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.25	0.25
Consensus Pricing with Discounted Cash Flow \| Discount Rates \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.25	0.25
Consensus Pricing with Discounted Cash Flow \| Discount Rates \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.20	0.20
Consensus Pricing with Discounted Cash Flow \| Discount Rates \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.20	0.20
Consensus Pricing with Discounted Cash Flow \| Discount Margins \| Minimum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.0170	0.0170
Consensus Pricing with Discounted Cash Flow \| Discount Margins \| Maximum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.1365	0.1800
Consensus Pricing with Discounted Cash Flow \| Discount Margins \| Weighted Average \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.0314	0.0386
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.02	0.02
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Minimum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.02	0.02
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.02	0.02
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.03	0.03
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Maximum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.03	0.03
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.03	0.03
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.03	0.03
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Weighted Average \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.02	0.02
Consensus Pricing with Discounted Cash Flow \| Default Rates \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.02	0.02
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.60	0.50
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Minimum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.60	0.50
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Minimum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.60	0.50
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.60	0.70
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Maximum \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.60	0.70
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Maximum \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.60	0.70
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Liabilities, measurement input	0.60	0.60
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Weighted Average \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.60	0.60
Consensus Pricing with Discounted Cash Flow \| Recovery Rates \| Weighted Average \| Subordinated notes and preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.60	0.60
Market Yield Analysis \| BDC preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 73.6	$ 76.9
Market Yield Analysis \| Market Yields \| Minimum \| BDC preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.11	0.11
Market Yield Analysis \| Market Yields \| Maximum \| BDC preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.11	0.11
Market Yield Analysis \| Market Yields \| Weighted Average \| BDC preferred shares \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Assets, measurement input	0.11	0.11
Other \| Senior secured notes \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of liabilities	$ 5,451.1
Other \| Equity securities \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets		$ 64
Other \| Loans \| Level III
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair value of assets	$ 0.5	$ 0.5

Investments - Schedule of Inves

Investments - Schedule of Investments (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Investments [Abstract]
Accrued performance allocations	$ 7,134	$ 7,117.7
Principal equity method investments, excluding performance allocations	2,915.6	2,922
Principal investments in CLOs	544.8	526.1
Other investments	189.7	202.1
Total	$ 10,784.1	$ 10,767.9

Investments - Investment Compon

Investments - Investment Components of Accrued Performance Fees (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Accrued performance allocations	$ 7,134	$ 7,117.7
Global Private Equity
Segment Reporting Information [Line Items]
Accrued performance allocations	5,484.4	5,577.1
Global Credit
Segment Reporting Information [Line Items]
Accrued performance allocations	226.3	193.9
Global Investment Solutions
Segment Reporting Information [Line Items]
Accrued performance allocations	$ 1,423.3	$ 1,346.7

Investments - Additional Inform

Investments - Additional Information, Accrued Performance Fees (Details) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2023 USD ($) financingVehicle	Mar. 31, 2022 USD ($)	Dec. 31, 2022 fund
Concentration Risk [Line Items]
Number of partnerships corporate private equity funds related to accrued performance fees	2		1
Total	$ 160.8	$ 710.2
Carlyle Partners VI, L.P. \| Accrued performance allocations \| Customer concentration risk
Concentration Risk [Line Items]
Percentage of accrued performance fees related to certain Corporate Private Equity funds (percent)	22%		13%

Investments - Components of Acc

Investments - Components of Accrued Giveback Obligations (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Accrued giveback obligations	$ (40.9)	$ (40.9)
Global Private Equity
Segment Reporting Information [Line Items]
Accrued giveback obligations	(18.4)	(18.4)
Global Credit
Segment Reporting Information [Line Items]
Accrued giveback obligations	$ (22.5)	$ (22.5)

Investments - Principal Investm

Investments - Principal Investments (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total	$ 2,915.6	$ 2,922
Global Private Equity
Segment Reporting Information [Line Items]
Total	1,826.3	1,853.5
Global Private Equity \| NGP Management
Segment Reporting Information [Line Items]
Total	1,011.2	1,015.7
Global Credit
Segment Reporting Information [Line Items]
Total	987.5	974.2
Global Credit \| Fortitude Group Holdings, LLC
Segment Reporting Information [Line Items]
Total	619.7	646
Global Investment Solutions
Segment Reporting Information [Line Items]
Total	$ 101.8	$ 94.3

Investments - Strategic Investm

Investments - Strategic Investment in Fortitude (Details) - USD ($) $ in Millions			1 Months Ended				3 Months Ended
	Jun. 02, 2020	Nov. 13, 2018	Dec. 31, 2023	May 31, 2022	Mar. 31, 2022	May 31, 2020	Mar. 31, 2023	Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]
Investment							$ 2,915.6	$ 2,922
Fortitude Group Holdings, LLC
Schedule of Equity Method Investments [Line Items]
Ownership percentage acquired		19.90%
Purchase of investment in Fortitude Re		$ 381
Deferred consideration, maximum		$ 95
Purchase price adjustment, maximum						$ 99.5
Purchase price adjustment, payable upon inability to make distribution						$ 79.6
Fortitude Group Holdings, LLC \| Fortitude Re \| Maximum
Schedule of Equity Method Investments [Line Items]
Committed capital							9,600
Fortitude Group Holdings, LLC \| Carlyle FRL
Schedule of Equity Method Investments [Line Items]
Ownership interest transferred	19.90%
Fortitude Group Holdings, LLC \| Forecast
Schedule of Equity Method Investments [Line Items]
Purchase price adjustment, payable upon inability to make distribution			$ 19.9
Fortitude Group Holdings, LLC \| Carlyle FRL
Schedule of Equity Method Investments [Line Items]
Ownership percentage acquired	51.60%
Ownership percentage	71.50%
Fortitude Group Holdings, LLC \| T&D
Schedule of Equity Method Investments [Line Items]
Ownership percentage acquired	25%
Fortitude Group Holdings, LLC \| Carlyle FRL and T&D
Schedule of Equity Method Investments [Line Items]
Ownership percentage	96.50%
Fortitude Re \| Fortitude Group Holdings, LLC
Schedule of Equity Method Investments [Line Items]
Ownership percentage		100%
Carlyle FRL
Schedule of Equity Method Investments [Line Items]
Equity capital raised				$ 1,100	$ 2,000
Investment loss				$ 176.9			117
Investment							619.7
Investment, cost							$ 514.7
Carlyle FRL \| Fortitude Group Holdings, LLC
Schedule of Equity Method Investments [Line Items]
Business acquisition further decrease funding percentage							10.50%
Carlyle FRL \| Fortitude Group Holdings, LLC \| Maximum
Schedule of Equity Method Investments [Line Items]
Ownership percentage				19.90%
Carlyle FRL \| Fortitude Group Holdings, LLC \| Minimum
Schedule of Equity Method Investments [Line Items]
Ownership percentage				13.50%
Carlyle FRL \| T&D
Schedule of Equity Method Investments [Line Items]
Investment company, committed capital					$ 100

Investments - Investment in NGP

Investments - Investment in NGP - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of Equity Method Investments [Line Items]
Amortization period of basis difference	10 years
Performance allocations, percentage (percent)	47.50%
NGP Management
Schedule of Equity Method Investments [Line Items]
Net investment earnings related to performance allocations	$ 1.7	$ 250.4
Net investment (losses) earnings related to principal investment income	$ (0.1)	$ 18
Investment in NGP Management
Schedule of Equity Method Investments [Line Items]
Performance allocations, percentage (percent)	47.50%
Minimum \| NGP Management
Schedule of Equity Method Investments [Line Items]
Management fee, percentage of commitments (percent)	1%
Management fee, percentage of invested capital (percent)	0.50%
Maximum \| NGP Management
Schedule of Equity Method Investments [Line Items]
Management fee, percentage of commitments (percent)	2%
Management fee, percentage of invested capital (percent)	2%
Management Fee Related Revenues \| Investment in NGP Management
Schedule of Equity Method Investments [Line Items]
Management fee-related revenues, allocation percentage (percent)	55%

Investments - Investments in NG

Investments - Investments in NGP (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Schedule of Equity Method Investments [Line Items]
Total	$ 2,915.6	$ 2,922
Investment in NGP Management
Schedule of Equity Method Investments [Line Items]
Total	370.1	369.7
Investments in NGP general partners - accrued performance allocations
Schedule of Equity Method Investments [Line Items]
Total	566.1	564.5
Principal investments in NGP funds
Schedule of Equity Method Investments [Line Items]
Total	$ 75	$ 81.5

Investments - Schedule of Net I

Investments - Schedule of Net Investment Earnings (Loss) (Details) - NGP Management - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of Equity Method Investments [Line Items]
Management fee related revenues from NGP Management	$ 18.1	$ 17
Expenses related to the investment in NGP Management	(3.4)	(2.8)
Amortization of basis differences from the investment in NGP Management	0	(0.3)
Net investment income from NGP Management	$ 14.7	$ 13.9

Investments - Principal Inves_2

Investments - Principal Investments in CLOs and Other Investments (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
TCG BDC, Inc.
Debt and Equity Securities, FV-NI [Line Items]
Trading securities	$ 73.6	$ 76.9
CLO Senior and Subordinated Notes and Derivative Instruments
Debt and Equity Securities, FV-NI [Line Items]
Trading securities	$ 544.8	$ 526.1

Investments - Components of Inv

Investments - Components of Investment Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Net Investment Income [Line Items]
Investment income (loss)	$ 172.5	$ 1,029.8
Performance allocations - realized
Net Investment Income [Line Items]
Investment income (loss)	179.6	266.9
Performance allocations - unrealized
Net Investment Income [Line Items]
Investment income (loss)	(18.8)	443.3
Performance allocations
Net Investment Income [Line Items]
Investment income (loss)	160.8	710.2
Principal investment income (loss) from equity method investments (excluding performance allocations) - realized
Net Investment Income [Line Items]
Investment income (loss)	38.5	32.8
Principal investment income (loss) from equity method investments (excluding performance allocations) - unrealized
Net Investment Income [Line Items]
Investment income (loss)	(30.2)	295.3
Principal investment income (loss) from equity method investments (excluding performance allocations)
Net Investment Income [Line Items]
Investment income (loss)	8.3	328.1
Principal investment income (loss) from investments in CLOs and other investments - realized
Net Investment Income [Line Items]
Investment income (loss)	(1.1)	2.3
Principal investment income (loss) from investments in CLOs and other investments - unrealized
Net Investment Income [Line Items]
Investment income (loss)	4.5	(10.8)
Principal investment income (loss) from investments in CLOs and other investments - unrealized \| Corporate Investment
Net Investment Income [Line Items]
Investment income (loss)	13.3
Principal investment income (loss) from investments in CLOs and other investments
Net Investment Income [Line Items]
Investment income (loss)	$ 3.4	$ (8.5)

Investments - Schedule of Perfo

Investments - Schedule of Performance Allocations Included in Revenues (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of Investments [Line Items]
Total	$ 160.8	$ 710.2
Global Private Equity
Schedule of Investments [Line Items]
Total	(3.8)	657.9
Global Credit
Schedule of Investments [Line Items]
Total	33.4	(34)
Global Investment Solutions
Schedule of Investments [Line Items]
Total	$ 131.2	$ 86.3

Investments - Additional Info_2

Investments - Additional Information (Details) - Performance Fee Revenue - Customer concentration risk - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Percentage of performance fees related to certain Corporate Private Equity funds (percent)	(5.00%)	49%
Performance fees	$ (7.6)	$ 350.4
Carlyle Partners VII, L.P
Segment Reporting Information [Line Items]
Performance fees	68.8	122.6
Carlyle Realty Partners VIII, L.P.
Segment Reporting Information [Line Items]
Performance fees		148
Carlyle Europe Partners V, L.P.
Segment Reporting Information [Line Items]
Performance fees	61
Carlyle US Equity Opportunities Fund II, L.P.
Segment Reporting Information [Line Items]
Performance fees	43.4
Carlyle Credit Opportunities Fund II, L.P.
Segment Reporting Information [Line Items]
Performance fees	27.8
AlpInvest ASF VII
Segment Reporting Information [Line Items]
Performance fees	19
Carlyle Asia Partners V, L.P
Segment Reporting Information [Line Items]
Performance fees	(11.1)
Carlyle International Energy Partners I
Segment Reporting Information [Line Items]
Performance fees	(23)	82.9
Carlyle Partners VI, L.P.
Segment Reporting Information [Line Items]
Performance fees	$ (74.4)
Carlyle Europe Partners IV, L.P.
Segment Reporting Information [Line Items]
Performance fees		$ 80.3

Investments - Income (Loss) fro

Investments - Income (Loss) from Principal Investments (Details) - Principal investment income (loss) from equity method investments (excluding performance allocations) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of Investments [Line Items]
Principal investment income from equity method investments	$ 8.3	$ 328.1
Global Private Equity
Schedule of Investments [Line Items]
Principal investment income from equity method investments	17.8	328.2
Global Credit
Schedule of Investments [Line Items]
Principal investment income from equity method investments	(18.9)	(2.7)
Global Investment Solutions
Schedule of Investments [Line Items]
Principal investment income from equity method investments	$ 9.4	$ 2.6

Investments - Investments of Co

Investments - Investments of Consolidated Funds (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Investments measured at net asset value		$ 7,577.8
Minimum percent of aggregate assets for individual investments with fair value	5%
Consolidated VIEs \| Equity securities
Schedule of Investments [Line Items]
Investments measured at net asset value	$ 382.7	$ 377.4

Investments - Interest and Othe

Investments - Interest and Other Income of Consolidated Funds (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Investments [Abstract]
Interest income from investments	$ 109.8	$ 56.5
Other income	12.1	5.2
Total	$ 121.9	$ 61.7

Investments - Net Investment Ga

Investments - Net Investment Gains (Losses) of Consolidated Funds (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Investments [Abstract]
Gains (losses) from investments of Consolidated Funds	$ 145	$ (43.4)
Gains (losses) from liabilities of CLOs	(141.4)	46.2
Total	$ 3.6	$ 2.8

Investments - Realized and Unre

Investments - Realized and Unrealized Gains (Losses) Earned from Investments of Consolidated Funds (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Investments [Abstract]
Realized gains (losses)	$ (17.4)	$ 2.7
Net change in unrealized gains (losses)	162.4	(46.1)
Total	$ 145	$ (43.4)

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Carrying Amount of Intangible Assets (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Acquired contractual rights	$ 921.7	$ 920.2
Accumulated amortization	(159.3)	(126.3)
Finite-lived intangible assets, net	762.4	793.9
Goodwill	104	103.9
Intangible Assets, net	$ 866.4	$ 897.8

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Impairment of intangible assets	$ 0	$ 4,000,000
Intangible asset amortization expense	$ 32,800,000	$ 4,900,000

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Estimated Amortization Expense (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2023 (excluding the three months ended March 31, 2023)	$ 98.6
2024	131.5
2025	131.4
2026	131.3
2027	121.2
Thereafter	148.4
Finite-lived intangible assets, net	$ 762.4	$ 793.9

Borrowings - Debt Obligations (

Borrowings - Debt Obligations (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2021	May 31, 2021
Debt Instrument [Line Items]
Borrowing Outstanding	$ 2,300.4	$ 2,296.7
Carrying Value	2,275.6	2,271.7
CLO Borrowings
Debt Instrument [Line Items]
Borrowing Outstanding	425.4	421.7
Carrying Value	$ 421.8	418.1
5.625% Senior Notes Due 3/30/2043
Debt Instrument [Line Items]
Interest rate (percent)	5.625%
Borrowing Outstanding	$ 600	600
Carrying Value	$ 600.6	600.6
5.650% Senior Notes Due 9/15/2048
Debt Instrument [Line Items]
Interest rate (percent)	5.65%
Borrowing Outstanding	$ 350	350
Carrying Value	$ 346.3	346.3
3.500% Senior Notes Due 9/19/2029
Debt Instrument [Line Items]
Interest rate (percent)	3.50%
Borrowing Outstanding	$ 425	425
Carrying Value	$ 422.1	422
4.625% Subordinated Notes Due 5/15/2061
Debt Instrument [Line Items]
Interest rate (percent)	4.625%			4.625%
Borrowing Outstanding	$ 500	500	$ 65	$ 435
Carrying Value	$ 484.8	$ 484.7

Borrowings - Additional Informa

Borrowings - Additional Information (Details) € in Millions		3 Months Ended
Borrowings - Additional Information (Details) € in Millions	Dec. 17, 2018	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Mar. 31, 2023 EUR (€)	Dec. 31, 2022 USD ($)	Jun. 30, 2021 USD ($)	May 31, 2021 USD ($)	Feb. 05, 2019 EUR (€)	Feb. 28, 2017 EUR (€)	Mar. 31, 2014 USD ($)	Mar. 31, 2013 USD ($)
Debt Instrument [Line Items]
Interest expense		$ 29,700,000	$ 27,800,000
Borrowings		2,300,400,000			$ 2,296,700,000
Interest expense		17,200,000	17,200,000
Fair value of collateralized loan obligation assets		$ 6,300,000,000			6,200,000,000
Senior Notes
Debt Instrument [Line Items]
Debt redemption price percentage (percent)		100%
CLO Borrowings
Debt Instrument [Line Items]
Interest expense		$ 5,200,000	1,700,000
Borrowings		425,400,000			421,700,000
CLO Term Loan Maturing November 2031
Debt Instrument [Line Items]
Borrowings \| €									€ 36.1
Outstanding borrowings		$ 39,300,000
CLO Term Loan Maturing November 2031 \| Euribor
Debt Instrument [Line Items]
Interest rate under credit facility		3.79%		3.79%
Master Credit Agreements - Term Loans
Debt Instrument [Line Items]
Outstanding borrowings		$ 97,800,000
CLO Financing Facility
Debt Instrument [Line Items]
Borrowing capacity \| €								€ 100
Outstanding borrowings		220,900,000		€ 203.2
CBAM CLO Financing Facility
Debt Instrument [Line Items]
Borrowing capacity \| €				100
Outstanding borrowings		67,300,000		€ 61.9
5.650% Senior Notes Due 9/15/2048
Debt Instrument [Line Items]
Borrowings		$ 350,000,000			350,000,000
Interest rate (percent)		5.65%		5.65%
5.650% Senior Notes Due 9/15/2048 \| Senior Notes
Debt Instrument [Line Items]
Borrowings		$ 350,000,000
Interest expense		5,000,000	5,000,000
Fair value of debt		$ 330,300,000			322,200,000
5.650% Senior Notes Due 9/15/2048 \| Treasury rate \| Senior Notes
Debt Instrument [Line Items]
Discount rate, spread on variable rate		0.40%
5.625% Senior Notes Due 3/30/2043
Debt Instrument [Line Items]
Borrowings		$ 600,000,000			600,000,000
Interest rate (percent)		5.625%		5.625%
5.625% Senior Notes Due 3/30/2043 \| Senior Notes
Debt Instrument [Line Items]
Borrowings		$ 600,000,000								$ 200,000,000	$ 400,000,000
Interest expense		8,400,000	8,400,000
Fair value of debt		$ 560,900,000			545,800,000
5.625% Senior Notes Due 3/30/2043 \| Treasury rate \| Senior Notes
Debt Instrument [Line Items]
Discount rate, spread on variable rate		0.40%
3.500% Senior Notes Due 9/19/2029
Debt Instrument [Line Items]
Borrowings		$ 425,000,000			425,000,000
Interest rate (percent)		3.50%		3.50%
3.500% Senior Notes Due 9/19/2029 \| Senior Notes
Debt Instrument [Line Items]
Borrowings		$ 425,000,000
Interest rate (percent)		3.50%		3.50%
Interest expense		$ 3,800,000	3,800,000
Fair value of debt		$ 390,600,000			364,100,000
3.500% Senior Notes Due 9/19/2029 \| Treasury rate \| Senior Notes
Debt Instrument [Line Items]
Discount rate, spread on variable rate		0.30%
4.625% Subordinated Notes Due 5/15/2061
Debt Instrument [Line Items]
Interest expense		$ 5,900,000	5,900,000
Borrowings		$ 500,000,000			500,000,000	$ 65,000,000	$ 435,000,000
Debt redemption price percentage (percent)		102%
Interest rate (percent)		4.625%		4.625%			4.625%
Period from Tax Redemption Event that debt may be redeemed		120 days
Period from rating agency event that debt may be redeemed		90 days
Fair value of debt		$ 368,000,000			$ 323,800,000
Revolving Credit Facility
Debt Instrument [Line Items]
Borrowing capacity		$ 1,000,000,000	$ 775,000,000
Interest rate under credit facility		5.90%		5.90%
Borrowings under credit facilities		$ 0
Repayments under credit facility		0
Outstanding borrowings		$ 0
Revolving Credit Facility \| Base rate
Debt Instrument [Line Items]
Margin spread on interest rate (percent)		0.50%	0.50%
Revolving Credit Facility \| SOFR
Debt Instrument [Line Items]
Margin spread on interest rate (percent)		0.10%
Revolving Credit Facility \| LIBOR
Debt Instrument [Line Items]
Margin spread on interest rate (percent)		1.50%	1.50%
Revolving Credit Facility \| Global Credit Revolving Credit Facility
Debt Instrument [Line Items]
Borrowing capacity		$ 250,000,000
Outstanding borrowings		0
Borrowings under credit facility		$ 0
Revolving Credit Facility \| Global Credit Revolving Credit Facility \| Base rate
Debt Instrument [Line Items]
Margin spread on interest rate (percent)	1%
Revolving Credit Facility \| Global Credit Revolving Credit Facility \| Eurocurrency
Debt Instrument [Line Items]
Margin spread on interest rate (percent)	2%

Borrowings - CLO Borrowings (De

Borrowings - CLO Borrowings (Details) € in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)	Mar. 31, 2023 EUR (€)	Dec. 31, 2022 USD ($)
CLO Term Loan Maturing November 2031
Debt Instrument [Line Items]
Borrowing Outstanding	$ 39.3	€ 36.1	$ 38.7
CLO Term Loan Maturing November 2031 \| Euribor
Debt Instrument [Line Items]
Interest Rate	3.79%	3.79%
CLO Term Loan June 2017 Maturing July 20, 2030
Debt Instrument [Line Items]
Borrowing Outstanding	$ 54.1		54.8
CLO Term Loan June 2017 Maturing July 20, 2030 \| LIBOR
Debt Instrument [Line Items]
Interest Rate	6.47%	6.47%
Margin spread on interest rate (percent)	1.66%
CLO Term Loan December 2017 Maturing January 15, 2031
Debt Instrument [Line Items]
Borrowing Outstanding	$ 43.8		43.8
CLO Term Loan December 2017 Maturing January 15, 2031 \| LIBOR
Debt Instrument [Line Items]
Interest Rate	6.16%	6.16%
Margin spread on interest rate (percent)	1.37%
CLO Term Loan March 2019 Maturing March 2032
Debt Instrument [Line Items]
Borrowing Outstanding	$ 1.8		1.8
CLO Term Loan March 2019 Maturing March 2032 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	11.06%	11.06%
CLO Term Loan August 2019 Maturing August 2032
Debt Instrument [Line Items]
Borrowing Outstanding	$ 3.9		3.9
CLO Term Loan August 2019 Maturing August 2032 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	7.39%	7.39%
CLO Term Loan September 2020 Maturing April 2033
Debt Instrument [Line Items]
Borrowing Outstanding	$ 19.3		19.1
CLO Term Loan September 2020 Maturing April 2033 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	3.87%	3.87%
CLO Term Loan Maturing January 2034
Debt Instrument [Line Items]
Borrowing Outstanding	$ 20.2		19.9
CLO Term Loan Maturing January 2034 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	4.78%	4.78%
CLO Term Loan Maturing August 2030
Debt Instrument [Line Items]
Borrowing Outstanding	$ 19		19.1
CLO Term Loan Maturing August 2030 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	4.03%	4.03%
CLO Term Loan March 2021 Maturing March 2032
Debt Instrument [Line Items]
Borrowing Outstanding	$ 18.3		18
CLO Term Loan March 2021 Maturing March 2032 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	4.66%	4.66%
CLO Term Loan Maturing April 2033
Debt Instrument [Line Items]
Borrowing Outstanding	$ 3.5		3.4
CLO Term Loan Maturing April 2033 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	8.14%	8.14%
CLO Term Loan May2021 Maturing November2031
Debt Instrument [Line Items]
Borrowing Outstanding	$ 15.2		15
CLO Term Loan May2021 Maturing November2031 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	4.02%	4.02%
CLO Term Loan June 2021 Maturing January 2034
Debt Instrument [Line Items]
Borrowing Outstanding	$ 20.3		20
CLO Term Loan June 2021 Maturing January 2034 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	4.57%	4.57%
CLO Term Loan Maturing November 2031
Debt Instrument [Line Items]
Borrowing Outstanding	$ 1.3		1.3
CLO Term Loan Maturing November 2031 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	5.50%	5.50%
CLO Term Loan July 2021 Maturing July 15, 2034
Debt Instrument [Line Items]
Borrowing Outstanding	$ 15.2		15
CLO Term Loan July 2021 Maturing July 15, 2034 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	4.58%	4.58%
CLO Term Loan July 2021 Maturing July 20, 2031
Debt Instrument [Line Items]
Borrowing Outstanding	$ 20.3		20
CLO Term Loan July 2021 Maturing July 20, 2031 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	4.62%	4.62%
CLO Term Loan August 2021 Maturing August 2032
Debt Instrument [Line Items]
Borrowing Outstanding	$ 16.4		16.2
CLO Term Loan August 2021 Maturing August 2032 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	4.40%	4.40%
CLO Term Loan October 2021 Maturing October 2035
Debt Instrument [Line Items]
Borrowing Outstanding	$ 23.6		23.3
CLO Term Loan October 2021 Maturing October 2035 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	4.69%	4.69%
CLO Term Loan November 2021 Maturing January 2034
Debt Instrument [Line Items]
Borrowing Outstanding	$ 14.1		13.8
CLO Term Loan November 2021 Maturing January 2034 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	4.37%	4.37%
CLO Term Loan January 2022 Maturing February 15, 2035
Debt Instrument [Line Items]
Borrowing Outstanding	$ 20.4		20.1
CLO Term Loan January 2022 Maturing February 15, 2035 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	5.03%	5.03%
CLO Term Loan February 2022 Maturing November 10, 2035
Debt Instrument [Line Items]
Borrowing Outstanding	$ 20.4		20.1
CLO Term Loan February 2022 Maturing November 10, 2035 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	5.06%	5.06%
CLO Term Loan July 2022 Maturing January 13, 2035
Debt Instrument [Line Items]
Borrowing Outstanding	$ 17.2		16.9
CLO Term Loan July 2022 Maturing January 13, 2035 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	5.54%	5.54%
CLO Term Loan October 2022 Maturing October 2035
Debt Instrument [Line Items]
Borrowing Outstanding	$ 17.8		17.5
CLO Term Loan October 2022 Maturing October 2035 \| Average effective interest rate
Debt Instrument [Line Items]
Interest Rate	5.62%	5.62%
CLO Borrowings
Debt Instrument [Line Items]
Borrowing Outstanding	$ 425.4		$ 421.7
CLO Term Loan Various \| Average effective interest rate
Debt Instrument [Line Items]
Margin spread on interest rate (percent)	0.50%

Borrowings - Senior Notes (Deta

Borrowings - Senior Notes (Details) - USD ($) $ in Millions	3 Months Ended
Borrowings - Senior Notes (Details) - USD ($) $ in Millions	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Sep. 30, 2019	Sep. 30, 2018	Mar. 31, 2014	Mar. 31, 2013
Debt Instrument [Line Items]
Aggregate Principal Amount	$ 2,300.4		$ 2,296.7
Interest Expense	$ 17.2	$ 17.2
5.625% Senior Notes Due 3/30/2043
Debt Instrument [Line Items]
Interest rate (percent)	5.625%
Aggregate Principal Amount	$ 600		600
5.650% Senior Notes Due 9/15/2048
Debt Instrument [Line Items]
Interest rate (percent)	5.65%
Aggregate Principal Amount	$ 350		350
3.500% Senior Notes Due 9/19/2029
Debt Instrument [Line Items]
Interest rate (percent)	3.50%
Aggregate Principal Amount	$ 425		425
Senior Notes \| 5.625% Senior Notes Due 3/30/2043
Debt Instrument [Line Items]
Aggregate Principal Amount	600					$ 200	$ 400
Fair Value	560.9		545.8
Interest Expense	8.4	8.4
Senior notes percentage of par value (percent)						104.315%	99.583%
Senior Notes \| 5.650% Senior Notes Due 9/15/2048
Debt Instrument [Line Items]
Aggregate Principal Amount	350
Fair Value	330.3		322.2
Interest Expense	$ 5	5
Senior notes percentage of par value (percent)					99.914%
Senior Notes \| 3.500% Senior Notes Due 9/19/2029
Debt Instrument [Line Items]
Interest rate (percent)	3.50%
Aggregate Principal Amount	$ 425
Fair Value	390.6		$ 364.1
Interest Expense	$ 3.8	$ 3.8
Senior notes percentage of par value (percent)				99.841%

Borrowings - Outstanding Loans

Borrowings - Outstanding Loans Payable of Consolidated Funds (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value of liabilities	$ 5,649.5	$ 5,494.8
Senior secured notes
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value of liabilities	280.5	235.6
Revolving Credit Facility
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value of liabilities	157.5	178
Loans Payable of Consolidated Funds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Borrowing Outstanding	6,163.9	6,083.2
Fair Value	5,647.9	5,491.6
Senior secured notes
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Borrowing Outstanding	5,909	5,849.2
Fair Value	$ 5,451.1	$ 5,303.3
Weighted Average Interest Rate	4.74%	3.97%
Weighted Average Remaining Maturity in Years	9 years 2 months 23 days	9 years 5 months 23 days
Subordinated notes
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Borrowing Outstanding	$ 254.9	$ 234
Fair Value	$ 196.8	$ 188.3
Weighted Average Remaining Maturity in Years	9 years 5 months 8 days	9 years 8 months 8 days

Accrued Compensation and Bene_3

Accrued Compensation and Benefits - Components (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2019
Business Acquisition [Line Items]
Accrued performance allocations and incentive fee related compensation	$ 3,637	$ 3,625.3
Accrued bonuses	132.8	466.6
Employment-based contingent cash consideration	2.4	76.5
Accrued pension liability	7.3	9.5
Other	114.7	143
Total	3,894.2	4,320.9
Make-whole cash incentive awards granted	4.8
Realized performance allocations and incentive fee-related compensation not yet paid	17.7	$ 26.7
Carlyle Aviation Partners/Apollo Aviation Group
Business Acquisition [Line Items]
Contingent consideration, estimated maximum range			$ 150
Payments for earn out	68.6
Earnout payable	2.4
Abingworth
Business Acquisition [Line Items]
Contingent consideration, estimated maximum range	$ 130

Accrued Compensation and Bene_4

Accrued Compensation and Benefits - Performance Allocations and Incentive Fee Related Compensation (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Retirement Benefits [Abstract]
Realized	$ 103.6	$ 137.6
Unrealized	2.1	233.1
Total	$ 105.7	$ 370.7

Commitments and Contingencies -

Commitments and Contingencies - Unfunded Commitments (Details)	Mar. 31, 2023 USD ($)
Segment Reporting Information [Line Items]
Unfunded Commitments	$ 4,175,900,000
Unfunded commitment subscribed individually by senior Carlyle professionals, operating executives and other professionals	3,500,000,000
Unfunded commitments related to origination and syndication of loans and securities	0
Global Private Equity
Segment Reporting Information [Line Items]
Unfunded Commitments	3,509,100,000
Global Credit
Segment Reporting Information [Line Items]
Unfunded Commitments	453,300,000
Global Investment Solutions
Segment Reporting Information [Line Items]
Unfunded Commitments	$ 213,500,000

Commitments and Contingencies_2

Commitments and Contingencies - Additional Information (Details) R$ in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) employee	Dec. 31, 2022 USD ($)	Aug. 31, 2021 BRL (R$)
Guarantor Obligations [Line Items]
Liability for potential repayment of previously received performance fees	$ 40.9	$ 40.9
Unbilled receivable for giveback obligations from current and former employees	10	$ 10.4
Amount of accrued giveback obligation of various current and former senior Carlyle professionals and other limited partners of Carlyle Holdings partnerships	18.9
Amount of net accrued giveback obligation attributable to Carlyle Holdings	$ 22
Options to extend (up to)	5 years
Options to terminate (within)	1 year
Number of employees serving on board of directors \| employee	2
Proceeds from sale of investment	$ 87.5
Loss contingency accrual	$ 35
Minimum
Guarantor Obligations [Line Items]
Term of lease	1 year
Maximum
Guarantor Obligations [Line Items]
Term of lease	14 years
Guaranteed Employee Credit Facility
Guarantor Obligations [Line Items]
Guarantor obligations, current carrying value	$ 6.7
Contingent Obligations (Giveback)
Guarantor Obligations [Line Items]
Cash withheld from carried interest distributions for potential giveback obligations	150.3
Amount of realized and distributed carried interest subject to potential giveback on after-tax basis	1,500
Amount of realized and distributed carried interest subject to potential giveback on after-tax basis, responsibility of current and former senior Carlyle professionals	700
Indemnifications
Guarantor Obligations [Line Items]
Guaranteed loans, aggregate program limit	$ 19.7		R$ 100.0

Commitments and Contingencies_3

Commitments and Contingencies - Lease Cost, Cash Flows and Other Supplemental Information - Operating Leases (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Operating lease cost	$ 14.1	$ 14
Sublease income	(1.5)	(1.5)
Total operating lease cost	12.6	12.5
Cash paid for amounts included in the measurement of operating lease liabilities	$ 16.3	$ 16
Weighted-average remaining lease term	10 years 10 months 24 days	11 years 9 months 18 days
Weighted-average discount rate	4.20%	4.10%

Commitments and Contingencies_4

Commitments and Contingencies - Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
2023 (excluding the three months ended March 31, 2023)	$ 51.4
2024	65
2025	61
2026	58.6
2027	59.2
Thereafter	340
Total lease payments	635.2
Less payments for leases that have not yet commenced	(25.8)
Less imputed interest	(114.5)
Total lease liabilities	$ 494.9	$ 502.9

Related Party Transactions - Du

Related Party Transactions - Due from Affiliates and Other Receivables (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Related Party Transactions [Abstract]
Accrued incentive fees	$ 17.5	$ 16.4
Unbilled receivable for giveback obligations from current and former employees	10	10.4
Notes receivable and accrued interest from affiliates	32.9	41.5
Management fee, reimbursable expenses and other receivables from unconsolidated funds and affiliates, net	438.9	511.1
Total	$ 499.3	$ 579.4

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions			3 Months Ended
	May 05, 2020	Jan. 01, 2020	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Related Party Transaction [Line Items]
Maximum percentage of interest on amounts due from affiliates (percent)			7.02%
Tax receivable agreement termination, cash payments per partnership unit exchanged (in dollars per share)		$ 1.50
Tax receivable agreement termination, term of annual installments		5 years
Tax receivable agreement termination, annual cash payments per partnership unit exchanged (in dollars per share)		$ 0.30
Conversion of units, deferred consideration obligation, discount		$ 11.3
Percentage of estimated realizable tax benefit to be paid by corporate taxpayers on exchange transactions			85%
Payment of aircraft related expenses			$ 0.4	$ 0.1
Fair value of assets			7,848.4		$ 7,049.3
Level III
Related Party Transaction [Line Items]
Fair value of assets			7,131.3		6,983.9
Level III \| BDC preferred shares
Related Party Transaction [Line Items]
Fair value of assets			73.6		76.9
Level III \| BDC preferred shares \| Market Yield Analysis
Related Party Transaction [Line Items]
Fair value of assets			73.6		76.9
Affiliated Entity
Related Party Transaction [Line Items]
Interest-bearing loans			$ 21.8		$ 23.2
Floor rate			3.50%
Actual rate			0.0700
Affiliated Entity \| WSJ Prime Rate
Related Party Transaction [Line Items]
Accrued interest percentage			1%
Carlyle Secured Lending, Inc. \| Affiliated Entity
Related Party Transaction [Line Items]
Purchase of investment (in shares)	2,000,000
Purchase of investment (in dollars per share)	$ 25
Dividend rate, percentage	7%
Dividend rate, payable in shares, percentage	9%
Initial conversion price (in usd per share)	$ 9.50
Interest income			$ 0.9	$ 0.9

Related Party Transactions - _2

Related Party Transactions - Due to Affiliates (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Related Party Transactions [Abstract]
Due to affiliates of Consolidated Funds	$ 11.6	$ 16.4
Due to non-consolidated affiliates	130.9	87.1
Amounts owed under the tax receivable agreement	79.6	100
Deferred consideration for Carlyle Holdings units	65.2	134.4
Other	26.8	24.6
Total	$ 314.1	$ 362.5

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income tax expense	$ 34.3	$ 147.9
Effective tax rate (percent)	21%	20%
Income taxes payable	$ 33.9		$ 39.7

Non-controlling Interests in _3

Non-controlling Interests in Consolidated Entities - Non-Controlling Interests in Consolidated Entities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Noncontrolling Interest [Line Items]
Non-controlling interests in consolidated entities	$ 636.7	$ 600.3
Non-Carlyle interests in Consolidated Funds
Noncontrolling Interest [Line Items]
Non-controlling interests in consolidated entities	444.5	412
Non-Carlyle interests in majority-owned subsidiaries
Noncontrolling Interest [Line Items]
Non-controlling interests in consolidated entities	189.4	186.9
Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions
Noncontrolling Interest [Line Items]
Non-controlling interests in consolidated entities	$ 2.8	$ 1.4

Non-controlling Interests in _4

Non-controlling Interests in Consolidated Entities - Non-Controlling Interests in Income (Loss) of Consolidated Entities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Noncontrolling Interest [Line Items]
Non-controlling interests in income of consolidated entities	$ 24.6	$ 23.2
Non-Carlyle interests in Consolidated Funds
Noncontrolling Interest [Line Items]
Net income (loss) attributable to other non-controlling interests in consolidated entities	17.2	25.1
Non-Carlyle interests in majority-owned subsidiaries
Noncontrolling Interest [Line Items]
Net income (loss) attributable to other non-controlling interests in consolidated entities	5.5	(2.4)
Non-controlling interest in carried interest, giveback obligations and cash held for carried interest distributions
Noncontrolling Interest [Line Items]
Net income (loss) attributable to other non-controlling interests in consolidated entities	$ 1.9	$ 0.5

Earnings Per Common Share - Bas

Earnings Per Common Share - Basic and Diluted Net Income Per Common Unit (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Basic
Net income attributable to common shares	$ 100,700,000	$ 571,600,000
Weighted-average common shares outstanding (in shares)	362,944,260	357,574,838
Net income per common share (in dollars per share)	$ 0.28	$ 1.60
Diluted
Net income attributable to common shares	$ 100,700,000	$ 571,600,000
Weighted-average common shares outstanding (in shares)	365,357,833	363,010,282
Net income per common share (in dollars per share)	$ 0.28	$ 1.57

Earnings Per Common Share - Wei

Earnings Per Common Share - Weighted-Average Common Units Outstanding, Basic and Diluted (Details) - shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Weighted-average common shares outstanding, basic (in shares)	362,944,260	357,574,838
Weighted-average common shares outstanding, diluted (in shares)	365,357,833	363,010,282
The Carlyle Group Inc. weighted-average common shares outstanding
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Weighted-average common shares outstanding, basic (in shares)	362,944,260	357,574,838
Weighted-average common shares outstanding, diluted (in shares)	362,944,260	357,574,838
Unvested restricted stock units
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Weighted-average common shares outstanding, basic (in shares)	0	0
Weighted-average common shares outstanding, diluted (in shares)	1,702,114	3,695,350
Issuable common shares and performance-vesting restricted stock units
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Weighted-average common shares outstanding, basic (in shares)	0	0
Weighted-average common shares outstanding, diluted (in shares)	711,459	1,740,094

Equity - Additional Information

Equity - Additional Information (Details) - USD ($)	1 Months Ended		3 Months Ended
Equity - Additional Information (Details) - USD ($)	Mar. 31, 2022	Oct. 31, 2021	Mar. 31, 2023	Mar. 31, 2022	Feb. 28, 2023
Equity, Class of Treasury Stock [Line Items]
Amount authorized for repurchase		$ 400,000,000			$ 500,000,000
Payments to repurchase units			$ 100,300,000	$ 80,400,000
Shares/units repurchased (in shares)			3,000,000	1,700,000
Remaining authorized amount			$ 500,000,000
Realized performance allocations and incentive fee related compensation, percentage		20%
Newly issued shares, fully vested in period (in shares)			0	636,461
Realized performance allocations and incentive fee related compensation				$ 31,300,000
Management Contracts
Equity, Class of Treasury Stock [Line Items]
Newly issued common shares (in shares)	4,200,000
Purchase price paid for acquisition of management contracts related portfolio of assets	$ 194,500,000

Equity - Quarterly Distribution

Equity - Quarterly Distributions on Common Units (Details) - USD ($) $ / shares in Units, $ in Millions						5 Months Ended	10 Months Ended
	May 23, 2023	Mar. 01, 2023	Nov. 25, 2022	Aug. 16, 2022	May 17, 2022	May 23, 2023	Mar. 01, 2023
Preferred Units [Line Items]
Dividend per Common Share (in dollars per share)		$ 0.325	$ 0.325	$ 0.325	$ 0.325		$ 1.30
Dividend to Common Stockholders		$ 118.4	$ 118.2	$ 118.3	$ 117.6		$ 472.5
Subsequent event
Preferred Units [Line Items]
Dividend per Common Share (in dollars per share)	$ 0.35					$ 0.35
Dividend to Common Stockholders	$ 126.7					$ 126.7

Equity-Based Compensation - Add

Equity-Based Compensation - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jun. 01, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)	3,527,870		16,000,000
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share based compensation expense	$ 54.4	$ 39.7
Tax benefits related to equity-based compensation expense	9.7	$ 7.9
Unrecognized equity-based compensation expense	$ 683.1
Weighted-average term for unrecognized compensation expense to be recognized	2 years 8 months 12 days

Equity-Based Compensation - Sum

Equity-Based Compensation - Summary of Status of Non-Vested Equity-Based Awards (Details)	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Weighted- Average Grant Date Fair Value
Shares reserved for issuance	63,849
Restricted Stock Units
Unvested Units
Beginning balance (in shares)	10,865,248
Granted (in shares)	16,729,897
Vested (in shares)	2,756,607
Forfeited (in shares)	102,310
Ending balance (in shares)	24,736,228
Weighted- Average Grant Date Fair Value
Beginning balance (in dollars per share) \| $ / shares	$ 35.78
Granted (in dollars per share) \| $ / shares	30.16
Vested (in dollars per share) \| $ / shares	27.94
Forfeited (in dollars per share) \| $ / shares	35.62
Ending balance (in dollars per share) \| $ / shares	$ 32.86
Restricted Stock Units \| Chief Executive Officer
Unvested Units
Granted (in shares)	6,762,219
Unvested Common Shares
Unvested Units
Beginning balance (in shares)	452,880
Granted (in shares)	258,579
Vested (in shares)	0
Forfeited (in shares)	0
Ending balance (in shares)	711,459
Weighted- Average Grant Date Fair Value
Beginning balance (in dollars per share) \| $ / shares	$ 39.73
Granted (in dollars per share) \| $ / shares	34.65
Vested (in dollars per share) \| $ / shares	0
Forfeited (in dollars per share) \| $ / shares	0
Ending balance (in dollars per share) \| $ / shares	$ 37.88

Segment Reporting - Additional

Segment Reporting - Additional Information (Details) - segment	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting [Abstract]
Number of reportable segments	3	3

Segment Reporting - Reportable

Segment Reporting - Reportable Segments Financial Data (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Fund level fee revenues
Investment income	$ 172.5	$ 1,029.8
Interest income	44	25.8
Total revenues	859	1,581.8
Compensation and benefits
Cash-based compensation and benefits	260.2	254.3
Realized performance revenues related compensation	105.7	370.7
Total compensation and benefits	420.3	664.7
General, administrative, and other indirect expenses	159.2	106.3
Interest expense	29.7	27.8
Total expenses	703	841.9
Segment assets	21,273.9		$ 21,403
Total Reportable Segments
Fund level fee revenues
Total fund level fee revenues	551.4	514.9
Interest income	13.9	2
Total revenues	754.2	779.5
Compensation and benefits
Cash-based compensation and benefits	260.6	245.8
Realized performance revenues related compensation	95.6	118.3
Total compensation and benefits	356.2	364.1
General, administrative, and other indirect expenses	87.5	76.3
Depreciation and amortization expense	9.9	9.5
Interest expense	29	26.8
Total expenses	482.6	476.7
Distributable Earnings	271.6	302.8
Realized net performance revenues	69.5	118
Realized principal investment income	23.8	26.3
Net interest	15.1	24.8
Fee Related Earnings	193.4	183.3
Segment assets	14,483.9
Total Reportable Segments \| Global Private Equity
Fund level fee revenues
Total fund level fee revenues	341.9	340.9
Interest income	5.4	0.4
Total revenues	458.2	555.4
Compensation and benefits
Cash-based compensation and benefits	148.7	153
Realized performance revenues related compensation	46.3	90.7
Total compensation and benefits	195	243.7
General, administrative, and other indirect expenses	57.1	45.5
Depreciation and amortization expense	6.7	6.3
Interest expense	16.6	15.8
Total expenses	275.4	311.3
Distributable Earnings	182.8	244.1
Realized net performance revenues	52.7	109.2
Realized principal investment income	11.9	14.2
Net interest	11.2	15.4
Fee Related Earnings	129.4	136.1
Segment assets	9,459.8
Total Reportable Segments \| Global Credit
Fund level fee revenues
Total fund level fee revenues	152	117.7
Interest income	7.2	1.5
Total revenues	195.9	143.2
Compensation and benefits
Cash-based compensation and benefits	80.4	67.2
Realized performance revenues related compensation	12.7	6.7
Total compensation and benefits	93.1	73.9
General, administrative, and other indirect expenses	21.7	23.5
Depreciation and amortization expense	2	2
Interest expense	10.2	8.2
Total expenses	127	107.6
Distributable Earnings	68.9	35.6
Realized net performance revenues	15	7
Realized principal investment income	9	10.3
Net interest	3	6.7
Fee Related Earnings	47.9	25
Segment assets	3,075.2
Total Reportable Segments \| Global Investment Solutions
Fund level fee revenues
Total fund level fee revenues	57.5	56.3
Interest income	1.3	0.1
Total revenues	100.1	80.9
Compensation and benefits
Cash-based compensation and benefits	31.5	25.6
Realized performance revenues related compensation	36.6	20.9
Total compensation and benefits	68.1	46.5
General, administrative, and other indirect expenses	8.7	7.3
Depreciation and amortization expense	1.2	1.2
Interest expense	2.2	2.8
Total expenses	80.2	57.8
Distributable Earnings	19.9	23.1
Realized net performance revenues	1.8	1.8
Realized principal investment income	2.9	1.8
Net interest	0.9	2.7
Fee Related Earnings	16.1	22.2
Segment assets	1,948.9
Fund management fees
Fund level fee revenues
Total fund level fee revenues	500.8	450.5
Fund management fees \| Total Reportable Segments
Fund level fee revenues
Total fund level fee revenues	506.2	454.2
Fund management fees \| Total Reportable Segments \| Global Private Equity
Fund level fee revenues
Total fund level fee revenues	326.9	304.2
Fund management fees \| Total Reportable Segments \| Global Credit
Fund level fee revenues
Total fund level fee revenues	122.6	93.7
Fund management fees \| Total Reportable Segments \| Global Investment Solutions
Fund level fee revenues
Total fund level fee revenues	56.7	56.3
Portfolio advisory and transaction fees, net and other \| Total Reportable Segments
Fund level fee revenues
Total fund level fee revenues	16.4	16.2
Portfolio advisory and transaction fees, net and other \| Total Reportable Segments \| Global Private Equity
Fund level fee revenues
Total fund level fee revenues	5.4	6.1
Portfolio advisory and transaction fees, net and other \| Total Reportable Segments \| Global Credit
Fund level fee revenues
Total fund level fee revenues	11	10.1
Portfolio advisory and transaction fees, net and other \| Total Reportable Segments \| Global Investment Solutions
Fund level fee revenues
Total fund level fee revenues	0	0
Fee related performance revenues \| Total Reportable Segments
Fund level fee revenues
Total fund level fee revenues	28.8	44.5
Fee related performance revenues \| Total Reportable Segments \| Global Private Equity
Fund level fee revenues
Total fund level fee revenues	9.6	30.6
Fee related performance revenues \| Total Reportable Segments \| Global Credit
Fund level fee revenues
Total fund level fee revenues	18.4	13.9
Fee related performance revenues \| Total Reportable Segments \| Global Investment Solutions
Fund level fee revenues
Total fund level fee revenues	0.8	0
Performance allocations
Fund level fee revenues
Investment income	160.8	710.2
Performance allocations \| Total Reportable Segments
Fund level fee revenues
Investment income	165.1	236.3
Performance allocations \| Total Reportable Segments \| Global Private Equity
Fund level fee revenues
Investment income	99	199.9
Performance allocations \| Total Reportable Segments \| Global Credit
Fund level fee revenues
Investment income	27.7	13.7
Performance allocations \| Total Reportable Segments \| Global Investment Solutions
Fund level fee revenues
Investment income	38.4	22.7
Principal investment income
Fund level fee revenues
Investment income	11.7	319.6
Principal investment income \| Total Reportable Segments
Fund level fee revenues
Investment income	23.8	26.3
Principal investment income \| Total Reportable Segments \| Global Private Equity
Fund level fee revenues
Investment income	11.9	14.2
Principal investment income \| Total Reportable Segments \| Global Credit
Fund level fee revenues
Investment income	9	10.3
Principal investment income \| Total Reportable Segments \| Global Investment Solutions
Fund level fee revenues
Investment income	$ 2.9	$ 1.8

Segment Reporting - Total Segme

Segment Reporting - Total Segments to Partnership Income Before Provision for Taxes Reconciliation (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Segment Reporting Information [Line Items]
Revenues	$ 859	$ 1,581.8
Expenses	703	841.9
Other income (loss)	3.6	2.8
Distributable earnings	159.6	742.7
Total assets	21,273.9		$ 21,403
Total Reportable Segments
Segment Reporting Information [Line Items]
Revenues	754.2	779.5
Expenses	482.6	476.7
Other income (loss)	0	0
Distributable earnings	271.6	302.8
Total assets	14,483.9
Consolidated Funds \| Consolidated Funds
Segment Reporting Information [Line Items]
Revenues	121.9	61.7
Expenses	97.2	52.9
Other income (loss)	3.6	2.8
Distributable earnings	28.3	11.6
Total assets	7,403.1		$ 7,213.3
Reconciling Items
Segment Reporting Information [Line Items]
Revenues	(17.1)	740.6
Expenses	123.2	312.3
Other income (loss)	0	0
Distributable earnings	(140.3)	$ 428.3
Total assets	$ (613.1)

Segment Reporting - Revenue Adj

Segment Reporting - Revenue Adjustments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Unrealized principal investment income (loss)	$ 7.7	$ 315.3
Revenues	859	1,581.8
Reconciling Items
Segment Reporting Information [Line Items]
Unrealized performance and fee related performance revenues	(20.7)	698.8
Unrealized principal investment income (loss)	(29)	23.7
Adjustments related to expenses associated with investments in NGP Management and its affiliates	(3.4)	(3.1)
Tax expense associated with certain foreign performance revenues	0	(0.1)
Non-controlling interests and other adjustments to present certain costs on a net basis	50.8	17.9
Revenues	(17.1)	740.6
Elimination of revenues of Consolidated Funds
Segment Reporting Information [Line Items]
Revenues	$ (14.8)	$ 3.4

Segment Reporting - Reconciliat

Segment Reporting - Reconciliation of Fund Level Fee Revenues (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Total Reportable Segments
Segment Reporting Information [Line Items]
Fund management fees and incentive fees	$ 551.4	$ 514.9
Elimination of revenues of Consolidated Funds
Segment Reporting Information [Line Items]
Adjustments	(50.6)	(64.4)
Fund management fees
Segment Reporting Information [Line Items]
Fund management fees and incentive fees	500.8	450.5
Fund management fees \| Total Reportable Segments
Segment Reporting Information [Line Items]
Fund management fees and incentive fees	506.2	454.2
Fund management fees \| Elimination of revenues of Consolidated Funds
Segment Reporting Information [Line Items]
Fund management fees and incentive fees	$ (7.6)	$ (6.4)

Segment Reporting - Expense Adj

Segment Reporting - Expense Adjustments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Unrealized performance and fee related performance revenue compensation expense	$ 2.1	$ 233.1
Equity-based compensation	54.4	39.7
Expenses	703	841.9
Total Reportable Segments
Segment Reporting Information [Line Items]
Unrealized performance and fee related performance revenue compensation expense	(2.3)	232.2
Expenses	482.6	476.7
Reconciling Items
Segment Reporting Information [Line Items]
Equity-based compensation	57.1	40.7
Acquisition or disposition-related charges (credits) and amortization of intangibles and impairment	28.7	29.1
Tax expense associated with certain foreign performance revenues related compensation	(0.5)	(0.7)
Non-controlling interests and other adjustments to present certain costs on a net basis	40	16.5
Other adjustments including severance	3.9	4.6
Expenses	123.2	312.3
Elimination of revenues of Consolidated Funds
Segment Reporting Information [Line Items]
Equity-based compensation	0	0
Expenses	$ (3.7)	$ (10.1)

Segment Reporting - Reconcili_2

Segment Reporting - Reconciliation of Income Before Provision for Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Income (loss) before provision for income taxes	$ 159.6	$ 742.7
Adjustments:
Unrealized principal investment (income) loss	(172.5)	(1,029.8)
Equity-based compensation	54.4	39.7
Net income attributable to non-controlling interests in consolidated entities	24.6	23.2
Total Reportable Segments
Adjustments:
Net unrealized performance and fee related performance revenues	18.4	(466.6)
Distributable Earnings	271.6	302.8
Realized net performance revenues	69.5	118
Realized principal investment income	23.8	26.3
Net interest	15.1	24.8
Fee Related Earnings	193.4	183.3
Total Reportable Segments \| Global Private Equity
Adjustments:
Distributable Earnings	182.8	244.1
Realized net performance revenues	52.7	109.2
Realized principal investment income	11.9	14.2
Net interest	11.2	15.4
Fee Related Earnings	129.4	136.1
Total Reportable Segments \| Global Credit
Adjustments:
Distributable Earnings	68.9	35.6
Realized net performance revenues	15	7
Realized principal investment income	9	10.3
Net interest	3	6.7
Fee Related Earnings	47.9	25
Total Reportable Segments \| Global Investment Solutions
Adjustments:
Distributable Earnings	19.9	23.1
Realized net performance revenues	1.8	1.8
Realized principal investment income	2.9	1.8
Net interest	0.9	2.7
Fee Related Earnings	16.1	22.2
Reconciling Items
Adjustments:
Equity-based compensation	57.1	40.7
Acquisition or disposition-related charges (credits) and amortization of intangibles and impairment	28.7	29.1
Tax expense associated with certain foreign performance revenues	(0.5)	(0.8)
Net income attributable to non-controlling interests in consolidated entities	(24.6)	(23.2)
Other adjustments including severance	3.9	4.6
Unrealized principal investment income (loss) \| Reconciling Items
Adjustments:
Unrealized principal investment (income) loss	$ 29	$ (23.7)

Segment Reporting - Adjustments

Segment Reporting - Adjustments for Performance Fees, Performance Fee Related Compensation and Investment Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Investment income	$ 172.5	$ 1,029.8
Performance revenues related compensation expense	105.7	370.7
Net performance revenues	55.1	339.5
Adjustments
Segment Reporting Information [Line Items]
Performance revenues related compensation expense	(10.1)	(252.4)
Net performance revenues	14.4	(221.5)
Total Reportable Segments
Segment Reporting Information [Line Items]
Performance revenues related compensation expense	95.6	118.3
Net performance revenues	69.5	118
Performance allocations
Segment Reporting Information [Line Items]
Investment income	160.8	710.2
Performance allocations \| Adjustments
Segment Reporting Information [Line Items]
Investment income	4.3	(473.9)
Performance allocations \| Total Reportable Segments
Segment Reporting Information [Line Items]
Investment income	165.1	236.3
Principal investment income
Segment Reporting Information [Line Items]
Investment income	11.7	319.6
Principal investment income \| Adjustments
Segment Reporting Information [Line Items]
Investment income	12.1	(293.3)
Principal investment income \| Total Reportable Segments
Segment Reporting Information [Line Items]
Investment income	$ 23.8	$ 26.3

Subsequent Events (Details)

Subsequent Events (Details)	May 31, 2023 $ / shares
Subsequent event
Subsequent Event [Line Items]
Distribution payable (in dollars per share)	$ 0.35

Supplemental Financial Inform_3

Supplemental Financial Information - Financial Position (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents	$ 1,010.1	$ 1,360.7	$ 1,290.2
Cash and cash equivalents held at Consolidated Funds	228.8	209	168.9
Restricted cash	16.8	0.8	0.6
Corporate treasury investments	102	20
Investments, including accrued performance allocations of $7,134.0 million and $7,117.7 million as of March 31, 2023 and December 31, 2022, respectively	10,784.1	10,767.9
Investments of Consolidated Funds	7,067.3	6,894.4
Due from affiliates and other receivables, net	499.3	579.4
Due from affiliates and other receivables of Consolidated Funds, net	100.6	101.9
Fixed assets, net	141.8	139.9
Lease right-of-use assets, net	331.5	337
Deposits and other	111.1	78.4
Intangible assets, net	866.4	897.8
Deferred tax assets	14.1	15.8
Total assets	21,273.9	21,403
Liabilities and equity
Long-Term Debt, Excluding Current Maturities	2,275.6	2,271.7
Loans payable of Consolidated Funds	6,085.9	5,905.2
Accounts payable, accrued expenses and other liabilities	304.8	369.2
Accrued compensation and benefits	3,894.2	4,320.9
Due to affiliates	314.1	362.5
Deferred revenue	411.7	126.4
Deferred tax liabilities	389.5	402.7
Other liabilities of Consolidated Funds	250.8	279.3
Lease liabilities	494.9	502.9
Accrued giveback obligations	40.9	40.9
Total liabilities	14,462.4	14,581.7
Common stock	3.6	3.6
Additional paid-in-capital	3,195.5	3,138.5
Retained earnings	3,280.9	3,401.1
Accumulated other comprehensive loss	(305.2)	(322.2)
Non-controlling interests in consolidated entities	636.7	600.3
Total equity	6,811.5	6,821.3	6,354.3	$ 5,706.2
Total liabilities and equity	21,273.9	21,403
Accrued performance allocations	7,134	7,117.7
Consolidated Operating Entities
Assets
Cash and cash equivalents	1,010.1		1,290.2
Cash and cash equivalents held at Consolidated Funds	228.8		168.9
Restricted cash	16.8		$ 0.6
Consolidated Entities and Consolidated Funds \| Consolidated Operating Entities
Assets
Cash and cash equivalents	1,010.1	1,360.7
Cash and cash equivalents held at Consolidated Funds	0	0
Restricted cash	16.8	0.8
Corporate treasury investments	102	20
Investments, including accrued performance allocations of $7,134.0 million and $7,117.7 million as of March 31, 2023 and December 31, 2022, respectively	11,013.5	10,989.9
Investments of Consolidated Funds	0	0
Due from affiliates and other receivables, net	883	960.5
Due from affiliates and other receivables of Consolidated Funds, net	0	0
Fixed assets, net	141.8	139.9
Lease right-of-use assets, net	331.5	337
Deposits and other	104.7	70.4
Intangible assets, net	866.4	897.8
Deferred tax assets	14.1	15.8
Total assets	14,483.9	14,792.8
Liabilities and equity
Long-Term Debt, Excluding Current Maturities	2,275.6	2,271.7
Loans payable of Consolidated Funds	0	0
Accounts payable, accrued expenses and other liabilities	304.8	369.2
Accrued compensation and benefits	3,894.2	4,320.9
Due to affiliates	302.5	346.1
Deferred revenue	411.7	126.4
Deferred tax liabilities	389.5	402.7
Other liabilities of Consolidated Funds	0	0
Lease liabilities	494.9	502.9
Accrued giveback obligations	40.9	40.9
Total liabilities	8,114.1	8,380.8
Common stock	3.6	3.6
Additional paid-in-capital	3,195.5	3,138.5
Retained earnings	3,280.9	3,401.1
Accumulated other comprehensive loss	(302.4)	(319.5)
Non-controlling interests in consolidated entities	192.2	188.3
Total equity	6,369.8	6,412
Total liabilities and equity	14,483.9	14,792.8
Consolidated Entities and Consolidated Funds \| Consolidated Funds
Assets
Cash and cash equivalents	0	0
Cash and cash equivalents held at Consolidated Funds	228.8	209
Restricted cash	0	0
Corporate treasury investments	0	0
Investments, including accrued performance allocations of $7,134.0 million and $7,117.7 million as of March 31, 2023 and December 31, 2022, respectively	0	0
Investments of Consolidated Funds	7,067.3	6,894.4
Due from affiliates and other receivables, net	0	0
Due from affiliates and other receivables of Consolidated Funds, net	100.6	101.9
Fixed assets, net	0	0
Lease right-of-use assets, net	0	0
Deposits and other	6.4	8
Intangible assets, net	0	0
Deferred tax assets	0	0
Total assets	7,403.1	7,213.3
Liabilities and equity
Long-Term Debt, Excluding Current Maturities	0	0
Loans payable of Consolidated Funds	6,462.4	6,279.7
Accounts payable, accrued expenses and other liabilities	0	0
Accrued compensation and benefits	0	0
Due to affiliates	11.6	16.5
Deferred revenue	0	0
Deferred tax liabilities	0	0
Other liabilities of Consolidated Funds	251.7	279.7
Lease liabilities	0	0
Accrued giveback obligations	0	0
Total liabilities	6,725.7	6,575.9
Common stock	0	0
Additional paid-in-capital	244.9	238.7
Retained earnings	0	0
Accumulated other comprehensive loss	(12)	(13.3)
Non-controlling interests in consolidated entities	444.5	412
Total equity	677.4	637.4
Total liabilities and equity	7,403.1	7,213.3
Eliminations
Assets
Cash and cash equivalents	0	0
Cash and cash equivalents held at Consolidated Funds	0	0
Restricted cash	0	0
Corporate treasury investments	0	0
Investments, including accrued performance allocations of $7,134.0 million and $7,117.7 million as of March 31, 2023 and December 31, 2022, respectively	(229.4)	(222)
Investments of Consolidated Funds	0	0
Due from affiliates and other receivables, net	(383.7)	(381.1)
Due from affiliates and other receivables of Consolidated Funds, net	0	0
Fixed assets, net	0	0
Lease right-of-use assets, net	0	0
Deposits and other	0	0
Intangible assets, net	0	0
Deferred tax assets	0	0
Total assets	(613.1)	(603.1)
Liabilities and equity
Long-Term Debt, Excluding Current Maturities	0	0
Loans payable of Consolidated Funds	(376.5)	(374.5)
Accounts payable, accrued expenses and other liabilities	0	0
Accrued compensation and benefits	0	0
Due to affiliates	0	(0.1)
Deferred revenue	0	0
Deferred tax liabilities	0	0
Other liabilities of Consolidated Funds	(0.9)	(0.4)
Lease liabilities	0	0
Accrued giveback obligations	0	0
Total liabilities	(377.4)	(375)
Common stock	0	0
Additional paid-in-capital	(244.9)	(238.7)
Retained earnings	0	0
Accumulated other comprehensive loss	9.2	10.6
Non-controlling interests in consolidated entities	0	0
Total equity	(235.7)	(228.1)
Total liabilities and equity	$ (613.1)	$ (603.1)

Supplemental Financial Inform_4

Supplemental Financial Information - Results of Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Condensed Income Statements, Captions [Line Items]
Investment income	$ 172.5	$ 1,029.8
Interest and other income	44	25.8
Interest and other income of Consolidated Funds	121.9	61.7
Total revenues	859	1,581.8
Compensation and benefits
Cash-based compensation and benefits	260.2	254.3
Equity-based compensation	54.4	39.7
Performance allocations and incentive fee related compensation	105.7	370.7
Total compensation and benefits	420.3	664.7
General, administrative and other expenses	159.2	106.3
Interest	29.7	27.8
Interest and other expenses of Consolidated Funds	93.7	42.8
Other non-operating expenses	0.1	0.3
Total expenses	703	841.9
Other income
Net investment income of Consolidated Funds	3.6	2.8
Income before provision for income taxes	159.6	742.7
Provision for income taxes	34.3	147.9
Net income	125.3	594.8
Net income attributable to non-controlling interests in consolidated entities	24.6	23.2
Net income attributable to The Carlyle Group Inc.	100.7	571.6
Consolidated Operating Entities
Compensation and benefits
Equity-based compensation	54.4	39.7
Other income
Net income	108.1	569.7
Consolidated Entities and Consolidated Funds \| Consolidated Operating Entities
Condensed Income Statements, Captions [Line Items]
Investment income	177	1,012.5
Interest and other income	46.6	33.3
Interest and other income of Consolidated Funds	0	0
Total revenues	751.9	1,516.7
Compensation and benefits
Cash-based compensation and benefits	260.2	254.3
Equity-based compensation	54.4	39.7
Performance allocations and incentive fee related compensation	105.7	370.7
Total compensation and benefits	420.3	664.7
General, administrative and other expenses	159.4	106.3
Interest	29.7	27.8
Interest and other expenses of Consolidated Funds	0	0
Other non-operating expenses	0.1	0.3
Total expenses	609.5	799.1
Other income
Net investment income of Consolidated Funds	0	0
Income before provision for income taxes	142.4	717.6
Provision for income taxes	34.3	147.9
Net income	108.1	569.7
Net income attributable to non-controlling interests in consolidated entities	7.4	(1.9)
Net income attributable to The Carlyle Group Inc.	100.7	571.6
Consolidated Entities and Consolidated Funds \| Consolidated Funds
Condensed Income Statements, Captions [Line Items]
Investment income	0	0
Interest and other income	0	0
Interest and other income of Consolidated Funds	121.9	61.7
Total revenues	121.9	61.7
Compensation and benefits
Cash-based compensation and benefits	0	0
Equity-based compensation	0	0
Performance allocations and incentive fee related compensation	0	0
Total compensation and benefits	0	0
General, administrative and other expenses	0	0
Interest	0	0
Interest and other expenses of Consolidated Funds	97.2	52.9
Other non-operating expenses	0	0
Total expenses	97.2	52.9
Other income
Net investment income of Consolidated Funds	3.6	2.8
Income before provision for income taxes	28.3	11.6
Provision for income taxes	0	0
Net income	28.3	11.6
Net income attributable to non-controlling interests in consolidated entities	0	0
Net income attributable to The Carlyle Group Inc.	28.3	11.6
Eliminations
Condensed Income Statements, Captions [Line Items]
Investment income	(4.5)	17.3
Interest and other income	(2.6)	(7.5)
Interest and other income of Consolidated Funds	0	0
Total revenues	(14.8)	3.4
Compensation and benefits
Cash-based compensation and benefits	0	0
Equity-based compensation	0	0
Performance allocations and incentive fee related compensation	0	0
Total compensation and benefits	0	0
General, administrative and other expenses	(0.2)	0
Interest	0	0
Interest and other expenses of Consolidated Funds	(3.5)	(10.1)
Other non-operating expenses	0	0
Total expenses	(3.7)	(10.1)
Other income
Net investment income of Consolidated Funds	0	0
Income before provision for income taxes	(11.1)	13.5
Provision for income taxes	0	0
Net income	(11.1)	13.5
Net income attributable to non-controlling interests in consolidated entities	17.2	25.1
Net income attributable to The Carlyle Group Inc.	(28.3)	(11.6)
Fund management fees
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	500.8	450.5
Fund management fees \| Consolidated Entities and Consolidated Funds \| Consolidated Operating Entities
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	508.4	456.9
Fund management fees \| Consolidated Entities and Consolidated Funds \| Consolidated Funds
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	0	0
Fund management fees \| Eliminations
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	(7.6)	(6.4)
Incentive fees
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	19.8	14
Incentive fees \| Consolidated Entities and Consolidated Funds \| Consolidated Operating Entities
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	19.9	14
Incentive fees \| Consolidated Entities and Consolidated Funds \| Consolidated Funds
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	0	0
Incentive fees \| Eliminations
Condensed Income Statements, Captions [Line Items]
Fund management fees and incentive fees	(0.1)	0
Performance allocations
Condensed Income Statements, Captions [Line Items]
Investment income	160.8	710.2
Performance allocations \| Consolidated Entities and Consolidated Funds \| Consolidated Operating Entities
Condensed Income Statements, Captions [Line Items]
Investment income	162.3	710.2
Performance allocations \| Consolidated Entities and Consolidated Funds \| Consolidated Funds
Condensed Income Statements, Captions [Line Items]
Investment income	0	0
Performance allocations \| Eliminations
Condensed Income Statements, Captions [Line Items]
Investment income	(1.5)	0
Principal investment income
Condensed Income Statements, Captions [Line Items]
Investment income	11.7	319.6
Principal investment income \| Consolidated Entities and Consolidated Funds \| Consolidated Operating Entities
Condensed Income Statements, Captions [Line Items]
Investment income	14.7	302.3
Principal investment income \| Consolidated Entities and Consolidated Funds \| Consolidated Funds
Condensed Income Statements, Captions [Line Items]
Investment income	0	0
Principal investment income \| Eliminations
Condensed Income Statements, Captions [Line Items]
Investment income	$ (3)	$ 17.3

Supplemental Financial Inform_5

Supplemental Financial Information - Cash Flows (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Cash flows from operating activities
Net income	$ 125.3	$ 594.8
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	44	19.4
Equity-based compensation	54.4	39.7
Non-cash performance allocations and incentive fees, net	(36.7)	(300.8)
Non-cash principal investment income	(7.7)	(315.3)
Other non-cash amounts	10.8	5.3
Purchases of investments	(18.5)	(307.5)
Proceeds from the sale of investments	78.6	158.3
Payments of contingent consideration	(68.6)	(5.7)
Changes in deferred taxes, net	(15.1)	110.9
Change in due from affiliates and other receivables	16.9	(9.5)
Change in deposits and other	(33.9)	(39.8)
Change in accounts payable, accrued expenses and other liabilities	(63.9)	(14.3)
Change in accrued compensation and benefits	(371.9)	(580.1)
Change in due to affiliates	(0.2)	(0.2)
Change in lease right-of-use assets and lease liabilities	(2.8)	(2.5)
Change in deferred revenue	284.7	254.5
Net cash used in operating activities	(112.5)	(371.7)
Cash flows from investing activities
Purchases of corporate treasury investments	(101.1)	0
Proceeds from corporate treasury investments	20.1	0
Purchases of fixed assets, net	(12.9)	(12.3)
Purchase of CBAM intangibles and investments, net	0	(618.4)
Net cash used in investing activities	(93.9)	(630.7)
Cash flows from financing activities
Payments on CLO borrowings	(1.1)	(8.9)
Proceeds from CLO borrowings, net of financing costs	0	40.8
Dividends to common stockholders	(118.4)	(89.5)
Payment of deferred consideration for Carlyle Holdings units	(68.8)	(68.8)
Contributions from non-controlling interest holders	18.7	146.8
Distributions to non-controlling interest holders	(9.9)	(147.1)
Common shares issued for performance allocations	0	31.3
Common shares repurchased	(100.3)	(80.4)
Change in due to/from affiliates financing activities	74.6	33.1
Net cash used in financing activities	(136.5)	(164.5)
Effect of foreign exchange rate changes	8.3	(17.4)
Decrease in cash, cash equivalents and restricted cash	(334.6)	(1,184.3)
Cash, cash equivalents and restricted cash, beginning of period	1,361.5	2,475.1
Cash, cash equivalents and restricted cash, end of period	1,026.9	1,290.8
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents	1,010.1	1,290.2	$ 1,360.7
Restricted cash	16.8	0.6	0.8
Total cash, cash equivalents and restricted cash, end of period	1,026.9	1,290.8	1,361.5
Cash and cash equivalents held at Consolidated Funds	228.8	168.9	209
Consolidated Operating Entities
Cash flows from operating activities
Net income	108.1	569.7
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	44	19.4
Equity-based compensation	54.4	39.7
Non-cash performance allocations and incentive fees, net	(38.2)	(300.8)
Non-cash principal investment income	(8.7)	(295.4)
Other non-cash amounts	10.8	5.3
Purchases of investments	(19)	(294.1)
Proceeds from the sale of investments	78.9	169.5
Payments of contingent consideration	(68.6)	(5.7)
Changes in deferred taxes, net	(15.1)	110.9
Change in due from affiliates and other receivables	17	(8.8)
Change in deposits and other	(33.9)	(39.8)
Change in accounts payable, accrued expenses and other liabilities	(63.9)	(14.3)
Change in accrued compensation and benefits	(371.9)	(580.1)
Change in due to affiliates	(0.2)	(0.2)
Change in lease right-of-use assets and lease liabilities	(2.8)	(2.5)
Change in deferred revenue	284.7	254.5
Net cash used in operating activities	(24.4)	(372.7)
Cash flows from investing activities
Purchases of corporate treasury investments	(101.1)	0
Purchases of fixed assets, net	(12.9)	(12.3)
Purchase of CBAM intangibles and investments, net	0	(618.4)
Net cash used in investing activities	(93.9)	(630.7)
Cash flows from financing activities
Payments on CLO borrowings	(1.1)	(8.9)
Proceeds from CLO borrowings, net of financing costs	0	40.8
Dividends to common stockholders	(118.4)	(89.5)
Payment of deferred consideration for Carlyle Holdings units	(68.8)	(68.8)
Contributions from non-controlling interest holders	2	5.8
Distributions to non-controlling interest holders	(8.5)	(27.1)
Common shares issued for performance allocations	0	31.3
Common shares repurchased	(100.3)	(80.4)
Change in due to/from affiliates financing activities	73	33.1
Net cash used in financing activities	(222.1)	(163.7)
Effect of foreign exchange rate changes	5.8	(17.2)
Decrease in cash, cash equivalents and restricted cash	(334.6)	(1,184.3)
Cash, cash equivalents and restricted cash, beginning of period	1,361.5	2,475.1
Cash, cash equivalents and restricted cash, end of period	1,026.9	1,290.8
Supplemental non-cash disclosures
Issuance of common shares related to the acquisition of CBAM	0	194.5
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents	1,010.1	1,290.2
Restricted cash	16.8	0.6
Total cash, cash equivalents and restricted cash, end of period	1,026.9	1,290.8	$ 1,361.5
Cash and cash equivalents held at Consolidated Funds	228.8	168.9
Consolidated Operating Entities \| MRE
Cash flows from investing activities
Proceeds from corporate treasury investments	$ 20.1	$ 0